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ABSTRACT 
The human macrophage cell line U93 7 was investigated as an in vitro model for human 
macrophage function in mycobacterial infections. This involved evaluating the ability of 
differentiated U937 cells to phagocytose Mycobacterium tuberculosis, control' intracellular 
mycobacterial growth, and present mycobacterial antigens to human I-Il..A class I-matched 
cytotoxic T lymphocytes (CTLs) . 
Differentiation of U937 cells usmg IFN-y, l,25-(0H)2 vitamin D3, or PMA significantly 
enhanced their ability to phagocytose M. tuberculosis but failed to induce a subsequent 
respiratory burst response. Following infection, U937 cells were found to be pennissive to the 
intracellular growth of both the virulent H37Rv strain of M tuberculosis and the attenuated 
vaccine strain of M. bovis BCG. U937 cells have been shown to constitutively express high 
levels of cell surface HLA class I while expressing undetectable levels of HLA class II both at 
the mRN A level and at the cell surface. I-Il..A class II expression was neither up-regulated 
following infection with M. tuberculosis nor inducible using IFN-y, l,25-(0H)2 vitamin 0 3, 
PMA, GM-CSF or a combination of these agents. In contrast, chronic infection of U937 cells 
with virulent H37Rv M. tuberculosis (but not with BCG) resulted in the cell surface expression 
of HLA class I being significantly up-regulated. Taken together, these characteristics made 
U93 7 cells a very attractive model for further investigations into their ability to present 
mycobacterial antigens to human HLA class I-restricted CTLs. 
Differentiation of U937 cells was found to completely abrogate their sensitivity to non-antigen 
specific cytolysis mediated by NK or LAK cells. Following infection with M. tuberculosis, 
U937 target cells were lysed by M. tuberculosis-primed CTLs from HLA class I-matched 
donors in an antigen-specific manner and with a similar efficiency to autologous macrophage 
targets. This cytolytic activity was restricted to live organisms since only U937 cells infected 
with virulent H37Rv M. tuberculosis and BCG but not those pulsed with soluble PPD were 
lysed by the HLA class I-matched effector cells . On the other hand, M. tuberculosis-
stimulated but ALA-mismatched CTLs failed to lyse infected U937 cells in an antigen-specific 
manner. T cell subset fractionation of the HLA class I-matched M. tuberculosis-primed CTL 
iv 
population and limiting dilution cloning demonstrated that the cytolytic activity was mediated 
by CD8 + cytolytic T cells and confirmed that CD4 + T cells showed no significant ability to 
lyse infected U937 target cells. Furthermore, this study found that M. tuberculosis-infected 
U937 target cells were lysed by CD8 + CTLs more rapidly and strongly than similarly infected 
autologous macrophage targets demonstrating the sensitivity of this in vitro model as an 
indicator for CD8 + cytolytic function in mycobacterial infections. 
M. tuberculosis-infected U937 cells were found to be highly sensitive to mycobacterial antigen-
specific cytolysis mediated by yf/ CTL. Mycobacterial antigen-specific y8~ CTLs consistently 
showed stronger cytolytic activity against infected U937 target cells than cos· CTL but were 
not restricted to classical HLA class I or class II molecules. A panel of cytolytic human M 
tuberculosis-reactive y8 • CTL clones was established to investigate more thoroughly the role of 
y8 · CTL lytic activity in human mycobacterial infections. This study examined the mechanism 
of cellular cytotoxicity used by these mycobacterial-specific y8+ CTL clones against infected 
U93 7 targets and further investigated the effect of y8+ T cell-mediated cytolysis on intracellular 
mycobacterial survival. Cytolysis mediated by the y8+ T cell clones was found to be dependent 
on cell-to-cell contact. Furthermore, the ability of the y8+ CTL clones to lyse infected targets 
was found to be strongly Ca2 • -dependent, sensitive to cyclosporine A (a specific inhibitor of 
granule exocytosis ), and completely abrogated following Sr2+ -induced de-granulation of the y8+ 
T cell effectors, indicating that cytoxicity was mediated predominantly by the granule 
exocytosis/perforin pathway. Despite being strongly cytolytic against infected U937 cells, 
however, the y8+ CTL clones did not have any impact on the survival of intracellular M 
tuberculosis. 
The major conclusions of this study are that U93 7 cells not only provide a useful in vitro human 
macrophage model allowing for selective evaluation of filA class I-restricted CD8+ CTL 
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Chapter 1 Literature Review 2 
1.1 INTRODUCTION 
Tuberculosis is the leading infectious cause of death world wide, being responsible for 3 
million deaths annually. Among those aged over 5 years, tuberculosis kills more people than 
AIDS, malaria, diarrhoea, leprosy and all other tropical diseases combined (WHO, 1994) . 
The tragedy of this situation is that treating tuberculosis is one of the most effective and 
inexpensive of all health interventions (WHO, 1994). It has been estimated that one-third 
(approximately 1. 7 billion) of the world's population are infected with Mycobacterium 
tuberculosis with 60 million people developing clinical symptoms (WHO, 1997) and about 7.3 
million new cases arising every year (Raviglione et al., 1997). The tuberculosis morbidity and 
mortality figures in South Africa are presently regarded as one of the highest in the world and 
the WHO has categorized South Africa as one of 16 countries hampering global efforts to 
control tuberculosis (WHO, 1998). In 1998, the South African National Department of Health 
reported that South Africa has 108 382 confirmed cases of tuberculosis (251 cases per 100 000 
population). Compared to the 21 337 cases reported in the USA during the same year (Centers 
for Disease Control and Prevention, United States, 1997), these figures are alarming . The 
Western Cape region of South Africa has a rate of pulmonary tuberculosis that is 170 % higher 
than the national figure (South African National Department of Health, 1991) with prevalence 
rates being as high as 1 505 per 100 000 population (Mizrahi, 1998). Worsening the crisis is 
the emergence of multi-drug resistant (MDR) strains of M. tuberculosis that are resistant to the 
major, and sometimes all, conventional antibiotics used to treat the disease. 
It is widely accepted that the clinical manifestations and outcome of tuberculosis in infected 
individuals is determined not only by the innate virulence of the tubercle bacillus but also by 
the host's immune response. It has been estimated that the overwhelming majority (90-95 %) 
of individuals infected with M. tuberculosis never progress towards clinical disease (Bloom and 
Murray , 1992). Some will develop active disease later , however, in the event of some form of 
immune impairment such as that caused by HIV infection, malnutrition, or advanced 
malignancy . Furthermore, active tuberculosis in the pre-antibiotic era was not always fatal and 
a substantial proportion of patients eventually recovered without specific therapy (Weisner, 
Chapter 1 Literature Review 
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1922; Mitchell, 1955; Stephens, 1941). Even today, a small subset of patients with MDR-
tuberculosis will recover (Turett et al., 1995; Park et al., 1996) . 
Despite the long history of tuberculosis and the existence of various effective treatments, there 
are still significant areas within the basic immunology of this infection that need to be 
elucidated. With renewed interest in this disease, information on the precise mechanisms of 
immune protection against tuberculosis is emerging. 
1.2 CELL-MEDIATED IMMUNITY IN TUBERCULOSIS 
Infection with M. tuberculosis triggers a broad spectrum of immune responses with efficient 
cell-mediated immunity (CMI) being pivotal to effective recovery from tuberculosis. 
Individuals with defective CMI (such as those infected with HIV or chronic renal failure) are 
significantly more susceptible to infection with M tuberculosis, whereas individuals with 
defective humoral immunity (such as those with sickle cell disease or multiple myeloma) show 
no increased predisposition to tuberculosis (Barnes et al., 1994). Macrophages and T cells in 
particular have been found to be key elements in the CMI response to tuberculosis (Orme and 
Collins, 1984). Macrophages play a dual role in tuberculosis, however, since they promote 
protection against the disease but also provide the preferred biotype of M tuberculosis 
(Kaufmann and Andersen, 1998). In the same way, T cells are critical for protective immunity 
but also contribute to the pathology of the disease. A co-ordinated interaction between T cells 
and macrophages is essential for optimum protection against tuberculosis and this is best 
achieved in the granulomatous lesion (Chan and Kaufmann, 1994). Within a granuloma, the 
intricate interplay between T cells, cytokines and macrophages succeed in containing pathogenic 
mycobacteria (Kaufmann and Andersen, 1998). 
Tuberculosis is typically a disease of the lung, being the maJor port of entry, the site of 
mycobacterial persistence, and the location of disease outbreak and manifestation (Kaufmann 
and Andersen, 1998). The disease is transmitted from one individual to another by coughing, 
sneezing and during speech and the principle risk factor for becoming infected with M 
tuberculosis is through inhalation of infectious particles (Bloom and Murray, 1992). A sneeze 
Chapter I Literature Review 
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may contain over a million particles with diameters of less that 100 µm that may carry between 3 
to 10 tubercle bacilli . Of the inhaled bacilli, it has been estimated that only 6% will reach the 
alveoli and produce tubercles while the majority of larger particles will settle in the upper 
respiratory mucosa and be expelled by the ciliated respiratory escalator. It has been estimated 
that the only particles able to remain suspended in the air-stream long enough to reach the 
alveolar spaces will contain no more than 3 bacilli (Riley et al. , 1995; Wells, 1955). 
Furthermore, the number that must be inhaled to establish infection is probably between 10 and 
50 infectious units (Lurie, 1964; Riley et al. , 1962). Once M tuberculosis reaches the alveolus, 
alveolar macrophages phagocytose the bacillus and often destroy it, Destruction depends on 
both the inherent microbicidal activity of the macrophage as well as the virulence of the invading 
organism (Lurie, 1964; Dannenberg & Tomashefski, 1988; Dannenberg, 1991). 
If the original alveolar macrophage does not inactivate or destroy the inhaled organisms at this 
point, the bacilli multiply until that macrophage bursts. The released bacterial load is then 
ingested by other alveolar macrophages and/or by non-activated monocytes/macrophages that 
have emigrated from the blood stream resulting in the formation of a primary granuloma. Both 
types of macrophages are attracted to the site by released bacilli, cellular debris, and a variety of 
chemotactic factors released by the host. Macrophages from the circulation eventually become 
completely responsible for the fate of the early lesion. In the early lesions, the alveolar 
macrophages rarely participate because they remain peripheral, far from the centrally located 
bacilli. The newly recruited macrophages from the bloodstream phagocytose the released bacilli. 
Because macrophages have not yet been activated during this early stage of infection, the disease 
is poorly controlled with the bacilli multiplying exponentially despite the increasing number of 
macrophages being recruited and accumulating in the lesion. 
As the pnmary granuloma develops and matures, logarithmic mycobacterial multiplication 
becomes static and the lesions undergo caseous necrosis in their centres. The bacillus can 
survive in this solid caseous material but cannot multiply because of the anoxic conditions, 
reduced pH, and the presence of inhibitory fatty acids (Poole and Florey, 1970; Hemsworth and 
Kochan, 1978). The host thus locally destroys its own tissues in order to control the uninhibited 
multiplication of bacilli that would otherwise be fatal (Canetti, 1955; Poole and Florey, 1970; 
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Dannenberg, 1991). Only after such control has been established can the activated macrophages 
that accumulate around the caseous focus prevent the disease spreading. Both the macrophage 
turnover rate and the accumulation of activated macrophages have peaked when T cell-mediated 
responses first develop. Within this now productive granuloma, the T cells come into close 
contact with infected macrophages at various differentiation and activation states. CD4+ T cells 
are the predominant T cell subset within the granuloma. They function to induce 
mycobacteriostatic activity in macrophages at the centre of the granuloma by releasing 
interferon-y (IFN-y), tumour necrosis factor-a (TNF-a) and 1,25-dihydroxyvitamin D3 (Denis, 
1991 ; Rook et al., 1987). These productive granulomas are also surrounded by mantle of CD8+ 
cells. Cytolysis of poorly bactericidal or incapacitated macrophages by CD8+ and CD4+ 
cytotoxic T lymphocytes (CTLs) may directly impact on mycobacterial survival (De Libero et 
al. , 1988) but will also facilitate release and subsequent uptake of multiplying bacilli by more 
efficiently activated macrophages. The presence of yf/ T cells within the developing granuloma 
is clearly demonstrable but their role is poorly understood (Inoue et al., 1991; Modlin et al., 
1989). In the majority of healthy individuals, the productive granuloma will successfully contain 
M tuberculosis at this stage within distinct foci and prevent dissemination and progression 
towards active disease (Kaufmann and Young, 1992). 
1.2.1 THE ROLE OF MACROPHAGES IN TUBERCULOSIS 
Because the alveolar macrophage is one of the first lines of defence encountered by M 
tuberculosis once it reaches the lower respiratory tract, it is likely that this interaction plays a key 
role in determining the outcome of infection. Alveolar macrophages and blood-derived 
monocytes/macrophages participate in defence against mycobacterial infection by fulfilling four 
important functions : (i) they are capable of phagocytosing M tuberculosis efficiently; (ii) they 
are capable of producing proteolytic enzymes and other metabolites following phagocytosis that 
exhibit mycobactericidal effects; (iii) they process and present antigens derived from M 
tuberculosis to T cells; and (iv) macrophages produce a characteristic pattern of cytokines in 
response to M tuberculosis infection that have the potential to exert potent immunoregulatory 
effects and mediate many of the clinical manifestations of tuberculosis (Valone et al., 1988; 
Toossi et al., 1991 ; Barnes et al. , 1992; Zhang et al., 1993 ; Barnes & Modlin, 1994). 
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Binding and phagocytosis of M tuberculosis by monocytes and macrophages 
Mycobacterial uptake by macrophages is generally accepted to be a macrophage-determined 
event that is initiated by direct bacterial binding to specific macrophage receptors (reviewed 
recently by Ernst, 1998). The most widely studied of these are the complement receptors (CRl, 
CR3 and CR4; Schlesinger et al., 1990; Schlesinger and Horwitz, 1991), mannose receptors 
(Schlesinger, 1993), surfactant receptors (Downing et al., 1995), scavenger receptors (Zimmerli 
et al., 1996), and CD14 (Pugin et al., 1994). Fe receptors (FcR) and the ~-glycan receptor do not 
seem to be of major importance in mediating binding of M tuberculosis (Schlesinger et al., 
1990; Czop et al. , 1991). 
Complement receptors 
Like many other bacteria, M tuberculosis can activate the alternative pathway of complement, 
resulting in opsonization with C3b and C3bi (Schlesinger et al., 1990). Bacilli that are 
sufficiently coated with these serum-derived ligands bind to CRl (CD35), CR3 (CD1 lb/CD18), 
and CR4 (CD11c/CD18) and are subsequently phagocytosed in membrane-bound phagosomes 
(Schlesinger, 1993; Schlesinger et al., 1990). Unlike other bacteria (such as Leishmania 
mexicana, Staphylococcus aureus, and Listeria monocytogenes), however, virulent mycobacteria 
have evolved additional mechanisms for acquiring opsonic C3. Pathogenic mycobacteria 
uniquely recruit the complement fragment C2a to form a C3 convertase and generate opsonically 
active C3b in the absence of early activation components of the alternative or classical pathways 
(Schorey et al., 1997). In addition, two recent studies provided evidence for association of 
mannose-binding lectin (MBL) with the surface of mycobacteria (Polotsky et al., 1997; Hoppe et 
al., 1997). MBL and its associated serine proteases can activate both the classical and the 
alternative complement pathways (Matsushita & Fujita, 1996). 
M tuberculosis can also bind to CR3 at two distinct sites on the receptor. Opsonized M 
tuberculosis binds CR3 at its C3bi binding domain, and nonopsonized M tuberculosis uses its 
endogenous capsular polysaccharide to interact with the ~-glucan binding site near the C 
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terminus of CD 11 b (Cywes et al., 1996, 1997). M tuberculosis can therefore exploit 
complement receptors through multiple mechanisms to bind to and enter macrophages. The 
mechanism and consequences that predominate in vivo may be determined by features of the 
individual bacterial strain (complement dependent or independent), the environment of the 
macrophage (such as the availability of complement proteins), and the state of differentiation or 
activation of the macrophage (Ernst, 1998). Although little is known about the trafficking of 
phagosomes that contain bacteria ingested by macrophages through complement receptors, it has 
been suggested that complement receptor-mediated entry of M tuberculosis may provide these 
pathogens safe passage into the macrophage by allowing them to circumvent the toxic release of 
reactive oxygen intermediates during the respiratory burst response (Wright and Silverstein, 
1983). 
Mannose receptors 
Mannose receptors (MR) have been implicated in mediating uptake of virulent stains of M 
tuberculosis (H37Rv and Erdmann) but not the avirulent strains (H37Ra) (Schlesinger, 1993). A 
well-characterised mycobacterial-ligand for MR is lipoarabinomannan (LAM), which 1s 
abundant, peripherally exposed and contains terminal mannose residues that interact with MR 
(Schlesinger et al. , 1994, 1996). LAM of both Erdman and H37Rv M tuberculosis contain core 
mannose units linked to long arabinose branches and Erdman differs from H3 7Ra LAM in that it 
contains mannose oligosaccharide "caps" on the arabinose saccharides at the terminal portions of 
the molecule. It is therefore possible that the involvement of MR in phagocytosis of virulent M 
tuberculosis strains relates to the presence of mannose "caps" that serve as ligands for this 
receptor (Chatterjee et al. , 1992). 
Surfactant protein A 
In addition to CR and MR, accumulating evidence exists for an important role for surfactant 
protein receptors in mediating bacterial binding. Sp-A is a member of the collectin family of 
proteins, which also includes mannose binding protein (MBP) and complement component Clq. 
Sp-A enhances macrophage binding and uptake of M tuberculosis, although the mechanism has 
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not been fully elucidated (Downing et al., 1995). Purified Sp-A binds directly to M tuberculosis 
H37Ra, and binding to the bacteria is dependent on calcium and on glycosylation of Sp-A 
(Pasula et al., 1997). There is evidence to suggest, however, that Sp-A can exert its function on 
M tuberculosis phagocytosis indirectly. Attachment of macrophages to Sp-A-coated surfaces 
enhances phagocytosis by FcRs, CRs and probably by MR.s (Tenner et al., 1989; Gaynor et al., 
1995). Because this mechanism extends to such structurally diverse receptors, it is improbable 
that Sp-A interacts physically with each of these receptors and it is more likely that this effect is 
exerted by Sp-A at a step in phagocytosis that is common to or downstream of these various 
receptors (Ernst, 1998). 
CD14 
The macrophage receptor CD 14 has also been implicated in mycobacterial binding. It is best 
known as the high-affinity receptor for lipopolysaccharide (LPS) of gram-negative bacteria. In 
mycobacterial infections, however, CD 14 has been shown to bind LAM of M tuberculosis. 
Furthermore, this binding has been shown to induce interleukin-8 (IL-8) secretion by 
macrophages (Pugin et al., 1994). 
Scavenger receptors 
Macrophage scavenger receptors bind polyanionic particles, including LPS of gram-negative 
bacteria and lipoteichoic acid of gram-positive bacteria (Krieger et al., 1993; Dunne et al., 1994). 
Class A scavenger receptors have recently been identified as important in the binding of M 
tuberculosis to human monocyte-derived macrophages (Zimmerli et al., 1996). Whether 
scavenger receptors directly activate the macrophage cytoskeleton to internalise mycobacteria, or 
whether these receptors act only to bind bacteria with phagocytosis being mediated by other 
receptors remains to be seen (Ernst, 1998). 
It is likely that a particulate target such as M tuberculosis, that displays numerous and diverse 
ligands on its surface, engages multiple receptor types simultaneously. Thus, in vivo, M 
tuberculosis is probably not internalised by macrophages using a single receptor-mediated 
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pathway. The degree of differentiation or the state of activation of the macrophage may also bias 
the receptors used by M tuberculosis to gain entry. Distinct types of receptors may also co-
operate to optimise binding and internalisation of a target particle. Co-operation between CRl 
and CR3 has been demonstrated in the binding of complement-opsonised particles (Sutterwala et 
al. , 1996), and co-operation between phosphatidylinositol glycan-linked FcyRs and CR3 
markedly enhances phagocytosis of IgG-opsonized targets (Krauss et al. , 1994). Such co-
operation may account for phagocytosis of particles bound to receptors that lack transmembrane 
and cytoplasmic domains, such as CD 14 (Ernst, 1998). 
Receptor choice and intracellular fate 
Certain intracellular pathogens exploit specific macrophage receptors to ensure their own 
survival. Leishmania major, for instance, activates the alternative complement pathway to 
deposit C3b on its surface (Mosser and Edelson, 1987). When C3b-opsonized L. major 
metacyclic promastigotes bind to CRl , they survive and replicate successfully within the 
macrophage. When non-infective L. major promastigotes enter macrophages through the lectin-
like domain of CR3, however, they are killed (Da Silva et al., 1989). Similarly, while 
Salmonella typhi entering macrophages through CR3 become enclosed in a vacuole that 
eventually fuses with lysosomes, entry via CRl allows S. typhi to survive in a phagosome which 
does not acquire lysosomal markers (Ishibashi and Arai, 1990). These observations suggest that 
successful pathogens may ensure their survival within macrophages by gaining entry using a 
receptor-mediated pathway that is not coupled to the activation of macrophage antimicrobial 
mechanisms. There have only been a limited number of studies investigating whether M 
tuberculosis uses such a mechanism to facilitate its own intracellular survival. By using 
monoclonal antibodies or competitive ligands to block CRl, CR3, CR4, MR, and class A 
scavenger receptors during initial entry of M tuberculosis into human macrophages, no apparent 
difference in the extent of survival or rate of intracellular growth of the virulent Erdman strain 
was observed (Zimmerli et al. , 1996). Earlier studies have shown, however, that entry of M 
tuberculosis via the CR pathway may provide the bacterium safe passage into the macrophage by 
allowing it to avoid the toxic consequences of a respiratory burst (Wilson et al. , 1980; Wright 
and Silverstein, 1983; Yamamoto and Johnston, 1984). 
Chapter 1 Literature Review 
10 
Activation of macrophage anti-mycobacterial mechanisms 
Once M tuberculosis has gained entry into the macrophage and become engulfed within 
phagosomes, they are confronted with a variety of macrophage mycobactericidal and/or 
mycobacteriostatic mechanisms aimed at limiting their intracellular growth. The ability of 
infected macrophages to produce reactive oxygen intermediates (ROI) by oxidative metabolism 
and reactive nitrogen intermediates (RNI) by the L-arginine-dependant cytotoxic pathway are the 
two best-characterized mechanisms. 
Reactive oxygen intermediates 
Early reports indicated that ROI (such as superoxide anions and hydrogen peroxide molecules) 
generated during oxidative metabolism are important components of host defence against a wide 
variety of microorganisms. It has been demonstrated that (i) low virulence of M tuberculosis in 
guinea pigs is correlated with the susceptibility of this bacterium to peroxide (Mitchison et al., 
1963); (ii) peroxide sensitive mutants of M tuberculosis fare far less well in the lungs of guinea 
pigs than peroxide resistant strains (Jacket et al., 1981); and (iii) addition of catalase abolishes 
killing of M microti by murine macrophages activated with a lymphocyte culture supernatant 
(Walker ·and Lowrie, 1981). Circumstantial evidence in humans comes from the clinical 
observation that patients whose macrophages cannot mount an oxidative burst because of chronic 
granulomatous disease are more at risk of developing complications due to mycobacterial 
infection (Sbarra and Kamovsky, 1959; Iyer et al. , 1961 ; Klebanoff, 1980). Macrophages from 
these patients can, however, be activated to mount an enhanced respiratory burst that does not 
concomitantly enhance their antimycobacterial activity (Rook et al. , 1986). 
More recent investigations have shown, however, that ROI have only a limited role to play in 
host defense against M tuberculosis. Flesch and Kaufmann ( 1988), for example, infected murine 
bone marrow-derived macrophages with M bovis BCG and determined the ability of these 
macrophages to inhibit mycobacterial growth in the presence and absence of scavengers of toxic 
oxygen species. In cell-free conditions, hydrogen peroxide, but not superoxide anions or 
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hydroxyl radicals, inhibited the growth of mycobacteria. They found, however, that growth 
inhibition of BCG was not reversed to any significant extent when superoxide dismutase or 
catalase was added to macrophages infected with BCG and stimulated with IFN-y. 
While the ability of ROI to restrict intracellular mycobacterial growth is unclear, the ability of 
various mycobacterial species to actively scavenge these toxic oxygen species has been clearly 
demonstrated. Several reports have implicated a variety of mycobacterial components or 
products, including LAM, sulfatides, and phenolicglycolipid I (PGL-I) . LAM is a major cell 
wall-associated, phosphotidylinositol-anchored complex lipopolysaccharide produced by M 
tuberculosis in large amounts (Hunter et al. , 1986; Hunter and Brennan, 1991). Two 
mechanisms have been proposed by which LAM may be capable of inactivating the toxic ROI-
mediated onslaught. Firstly, LAM has been shown to be an effective ROI scavenger; and 
secondly, LAM can down regulate the oxidative burst by inhibiting the activity of protein kinase 
C (an enzyme which plays an important role in activation of the oxidative burst in phagocytic 
cells; Chan et al. , 1991). Both PGL-I and sulfatides also demonstrate the in vitro capacity to 
down regulate ROI production in macrophages and PGL-I has been found to directly scavenge 
oxygen radicals in a cell-free system (Chan et al. , 1989). While the sulfatides are widely 
expressed among the different strains of M tuberculosis (Middlebrook et al., 1959; Goren et al. , 
1974, 1976), the expression of PGL-I is more restricted (Brennan et al. , 1990). In addition to 
these mycobacterial components, the most abundant proteins secreted by M tuberculosis in 
short-term culture is superoxide dismutase and catalase (Andersen et al. , 1991 ). 
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Reactive nitrogen intermediates 
Chan et al. (1992) demonstrated that murine macrophages stimulated with either IFN-y, LPS or 
TNF-a are capable of inhibiting the growth of M tuberculosis using a mechanism that is 
independent of the respiratory burst and ROI generation. They found that the antimycobacterial 
activity of these macrophages seemed to correlate with induction of L-arginine-dependent 
production of toxic nitrogen species, including nitric oxide (NO), nitrogen dioxide (N02), and 
nitric acid (HN03) . A number of studies have demonstrated that RNI contributes to the activity 
of murine macrophages against M tuberculosis (Denis, 1991; Chan et al., 1992), M bovis BCG 
(Flesch and Kaufmann, 1991), M leprae (Adams et al., 1991) and M avium (Doi et al., 1993). 
More recently, knockout mice containing an interferon regulatory factor (IRF-1) gene deletion, 
and whose macrophages are subsequently incapable of releasing NO, were shown to rapidly 
succumb to BCG infection (Kamijo et al. , 1994). MacMicking and colleagues (1997) recently 
confirmed that mice lacking the ability to produce inducible NO synthase (iNOS -/- knockout 
mice) showed more rapid M tuberculosis replication and had a greater bacterial load than their 
wild-type littermates. Some evidence for up regulation of iNOS in alveolar macrophages from 
human patients with tuberculosis has also been presented recently (Nicholson et al., 1996). 
Apoptosis 
Another potential mechanism involved in macrophage defense against M tuberculosis is 
apoptosis or programmed cell death. Placido et al. (1997) reported that virulent M tuberculosis 
H37Rv induces apoptosis in a dose-dependent manner in BAL cells recovered from tuberculosis 
patients. Klinger et al. (1997) have demonstrated that apoptosis associated with tuberculosis is 
mediated through a down-regulation of bcl-2, an inhibitor of programmed cell death. 
Furthermore, Molloy et al. ( 1994) have shown that apoptosis of macrophages is associated with 
reduced viability of intracellular mycobacteria. 
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1.2.2 MYCOBACTERIAL LOCALIZATION AND ANTIGEN PRESENTATION 
Macrophages have evolved two clearly defined pathways for the processing of exogenous and 
endogenous antigens (Fig. 1.1 ). The first being the filA class I or endogenous antigen 
processing pathway (Fig. 1. la) wherein peptides derived from endogenous proteins are presented 
to CD8+ T cells by filA class I molecules. The second being the filA class II or exogenous 
processing pathway (Fig. 1.1 b) wherein peptides derived :from extracellular sources are presented 
to CD4+ T cells in association with filA class II molecules (Germain, 1994). In general, M 
tuberculosis follows the filA class II processing pathway which predominantly elicits a CD4+ T 
cell response (Kaufmann and Flesch, 1986; Ottenhoff et al. , 1988; Barnes et al., 1989; reviewed 
by Kaufmann and Andersen, 1998). 
More recent studies have demonstrated several additional antigen processing pathways operative 
within professional phagocytes. Alternative filA class I pathways have been described that 
facilitate the filA class I presentation of exogenously derived antigens to CD8+ CTLs (Pfeifer et 
al., 1993; Kovacsovics-Bankowski et al. , 1993; Harding and Song, 1994; Kovacsovics-
Bankowski and Rock, 1995). Abundant evidence for CD8+ CTL activity in both murine and 
human tuberculosis provides evidence for the existence of such a pathway in mycobacterial 
infections (Bonato et al. , 1998; Silva et al. , 1996; De Libero et al. , 1988; Turner & Dockrell, 
1996; Tan et al. , 1997; Lalvani et al. , 1998; Lewinsohn et al. , 1998). The processing pathway 
used by the non-classical, highly conserved CD 1 molecules to present non-proteinaceous 
mycobacterial antigens to CD8+ and CD4-CD8- a~ T cells represents another alternative to the 
classical filA class I and II processing pathways (Jullien et al. , 1996). Finally, presentation of 
antigens to yf/ T cells does not require filA class I or class II processing and neither is yf/ T 






















The classical HLA class I and class II antigen processing pathways. (a) HLA class I molecules 
acquire antigenic peptides derived from antigens present in the cytoplasm. In the endoplasmic reticulum (ER), 
newly synthesized HLA class I heavy chains bind Pr microglobulin. The assembled class I heterodimer then 
associates with the transporter associated with antigen processing (TAP) and awaits a peptide. Peptides, generated 
from proteins in the cytosol by the proteasome, are transported into the ER by TAP. After binding peptide, class I 
molecules dissociate from TAP and are transported by the default exocytic pathway to the plasma membrane. 
Peptides are presented to CD8+ CTL's bearing the appropriate T cell receptor. (b) HLA class II molecules, in 
contrast, acquire antigenic peptides derived from antigens that are internalized in the endocytic pathway. Newly 
synthesized HLA class II heterodimers assemble in the ER with invarient chains (Ii) . At the trans-Golgi network, 
these complexes are targeted to HLA class II compartments in the endocytic pathway due to targeting signals within 
the Ii cytoplasmic tail . There, the HLA class II associated Ii is degraded leaving CLIP (class II associated invariant 
chain peptide) associated with the HLA class II peptide binding groove. CLIP can then be exchanged for antigenic 
peptides, a process catalyzed by HLA-DM molecules. Peptide loaded HLA class II complexes are then transported 
to the plasma membrane for presentation to CD4+ T cells. In most cells, proteins in the extracellular fluids do not 
intersect the HLA class I processing pathway but follow the classical HLA class II antigen processing pathway 
(adapted from Engelhard, 1994; Pieters et al. , 1997; and Rock, 1996) 
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The HLA class II processing pathway and CD4+ T cells 
Internalized exogenous antigen initially enters early endosomes, then late endosomes, and finally 
lysosomes (Neefjes & Ploegh, 1992). A gradient of pH is observed between early endosomes 
(pH 6.0-6.5), late endosomes (pH 5.5), and lysosomes (pH 4.5-5 .0) because of the action of 
ATP-dependent proton pumps in the endosomal membrane which pump W from the cytosol into 
these compartments. It has been suggested that the pH gradient results in the activation of 
different proteases in these cellular compartments (Forquet et al., 1993). Proteolytic degradation 
of exogenous antigens begins once they enter endosomes and continues to the lysosomes 
(Guagliardi et al. , 1990). The exact endocytic compartment in which HLA class II molecules 
bind to antigenic peptides still remains unclear, however. After peptide binding to Ml-IC class II, 
the assembled complexes move towards the plasma membrane of the APC where they can be 
recognised by CD4+ T cells. Studies have shown that CD4+ T cells can become activated by as 
few as 100 to 200 peptide-HLA class II complexes on the APC surface (Demotz et al., 1990; 
Harding & Unanue, 1990). 
Mycobacterial intracellular trafficking and inhibition of phagosome-lysosome fusion 
Once M tuberculosis has become engulfed by the macrophage, the intracellular bacteria reside 
in membrane-bound phagosomes. Even if the organism is capable of surviving the onslaught of 
both ROI and RNI, it is confronted with the usual fate of phagocytosed material which are 
earmarked for the classical exogenous processing pathway and eventually undergo degradation 
in lysosomes, highly acidic compartments filled with hydrolases and other noxious products. It 
is thus not surprising that facultative intracellular pathogens, including M tuberculosis, have 
evolved a variety of strategies to avoid this pathway of destruction. Intracellular pathogens 
follow one of three general pathways within the host cell leading either to escape into the 
cytoplasm (Trypanosoma cruzi and Listeria monocytogenes); residence in a phagolysosome 
(Leishmania donovani and Coxiella burnetti) ; or residence in a phagosome that does not fuse 
with lysosomes. Although it is generally accepted that M tuberculosis resembles several other 
intracellular pathogens (including Legionella pneumophila, Toxoplasma gondii and Chlamydia 
psittaci) in following the latter pathway and residing in non-fused phagosomes, there have also 
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been isolated reports suggesting that mycobacteria exhibit haemolytic activity (King et al., 1993) 
and demonstrate restricted ability to escape into the cytoplasm (McDonough et al. , 1993; Myrvik 
et al. , 1984). 
The lack of mixing between M tuberculosis phagosomes and lysosomal compartments in 
macrophages was first thoroughly documented in the classical studies by Armstrong and Hart 
(1971) . While early studies described the ability of sulphatides produced by virulent M 
tuberculosis to block the maturation of phagosomes to lysosomes, this observation turned out to 
be an artifact associated with entrapment of markers in polyanionic colloids (Goren et al., 1976; 
1987). Instead, attention has been turned to the inhibition of phagosomal-lysosomal fusion by 
mycobacterial products, such as ammonia which is found to accumulate in M tuberculosis 
culture filtrates at concentrations of up to 20 mM (Gordon et al. , 1980). Later studies 
demonstrated that live M tuberculosis reside within non-acidified vacuoles (pH 6.0-6.5; Crowle 
et al., 1991). Strugill-Koszycki and colleagues (1994) have subsequently demonstrated the 
selective exclusion of vescicular proton-ATPase on mycobacterial phagosomes. The proton 
translocating ATPase is usually present on the majority of vesicles of endocytic and exocytic 
pathways that become acidified to varing degrees, but appears to be absent on mycobacterial 
phagosomes. The precise trafficking events underlying this exclusion are not yet known, and it 
is not clear whether additional factors may play a role in modulating the pH of the phagosome. 
It is possible that the Na+/K+-ATPase persists on the M tuberculosis phagosome, thereby 
counteracting the action of the proton pump (Clemens, 1996). 
Although little is known about the precise trafficking events followed by mycobacterial vesicles, 
clues have been provided by investigations into the distribution of several markers on 
mycobacterial phagosomes (reviewed recently by Deretic et al., 1997; and Clemens, 1996). The 
distribution of markers such as HLA molecules, transferrin receptors, late endosomal and 
lysosomal markers and rab proteins on mycobacterial phagosomes are best understood relative to 
the intracellular fates of either inert particles (such as latex beads) or L. pneumophila (Fig. 1.2) . 
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HLA molecules 
The M tuberculosis phagosomal membrane shows relatively slow clearance of HLA class I 
molecules. Phagosomes containing latex beads or L. pneumophila, by comparison, show 
comparatively rapid HLA class I clearance with levels being barely detectable a day after 
phagocytosis (Clemens & Horwitz, 1992, 1993). Clemens and Horwitz (1995) demonstrated that 
HLA class II molecules also persisted on the mycobacterial phagosomal membrane. Whereas 
HLA class I molecules disappeared from the M tuberculosis phagosome later than 2 days after 
phagocytosis, HLA class II molecules were still detectable on the phagosome 5 days post-
phagocytosis. These HLA class II molecules may initially be acquired from both the plasma 
membrane internalised during phagocytosis and the interaction of the M tuberculosis phagosome 
with HLA class II-containing endocytic vesicles at a later stage. By comparison, phagosomes 
containing mature L. pneumophila or latex beads have negligible staining for HLA class II 
(Clemens, 1996). 
Tranferrin receptor 
Whereas mature phagosomes containing latex beads or L. pneumophila do not stain for 
transferrin receptor, this receptor is clearly detectable on M tuberculosis phagosomal membrane 
(Clemens & Horwitz, 1995; Strugill-Koszycki et al. , 1996). This suggests that, although 
mycobacterial phagosomes demonstrate limited fusogenicity with lysosomes, they do interact 
with other components of the intracellular trafficking pathway. 
The presence of LAM in vesicles outside mycobacterial phagosomes may be another indication 
that M tuberculosis phagosomes interact with the endocytic pathway (Xu et al. , 1994). This 
could, however, also be due to uptake of LAM from culture media or to degradation of dead 
mycobacteria. Russell and colleagues (1994, 1996) have also presented evidence to suggest that 
certain markers such as plasma membrane glycosphingolipids are able to traffic into and out of 
the mycobacterial phagosome. 
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FIGURE 1.2. Postulated relationship of the endosomal-lysosomal pathway to phagosomes containing 
Mycobacterium tuberculosis, Legione/la pneumophi/a or latex beads. L. pneumophi/a phagosomes interact 
minimally with the endosomal-lysosomal pathway and do not acquire endosomal or lysosomal markers. M 
tuberculosis phagosomes show a delayed clearance of HLA class I molecules and interact with endosomes, 
acquiring various endosomal markers including HLA class II, transferrin receptor molecules and modest amounts of 
lysosomal membrane glycoproteins (CD63 and LAMP-1). However, the M tuberculosis phagosome does not fuse 
with lysosomes and does not acquire the abundant amounts of lysosomal membrane glycoproteins present on 
lysosomes. Latex-bead-containing phagosomes, in contrast, fuse with lysosomes and acquire abundant amounts of 
lysosomal proteins (modified from Clemens, 1996). 
Late endosomal and lysosomal markers 
Both Clemens (1996) and Xu et al. (1994) have reported the presence of lysosomal membrane 
glycoproteins (LAMP) and cathepsin D in M tuberculosis-containing phagosomes. While Xu et 
al. (1994) reported intense staining, however, Clemens & Horwitz (1995) demonstrated reduced 
levels of LAMP and cathepsin D compared with the levels seen on latex bead phagosomes in the 
same cells. Based on their study, Clemens (1996) has suggested that the limited acquisition of 
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LAMP and cathepsin D is consistent with both the restricted fusogenicity of the mycobacterial 
phagosome and the retarded maturation of the phagosome along the endosomal-lysosomal 
pathway. Alternatively, these results may reflect altered trafficking events within the endosomal 
pathway upstream of lysosomes. This is alluded to by the recent report by Rohrer and colleagues 
(1996) which showed that a significant portion of newly synthesized LAMP molecules are sorted 
in the trans-Golgi network for delivery to early/sorting endosomes and the plasma membrane, 
with subsequent trafficking to late endosomes and lysosomes. In keeping with this model, it has 
been suggested that mycobacterial phagosomes acquire LAMP and cathepsin D prior to the 
scheduled addition of proton-ATPase to the vesicles (Deretic et al., 1997). In contrast to 
phagosomes containing M tuberculosis or latex beads and consistent with their ability to persist 
outside the endosomal-lysosomal pathway, L. pneumophila-containing phagosomes do not 
acquire staining for LAMP or cathepsin D (Clemens & Horwitz, 1995). 
Rab proteins 
Further clues to intracellular mycobacterial trafficking have been provided by a recent study of 
the distribution of small GTP binding proteins on the membranes of mycobacterial phagosomes 
(Via et al. , 1997). Members of the rab subfamily of small GIP-binding proteins control 
vesicular trafficking in various compartments of eukaryotic cells (Zerial and Stenmark, 1993). 
Along the subdivisions of the endocytic pathway, rab4, rab5 , rab7, and rab9 play distinct roles in 
regulating membrane fusion events (Zerial, 1995). For example, rab5 isoforms are associated 
with the plasma membrane and early endosomes and represent a rate-limiting factor in the 
process of membrane docking and fusion within the early endocytic pathway. Whereas rab4 is 
primarily involved in recycling steps (van der Slujis et al., 1992), rab7 appears to regulate 
transport from early to the late endosomes (Feng et al. , 1995). The recycling of mannose-6-
phosphate receptors from late endosomes back to the trans-Golgi network is stimulated by rab9 
(Riederer et al. , 1994). 
Compared to latex bead phagosomes which at first acquire and then gradually lose rab5 , Via et 
al. (1997) demonstrated that rab5 continues to accumulate on the membrane of mycobacterial 
phagosomes. Furthermore, the latex bead phagosomes later acquire rab7, reflecting phagosome 
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maturation towards late endosomes and lysosomes. By contrast, mycobacterial phagosomes do 
not acquire any appreciable amounts of rab7. It seems likely therefore that rab5 accumulation is 
possibly at the expense of rab7, defining the checkpoint that has been compromised in the 
process of mycobacterial phagosome maturation (Via et al., 1997). 
The mechanism that allows for mycobacterial control of phagosome maturation and inhibition of 
phagosome-lysosome fusion is probably multi-factorial. It has been proposed that these 
mechanisms may include the involvement of major mycobacterial cell wall constituents, bio-
active molecules secreted from viable intracellular mycobacteria, and the receptor pathway 
selected during phagocytosis (Clemens, 1996; Schlesinger, 1996). Regardless of the virulence 
determinants it uses to survive and multiply within the phagosome of host macrophages, M 
tuberculosis have demonstrated an ability to modify both the composition of their phagosomes 
and the interaction of these phagosomes with other host-cell organelles that presumably results in 
a more hospitable phagosomal compartments. By residing in a phagosome that retains some, 
albeit restricted, interaction with endosomes, M tuberculosis is also able to obtain both nutrients 
needed for intracellular growth and membrane components for its expanding phagosome 
(Deretic et al., 1997). 
Mycobacterial modulation of antigen presentation 
Because macrophages form part of a complex network by communicating with and alerting other 
components of the CMI response, particularly T cells, the ability of M tuberculosis to modify its 
intracellular phagosome and endosomal trafficking pathway is likely to have important 
implications with regard to mycobacterial antigen presentation. Pancholi et al. (1993) provided 
evidence for this by demonstrating that macrophages ' chronically' infected with BCG stimulated 
T cell proliferation poorly compared to cells infected for shorter periods of time, suggesting a 
defect in antigen presentation. Monocytes infected with M tuberculosis and concomitantly 
pulsed with tetanus toxoid (TT) have been found to present TT poorly and to inefficiently prime 
TT-specific T cell proliferation due to both reduced expression of HLA class II antigens and 
reduced accessory cell function (Gercken et al. , 1994). A 25-kDa M tuberculosis 
glycolipoprotein component has been reported to counteract the enhanced IFN-y or LPS-induced 
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expression of HLA class II molecules on monocytes (Wadee et al. , 1995). More recently, 
Hmama et al. (1998) demonstrated that diminished cell surface HLA class II expression in cells 
infected with M tuberculosis was due to intracellular sequestration of immature HLA class II 
molecules. M tuberculosis-infected macrophages from susceptible mice were found to have 
reduced expression of the co-stimulatory molecule B7 and increased expression of the adhesion 
molecule ICAM-1 . This was shown to result in T cell unresponsiveness, which appeared linked 
to prostaglandin synthesis in response to infection with live bacteria (Saha et al., 1994). 
Similarly, incubation of human macrophage cell lines with M tuberculosis or LAM results in 
increased expression ofICAM-1, which was partially due to secretion ofTNF-a (Lopez-Ramirez 
et al., 1994). Despite these mechanisms aimed at avoiding normal antigen presentation, a wide 
spectrum of T cell responses are elicited by M tuberculosis-infected macrophages. 
The dominance of CD4+ T cells in protective immunity to both murine and human tuberculosis 
has been clearly demonstrated (Kaufmann and Flesch, 1986; Ottenhoff et al., 1988; Barnes et al. , 
1989; reviewed by Kaufmann and Andersen, 1998). Mice depleted of CD4+ T cells prior to 
infection with avirulent BCG or virulent M tuberculosis are unable to control mycobacterial 
growth (Muller et al. , 1987; Pedrazzini et al. , 1987) and adoptive transfer of CD4+ T cells from 
sensitised animals confers protection against tuberculosis (Orme, 1987, 1988). Ladel and 
collaborators (1995) demonstrated that disruption of the HLA class II genes or of the gene for the 
~ chain of the a~+ TCR, resulting in a deficiency of CD4+ T cells, rendered mice more 
susceptible to mycobacterial infection. In humans, CD4+ T cells are selectively expanded at the 
site of disease in patients with tuberculous pleuritis (Barnes et al., 1989), and depletion of CD4+ 
cells by HIV infection markedly increases susceptibility to primary and reactivation tuberculosis 
(Barnes et al. , 1991 ). Furthermore, in HIV-infected tuberculosis patients, clinical indicators of 
severe disease, such as extrapulmonary involvement, mycobacteremia and positive acid-fast 
smears, become progressively more common as the CD4+ cell count declines (Jones et al., 1993). 
The two major functions mediated by CD4+ T cells in mycobacterial infections are their ability 
to produce protective cytokines in response to infection and their ability to directly lyse infected 
target cells in an HLA class II-restricted manner. Studies in mice have shown that protective, 
mycobacterial-reactive CD4+ T cells predominantly produce Th1-type cytokines, IFN-y and IL-2 
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(Huygen et al., 1992; Kaufmann & Anderson, 1998). Studies of human tuberculosis, however, 
have yielded conflicting results. Some authors found that the majority of mycobacterial-specific 
CD4+ T cell clones are Th1-like, producing high concentrations of IFN-y, but low concentrations 
ofIL-4 and IL-5 (Del Prete et al. , 1991 ; Haanen et al. , 1991). In contrast, others have reported 
that human M tuberculosis-specific CD4+ cells secrete a broad spectrum of cytokines, including 
IFN-y, IL-2, IL-4, IL-5 and IL-10 (Boom et al., 1991 ; Barnes et al., 1993a, 1993b). At the site of 
mycobacterial disease, however, mRNA for the Th1 cytokines IFN-y and IL-2 is greater in the 
tuberculous pleural fluid than in the peripheral blood, and concentrations of IFN-y are 15-fold 
higher than the serum concentrations (Barnes et al., 1993b ). Furthermore, expression of mRNA 
for the Th2 cytokine IL-4 was found to be lower in the pleural fluid than in the peripheral blood. 
An alternative mechanism by which CD4+ T cells may contribute to immune defense in 
mycobacterial infections is through direct cytolysis of macrophages and other phagocytic cells 
infected with M tuberculosis. Human M tuberculosis-specific CTLs cultured in vitro were 
found to be predominantly CD4+ (Ottenhoff and Mutis, 1990; Lorgat et al. , 1992), and M 
tuberculosis-specific cytolytic activity of CD4+ cells at the site of disease was found to be greatly 
enhanced compared to that of peripheral blood mononuclear cells (Lorgat et al. , 1992). 
The HLA class I processing pathway and CDS+ T cells 
The classical HLA class I processing pathway (Fig. 1.1) is operative in almost all cells and 
allows the immune system to monitor tissues for the presence of cytoplasmically-situated viral 
and bacterial infections, and tumours. Protein antigens in the cytosol are degraded primarily by 
proteosomes (large multicatalytic proteolytic particles), transported into the endoplasmic 
reticulum by the transporter associated with antigen processing (TAP) where they become 
associated with newly synthesized HLA class I heavy chain/f32-microglobulin (f32m) 
heterodimers (reviewed in Heemels & Ploegh, 1995; York & Rock, 1996). The 
peptide/f32m/class I heavy chain complexes are then routed through the Golgi complex and 
carried to the cell surface where they may be presented to CD8+ CTLs. 
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In most cells, exogenous antigens cannot be presented by filA class I because the antigens are 
unable to gain access to the cytosolic compartment (Moore et al. , 1988). And because filA 
class I generally present peptides to CTLs, whose effector function is best restricted to actively 
infected cells, it makes biological sense that these filA molecules should be limited in their 
ability to acquire peptides derived from proteins in the extracellular milieu (exogenous antigens) . 
This would help prevent healthy cells from becoming sensitised for CTL lysis by foreign, non-
infectious proteins released from neighbouring infected or transformed cells (Reis e Sousa and 
Germain, 1995). 
Because M tuberculosis is generally assumed to remain within the exogenous antigen processing 
pathway, within membrane-bound vacuoles, access of mycobacterial antigens to the classical 
filA class I processing pathway seems improbable. Despite this, several studies have emerged 
clearly demonstrating the protective role of CD8+ CTLs in mycobacterial infections. Adoptive 
transfer and cell depletion studies in vivo have demonstrated that CD8+ T cells are involved in 
controlling M tuberculosis infections (Orme & Collins, 1984; Orme, 1987; Muller et al. , 1987; 
Silva et al., 1994) and are required for immunologic memory (Hubbard et al., 1991). Mice with a 
disruption in the gene for CD8 were shown to be highly susceptible to infection with M 
tuberculosis (D' Sousa et al., 1998). Mycobacterium-specific CD8+ T cell lines and clones have 
been isolated from both M tuberculosis and BCG-immune mice and have been shown to directly 
lyse M tuberculosis-infected cells in an antigen-specific manner and restrict the growth of 
intracellular M tuberculosis (Bonato et al. , 1998; Silva et al. , 1996; De Libero et al. , 1988). 
Furthermore, mice with a targeted disruption in the f3 2-microglobulin gene, lacking functional 
CD8+ T cells, are significantly more susceptible to M tuberculosis but not BCG infection than 
their wild type litter mates (Flynn et al. , 1992; Ladel et al., 1995). These f32-microglobulin-
knockout mice were found to be able to form normal granuloma's but showed a ten-fold higher 
bacillary load in infected tissue when compared with control mice. This evidence is less 
compelling in light of the recent finding that f32-microglobulin also associates with the non-
classical CDl molecule, which is able to present antigen to both CD8+ CTLs (Stenger et al. , 
1997) and CD4-CD8- af3+ T cells (Beckman et al. , 1994). 
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Until recently, mycobacteria-responsive CDS+ T cells had only rarely been isolated from patients 
with tuberculosis (Rees et al., 1988) and little success had been achieved in determining the role 
ofHLA class I-restricted CDS+ T cells in human immunity to tuberculosis. Several studies have 
since emerged, however, demonstrating classical HLA class I-restricted mycobacterial antigen-
responsive CDS+ T cells which acquire activation markers following stimulation, are capable of 
mycobacterial-specific cytolytic activity and of IFN-y production (Lewinsohn et al., 1998; 
Turner & Dockrell, 1996; Tan et al., 1997; Lalvani et al. , 1998; Mohagheghapour et al. , 1998). 
Although both murine and human CDS+ T cells are capable of producing significant levels of 
IFN-y in response to M tuberculosis infection (De Libero et al. , 1988; Bonato et al. , 1998; 
Lalvani et al. , 1998; Lewinsohn et al. , 1998), evidence suggests that their strong cytolytic 
activity is more important for protective immunity in mycobacterial infections (Bonato et al., 
1998; Stenger et al. , 1997). 
Although isolated reports have suggested that intracellular M tuberculosis is able to escape into 
the cytoplasm (Leake et al. , 1984; McDonough et al., 1993), more recent studies have clearly 
shown that M tuberculosis resides exclusively within membrane-bound phagosomes (Xu et al. , 
1994; Clemens & Horwitz, 1995). The mechanism by which M tuberculosis antigens might 
gain access to the HLA class I presentation pathway is not well characterized. Mazzaccaro et al. 
(1 996) has demonstrated that infection with M tuberculosis is able to facilitate exchange of 
exogenous antigenic material between phagosomes and the cytoplasm. In a more recent study, 
Hess et al. (1998) made use of recombinant BCG expressing a biologically active listeriolysin 
fus ion protein of Listeria monocytogenes. They found that while this did not enable BCG 
egression into the cytoplasm of infected cells, it did facilitate improved HLA class I presentation 
of co-phagocytosed soluble protein compared with wild type BCG. 
The ability of exogenous antigens, such as M tuberculosis and its secreted products, to gain 
access to the HLA class I processing pathway has become an area of great interest with a number 
of recent reports describing alternative pathways for HLA class I processing (Pfeifer et al. , 1993; 
Kovacsovics-Bankowski et al. , 1993; Harding and Song, 1994; Kovacsovics-Bankowski and 
Rock, 1995). A significant body of evidence now exists to indicate that HLA class I processing 
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can occur independently of microbial egress1on into the cytoplasm (Pfeifer et al., 1993; 
Kovacsovics-Bankowski et al., 1993). 
Phagosomal "leakage " or indigestion model 
The mechanism by which exogenous antigens intersect the HLA class I processing pathway and 
become associated with HLA class I molecules is one of the most important issues that remains 
to be resolved. Some antigens have been found to escape from phagosomes into the cytosolic 
compartment, where they presumably enter the endogenous processing pathway as judged by the 
inhibitory effects of proteosomal inhibitors and brefaldin A (BF A blocks HLA class I trafficking 
through the Golgi ; Takahashi et al., 1990; van Binnendijk et al. , 1992; Aggarwal et al., 1990; 
Aldovini and Young, 1991; Stover et al., 1991 , 1993; Schafer et al., 1992; Rock, 1996). Little is 
presently known about this "leakage" from phagosome to cytosol; whether it is an energy 
dependent process regulated by specific transporters, whether it depends on unspecified damage 
to the vesicular membrane, or whether it represents an important in vivo event is unknown. The 
phagosome to cytosol transfer process has been demonstrated with (i) internalised toxins, which 
lack the capacity to penetrate membranes but still can enter the cytosol to act on ribosomes (Reis 
e Sousa and Germain, 1995; Norbury et al., 1995; Kovacsovics-Bankowski and Rock, 1995), (ii) 
fluoresceinated dextran and ISCOM-associated protein antigen, and (iii) in different intracellular 
microbial systems (Norbury et al. , 1995; Andrews, 1994; Morein et al. , 1994). Germain et al. 
(1996) and Jondal et al. (1996) proposed that HLA class I-presentation of some modified 
exogenous antigens may simply reflect a stochastic loss of phagosome integrity and leakage of 
antigen into the cytoplasm rather than the action of a novel intracellular transport system (Fig 
1.3). Consistent with this, Orme (1993) suggested that high mycobacterial load in chronically 
infected macrophages may result in disruption of the phagosomal membrane, facilitating the 
escape of mycobacterial proteins into the cytoplasm. 
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FIGURE 1.3 Access of exogenous antigen to the HLA class I pathway in a fraction of phagocytic cells. Cells 
given a low phagocytic 'dose' (upper left panel) internalise particles while preserving the integrity of the 
endocytic/phagocytic compartments (expanded view in lower left panel). In a small fraction of cells given a high 
phagocytic ' dose' (upper right panel), overloading of forming phagosomes leads to a leak of antigen into the cytosol 
because of incomplete membrane fusion events or rupture of the vesicle membrane ( expanded view in lower right 
panel) . Some leaks would permit escape of soluble material either cleaved from the particle by endosomal proteases 
or co-internalised during the phagocytic event. In some cases, entire particles may escape. Once in the cytosol, the 
antigen is available to the classical HLA class I processing and loading pathway, as with conventional endogenous 
antigens (reproduced from Germain et al. , 1996). 
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Transiting HLA class I loading model 
' Transiting HLA class I loading' has also been proposed as a possible mechanism whereby 
newly formed HLA class I molecules exchange the peptides they capture in the ER for 
exogenous antigens in vesicular compartments whilst on their way from the ER to the cell 
surface (Fig. 1.4b). It is controversial whether ' empty' HLA class I molecules can leave the ER 
and be loaded with peptides in a vacuolar compartment. Despite the fact that the peptide 
presentation capacity of such chaperoned HLA class I molecules remains to be determined, the 
invariant chain used for trafficking of HLA class II molecules has been shown to direct a subset 
of HLA class I molecules directly to the endocytic compartment (Sugita and Brenner, 1995). 
Endosomal compartment or recycling HLA class I loading 
An alternative to transiting HLA class I loading or antigen translocation into the cytoplasm 
would be HLA class I loading within the endosomal compartment (Fig. 1.4c). HLA class I 
molecules within the endosomal compartment could be derived by recycling from the cell 
surface, from the formation of membrane vesicles containing correctly positioned HLA class I 
molecules, or by direct transport from the ER (Jondal et al., 1996). Recycling of HLA class I 
molecules between the cell membrane and an endosomal compartment has been demonstrated in 
both T cells and macrophages and has been shown to exceed the de nova synthesis pathway in 
terms of membrane expression (Yewdell and Bennick, 1992; Reid and Watts, 1990). Phagocytic 
vesicles, derived from the plasma membrane, might contain peptide-receptive HLA class I 
molecules, or newly synthesised class I molecules might be directly transported to these with the 
help of chaperone proteins (De Bruijn et al., 1995). Eventually, these class I molecules might be 
transferred to an endocytic compartment by vesicular transport. Two recent studies have 
described a thermostable population of 'empty' HLA class I molecules expressed on the surface 
that binds neither antigenic peptides, nor exogenous ~2-microglobulin (Smith et al., 1993; 
Schirmbeck and Reimann, 1996). These presentation-incompetent HLA class 1-isoforms recycle 
through endosomal compartments where they seem to be assembled into presentation-competent 
complexes (Schirmbeck and Reimann, 1996). This class of ' empty', recycling HLA class I 
molecules may be involved in endolysosomal loading of peptides from endocytosed exogenous 
antigens. This pathway also points to the possibility that following presentation of a ' first 
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generation' of peptides (generated by endogenous processing of endogenous antigens), a 'second 
generation' of antigenic peptides (generated by exogenous processing of exogenous antigens) 
can be loaded onto recycling HLA class I molecules. The precedent for this pathway comes 
from a recent study which demonstrated that recycling HLA class II molecules are able to 
capture a new set of antigenic peptides in an HLA-DM- and invariant chain-independent 
pathway following the initial HLA-DM- and invariant chain-dependent loading of nascent HLA 






FIGURE 1.4 Peptide loading onto HLA class I molecules. After processing of microbial antigens, the resultant 
peptides are loaded onto HLA class I molecules for presentation to other cells of the immune system. Exogenous 
peptide loading has been suggested to occur by three alternative pathways: (a and b) during intracellular HLA class I 
transport; (c) during HLA class I recycling; and (d) during peptide exocytosis at the cell surface. (a) Endogenously 
derived peptides are loaded onto nascent HLA class I molecules in the ER lumen and are transported to the cell 
surface via the Golgi and endolysosomal compartments. (b) These peptides may then be exchanged for exogenously 
derived peptides during transit of the HLA class I molecules through endolysosomal vesicles. (c) Loading or 
exchange of peptides may also take place during recycling of surface-derived HLA class I molecules though 
endolysosomal vesicles. (d) Regurgitated peptides, derived from exogenous antigen processed in phagolysosomes, 
can bind or replace peptides ofHLA class I molecules on the cell surface (from Reimann and Kaufmann, 1997). 
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Surface HLA class I loading or the 'regurgitation ' model 
Surface HLA class I loading may also be involved in presentation of exogenous antigens to HLA 
class I molecules. This could occur when secreted antigens from partially digested exogenous 
antigens in phagosomes can bind membrane HLA class I by ' regurgitation' (Fig. 1.4d; Harding, 
1996). These peptides would unfortunately also sensitise ' bystander' cells in the immediate 
vicinity (Pfeifer et al., 1993a; Rock, 1996). While some studies have demonstrated this pathway 
for the HLA class I presentation of exogenous ovalbumin ( either present as a bacterial fusion 
protein or associated with beads), it has not been observable in others (Pfeifer et al., 1993b; Reis 
e Sousa and Germain, 1995; Rock, 1996). 'Empty' HLA class I molecules (apparently not 
associated with f32-microglobulin or peptides) are found on the surface of both murine and 
human cells (Ljunggren et al., 1995; Smith et al., 1993; Schirmbeck and Reimann, 1996). 
Heat shock protein-mediated HLA class I loading 
Stress proteins may play an important role in facilitating the processing of exogenous proteins 
and in peptide loading onto HLA class I molecules (Nieland et al., 1996; Schirmbeck and 
Reimann, 1994; Suto and Srivastava, 1995; Roman and Moreno, 1996). Sequence homologies 
and secondary structure predictions of the peptide-binding domains of HLA class I and heat 
shock protein 70 (hsp 70) polypeptides suggest a phylogenetic relationship between both classes 
of molecules. Polypeptides non-covalently bound to molecules of the hsp70 and hsp90 families 
have been shown to efficiently prime CTL responses in vivo against microbial antigens, minor 
histocompatibility antigens, and tumour-associated antigens (Reimann and Kaufmann, 1997). 
Immunodominant viral peptides endogenously bound to stress protein gp96/grp94 have recently 
been isolated (Nieland et al., 1996). How, and in which subcellular compartment, endogenous or 
exogenous hsp-bound peptides are 'loaded' onto HLA class I molecules remains unknown. A 
TAP-independent, hsp73-dependent processing pathway for the HLA class I-restricted 
presentation of endogenous peptides from truncated viral proteins has been identified 
(Schirmbeck and Reimann, 1994). A different pathway seems to operate for hsp96. In this 
system, peptides from endocytosed hsp96-peptide complexes seem to be loaded to nascent HLA 
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class I molecules in the ER of a subset of macrophages using a BF A-sensitive, chloroquine-
resistant pathway ( chloroquine inhibits endosomal acidification; Suto and Srivastava, 1995). 
Dendritic cell and apoptotic body facilitated 'cross-presentation' 
Accumulating evidence has identified dendritic cells as potent mediators of 'cross-presentation'. 
In a recent study, Albert et al. (1998a) have shown that immature dendritic cells are able to 
efficiently phagocytose apoptotic cells and cross-present antigens from these bodies to induce 
HLA class I-restricted CTLs. Previously, the ability of antigens to become highly concentrated 
within apoptotic bodies has been described (Casciola-Rosen et al., 1994). Further investigations 
revealed that dendritic cells engulf apoptotic cells by receptor-mediated phagocytosis, involving 
CD36 and the integrin receptor av~s (Albert et al., 1998b). Following uptake, apoptotic cells 
were shown to enter the classical endocytic pathway. The site where apoptotic cell-derived 
antigens intersect the HLA class I processing pathway and are loaded onto HLA class I 
molecules is yet to be defined. The ability of apoptotic cells to deliver antigens to the HLA class 
I pathway has also been described in a recent report by Kurts et al. (1998). These authors found 
that CTL-mediated tissue destruction and apoptosis facilitated cross-presentation of exogenous 
antigens to CD8+ CTLs. In tuberculosis, it is likely that target cell apoptosis may be a major 
determinate in HLA class I-presentation of mycobacterial antigens. M tuberculosis-infected 
targets cells undergoing apoptosis would provide a ready source of antigens for cross-
presentation to CD8+ CTLs. 
In summary, this review has presented new evidence from different in vivo and in vitro systems 
has indicated that priming HLA class I-restricted CTL responses by exogenous antigens is much 
more regular and efficient than previously thought. In vitro studies investigating the cell biology 
of the antigen processing pathways followed by endogenous and exogenous antigens for HLA 
class I-restricted epitope presentation have revealed a substantial number of alternative 
pathways, the characterization of which are still unclear (Reimann and Kaufmann, 1997). 
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The CD1 processing pathway 
Unlike the classical HLA molecules, which present peptide fragments of antigens to most T 
cells, CDl proteins are not polymorphic (Van Agthoven and Terhorst, 1982) but comprise 
different isotypes (CDla, b, c, d, and e) that are conserved in several mammalian species (Calabi 
et al., 1989). These glycoproteins have a typical HLA class I molecular structure, however. 
They are heterodimers consisting of an approximately 45kDa glycosylated heavy chain 
interacting non-covalently with the ~2-microglobulin light chain (Porcelli, 1995). Based on their 
lack of polymorphism, it was predicted that CD 1 may have specialized in capturing and 
presenting antigens with limited structural variability (Beckman et al. , 1994). This prediction 
proved accurate since recent studies have demonstrated that CDI molecules, unlike classical 
HLA molecules, present mycobacterial lipids (LAM and mycolic acid) rather than peptide 
antigens to T cells (Beckman et al., 1994). 
The CDl presentation pathway appears to be unique, although it shares some features with the 
classical HLA pathways. The earliest functional studies of CD I-restricted mycobacterial antigen 
presentation suggested a need for antigen processing prior to T cell recognition (Procelli et al. , 
1992). T cells do not respond to free mycobacterial lipids in the absence of APCs, and CD 1-
bearing APCs must be exposed to antigen for a discrete period of time (usually more than 30 
minutes) before they can activate T cells. T cell recognition of all lipid antigens was abrogated 
by gluteraldehyde fixation of the surface of APCs before but not after exposure to antigen. In 
addition, lipid antigen recognition is also blocked by agents that inhibit acidification of 
endosomes by different mechanisms such as chloroquine, monensin and concanamycin A 
(Porcelli et al. , 1992; Sieling et al. , 1995). There is substantial co-localization of CD 1 b and 
markers of late endosomes and lysosomes (mannose-6-phosphate and LAMP-1 , respectively). 
Furthermore, CD 1 b containing vesicles also contain HLA class II and HLA-DM (Sugita et al. , 
1996). These characteristics demonstrate that these late endosomal compartments overlap 
extensively or completely with HLA class II compartments in which peptide loading onto filA 
class II molecules is believed to occur. 
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Two candidate pathways for CD 1 b entry into the endosomal network have been considered and 
partially examined. CD 1 b may be directly trafficked to endosomes, in a manner similar to HLA 
class II proteins, which are diverted from the default secretory pathway, directly to endosomes 
because of targeting signals present in the associated invariant chain. Alternatively, CD 1 b may 
first be trafficked to the surface and then recycled via clathrin-mediated endocytosis back to the 
endosomal pathway. Recent studies have demonstrated that CDlb recycling is the major 
pathway accounting for localization of CD 1 b to the endocytic system (Jullien et al., 1996). 
Because the initial discovery of CDl reactivity was made using CD4-CD8- ap or "double-
negative" (DN) T cells (Porcelli et al., 1989, 1992; Beckman et al. , 1994), initial work on CD1-
restricted T cells focused on this relatively small T cell population. However, it is becoming 
increasingly evident that antigen presentation by CD 1 is not exclusively restricted to this T cell 
subset with CDl-restricted CD8+ ap T cells also being implicated (Stenger et al. , 1997). CD1-
restricted T cells may provide protection in mycobacterial infections by either secreting Th1-type 
cytokines or by direct cytolysis of infected CDl-expressing phagocytes (Rook & Hernandez-
Pando, 1996). Recently, Stenger et al. (1997) clearly demonstrated this by showing that CD8+ 
CD 1 b-restricted cytolytic activity against M tuberculosis-infected target cells was associated 
with a reduction in intracellular mycobacterial survival. 
Direct presentation of mycobacterial antigens to yo+ T cells 
yo+ T cells recognize an entirely different class of antigens through an extracellular presentation 
pathway that does not require antigen uptake, antigen processing or known antigen-presenting 
elements (Morita et al. , 1995). There are many indications that antigen recognition by yo+ T 
cells might be very different from antigen recognition by ap T cells. Although human ap and yo 
T cells have antigen receptors which share a similar structure (both have a variable heterodimer 
that associated with the invariant CD3 signaling complex), ap T cells have more than 50 Va and 
46 VP gene segments that can pair to make several thousand receptor combinations while yo T 
cells have only 6 Vy and 3-10 Vo gene segments which could only yield between 18 and 60 
different receptor combinations (Porcelli et al. , 1991 ). The actual peripheral blood repertoire of 
yo T cells, however, is dominated by 2 main subsets, Vy9/V62 and Vy(2,3,4)/Vol (Parker et al. , 
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1990). Of these, the Vy9/V82 TCR subset comprises the major group making up approximately 
75% of all y8 T cells. Furthermore, the M tuberculosis-reactive y8 T cells are predominantly 
Vy9/V82 (De Libero et al. , 1991 ; Kabelitz et al. , 1991 ; Panchamoorthy et al., 1991 ; Tanaka et 
al. , 1994). 
Early studies described a rapid amplification of Vy9/V82 T cells following stimulation of PBL 
with M tuberculosis extracts (Kabelitz et al. , 1990) and identified the stimulatory antigens as 
low molecular weight, protease-resistant compounds (Pfeffer et al. , 1990, 1992). The 
stimulatory antigens were subsequently found to be non-peptidic phosphorylated moeities 
(Constant et al. , 1994; Schoel et al. , 1994; Tanaka et al. , 1994; 1995; Burk et al., 1995). Some 
of the more well characterized phosphorylated metabolites recognized by y8 T cells include 
TubAgl-4 moeities (Constant et al. , 1994), monoethylphosphate (Tanaka et al. , 1994), 
phosphoglycolic acid (Tanaka et al., 1994), isopentenyl pyrophosphate (IPP; Tanaka et al. , 
1995), dimethyl pyrophosphate (Tanaka et al., 1995), famesyl pyrophosphate, geranyl 
pyrophosphate (Tanaka et al. , 1995), and diphosphoglyceric acid (Burk et al. , 1995). IPP is not 
restricted to prokaryotes but is also widely produced by eukaryotic cells. It is an essential 
precursor for a variety of biological molecules such as cholesterol and its derivatives, vitamins, 
dolicol phosphates and ubiquinones and is required for the membrane anchoring of a number of 
important signal transduction molecules such as ras (Tanaka et al. , 1995; Morita et al. , 1996). 
Similar phosphorylated compounds can also be produced by stressed cells and may explain the 
ability of several different transformed cell lines (Penninger et al., 1995) or cells infected with 
different pathogens to activate the same y8 T cell clone (Bukowski et al. , 1994; Wallace et al. , 
1995; Ponniah et al. , 1996;). 
Recognition by y8 T cells was found to be TCR-dependent since the in vitro activation of 
Vy9/V82 T cells by phosphoantigens was blocked by TCR-specific monoclonal antibodies 
(Munk et al., 1990; Constant et al. , 1994; Tanaka et al. , 1994). More direct evidence has been 
provided by a recent study which showed that phosphoantigen recognition could be conferred 
when a TCR-deficient Jurkat T cell line was transfected with cDNAs encoding Vy9/V82 chains 
(Bukowski et al. , 1995). 
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The presentation of phosphoantigens does not require the presence of professional antigen-
presenting cells (Morita et al., 1995; Vila et al., 1995). The majority of Vy9/Vo2 T cell clones 
have been found to respond to these antigens in the absence of additional APCs. Recognition 
was found to be rapid, occurring as soon as 2-3 minutes after the addition of phosphorylated 
antigens (Morita et al. , 1995). Furthermore, both non-fixed and paraformaldehyde-fixed APC 
were shown to present prenyl pyrophosphate antigens to APC-dependent Vy9/Vo2 T cell clones 
(Fisch et al. , l 990; Morita et al. , 1995). Together this data suggests that antigen uptake and 
processing are not requirements for yo T cell antigen recognition. Presentation of prenyl 
pyrophosphate is dependent, however, on cell-cell contact (Morita et al., 1995; Lang et al. , 
1995). Even though the presentation of prenyl pyrophosphate antigens was found to require cell-
cell contact, none of the known antigen-presenting molecules were necessary for their 
recognition (Fisch et al. , 1990; Holoshitz et al. , 1993; Morita et al. , 1995). Monoclonal 
antibodies against HLA class I, class II and CD 1 molecules did not block the recognition of 
prenyl pyrophosphate antigens by yo T cells (Morita et al., 1995). In addition, mutant APCs 
lacking classical HLA class I, ~2-microglobulin or HLA class II molecules were as efficient as 
wild type APCs at presenting mycobacterial phosphoantigens to an APC-dependent yo T cell 
clone (Morita et al., 1995). It is not clear if a novel antigen-presenting element exists for the 
prenyl pyrophosphate antigens. Unlike most peptide antigens, culturing APCs with prenyl 
pyrophosphate antigens does not render the 'pulsed ' APCs stimulatory for Vy9/Vo2 bearing T 
cells (Lang et al., 1995; Morita et al. , 1995) suggesting that the antigen does not form a stable 
association with the APC element on the cell surface. 
A model for the extracellular presentation of prenyl pyrophosphate antigens has been proposed 
by Morita et al. (1996). Mycobacteria secrete IPP and related prenyl pyrophosphates 
extracellularly where they can associate with the surface of an APC, perhaps by binding to a 
novel antigen-presenting element. Vy9/Vo2 T cells can recognize these compounds in a TCR-
dependent fashion . The T cells then become activated to secrete cytokines, proliferate, and kill 
neighboring cells . This process does not require that the presenting cell be a professional APC 
and does not require antigen uptake or processing. 
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The ability of y'6 T cells to release cytokines following activation is rapid and can precede a~ T 
cell activation by several hours to several days (Ferrick et al. , 1995). This observation has led to 
the hypothesis that the initial pattern of cytokine production by y'6 T cells may influence the 
ensuing a~ T cell response. Several studies have demonstrated that differentiation of CD4+ a~ 
T cells into either Th1 or Th2 cells is influenced by the cytokine milieu in which the initial 
antigen priming of these cells occurs (Rocken et al. , 1992; Hsieh et al. , 1992; Seder et al., 1992). 
Furthermore, Ferrick et al. (1995) have recently demonstrated that y'6 T cells are able to 
discriminate between L. monocytogenes or Nippostrongylus brasiliensis early in infection by 
producing cytokines associated with the appropriate T-helper response. A similar mechanism 
may allow y'6 T cells to influence cytokine production by NK cells (Ladel et al., 1996) and lg 
production by B cells (Hacker et al., 1995; McMenamin et al., 1995). The central role of y'6 T 
cells in regulating both the innate and acquired immune response has been summarized in Fig. 
1.5 . 
At the same time, an increasingly noted characteristic of TCR '6-
1
- knockout mice is one of 
dysregulated, hyperactive immune function towards both foreign and self-antigens (Roberts et 
al. , 1996; Peng et al., l 996; Szczepanik et al., 1996). These studies have suggested that y'6 cells 
ordinarily down-regulate a~ T cells of either Th1 (Roberts et al., 1996; Peng et al., 1996; 
Szczepanik et al. , 1996; Mukasa et al., 1995) or Th2 (McMenamin et al., 1994) function . In 
mycobacterial infections, y'6 T cells have been shown to regulate local cellular trafficking in 
granuloma formation by both promoting the influx of protective lymphocytes and monocytes and 
limiting the access of inflammatory neutrophils that do not contribute to protection but may 
cause tissue damage (D'Souza et al., 1997). It is conceivable that y'6 regulation is mediated by 
their ability to produce both Th1 and Th2 cytokines (D'Souza et al., 1997; Wen et al., 1998). 
With regard to their cytolytic ability, Vy9/V'62 T cells demonstrate an inherent ability to lyse M 
tuberculosis-infected target cells (Kabelitz et al., 1990). This cytolytic activity is not restricted 
to M tuberculosis infected cells, however, as the same y'6 T cells are broadly cytotoxic towards 
various transformed cell lines, Daudi in particular (Haas et al., 1993), as well as cells infected 
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Macrophage 
Tcell 
FIGURE 1.5 y8 T cells recognize bacterial and self-ligands on different antigen present cells (APCs). Bacterial 
ligand (BAg) is released by extracellular live bacteria or after their internalization within phagosomes. This cellular 
localization allows the surface display of the BAg in cells harboring live bacteria and, subsequently, the stimulation 
of y8 T cells. Self-generated metabolic ligands in intact cells do not have access to the cell surface, and therefore do 
not stimulate y8 T cells. However, following cell lysis (for example, due to persistent bacterial or viral infection or 
tissue necrosis), self-ligands are exposed on the surface and can stimulate y8 T cells. Activated y8 T cells secrete 
lymphokines capable of activating various types of cells and can induce functional maturation of professional APCs 
through soluble factors, thus facilitating the recruitment of antigen-specific exp T cells. y8 T cells can also activate 
macrophages thus promoting uptake and destruction of invading bacteria. Furthermore, some y8 T cells are strongly 
cytolytic and can lyse infected phagocytes. Cytolysis may lead to the release of intracellular pathogens, which can 
then be internalized and destroyed by recently activated macrophages (adapted from De Libero, 1997). 
1.3 CONCLUSION 
In conclusion, it is obvious from this review of the literature that the human host response to 
tuberculosis is a complex reaction to infection with a vigorous pathogen that involves many 
different components. Unfortunately, research into the initial macrophage-mycobacterial 
interaction, the intracellular lifestyle of M tuberculosis, the role of the many different T cell 
subsets and the mechanism by which mycobacteria are eliminated are only beginning to yield 
useful insights into this complex disease. A better understanding of the intricate cross talk 
between T cells, macrophages and infected host cells will no doubt directly promote the 
development of improved control measures. 
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1.4 PROJECT AIMS AND BACKGROUND 
Although it is well recognized that macrophages are key components of a protective immune 
response to M. tuberculosis, the heterogeneity within and between even steady state human 
macrophages has presented a significant obstacle to the study of macrophage-mycobacterial 
interaction in vitro. In fact , O'Brien et al. (1994) recently observed that our present 
understanding of the interaction between macrophages and mycobacterial species is based on 
macrophages collected from different anatomical sites with differing maturational statuses, and 
from different animal species and the results presented seem to reflect this variability. 
This situation has been partially remedied by the estalishment of several human leukemic cell 
lines, such as THP-1, Monomac-6, U937, HL-60 and KG-1, which are blocked at different steps 
along the monocyte to macrophage differentiation pathway (Sundstrom and Nilsson, 1976; 
Tsuchiya et al., 1980; Collins, 1987; Ziegler-Heitbrook et al. , 1988). These cell lines have 
allowed the investigation of relatively homogenous cell populations during defined stages of 
maturation and differentiation. When I took up this challenge in 1994, one of the most well 
characterized and widely used of these human monocytic cell lines U937 had not been 
investigated in the context of mycobacterial infection. 
The first major aim of this study was, therefore, to investigate the feasibility of using U93 7 as a 
representative in vitro model for human macrophage function in M tuberculosis infections 
(Chapter 2) and to compare it to another commonly used monocytic cell line THP-1. It is 
appropriate, at this point, to briefly overview some of the salient characteristics of this cell line 
and it ' s potential for use as a model for human macrophage function. 
Sundstrom and Nilsson (1976) first established the promonocytic U937 cell line from the pleural 
fluid of a patient with diffuse histiocytic lymphoma. These cells are not considered to be mature 
monocytes but are thought to be precursors of the monocyte/macrophage lineage. Accordingly, 
they possess many macrophage-like characteristics including (i) positive staining for non-
specific esterases (Nilsson et al. , 1981 ), (ii) the ability to produce lysozyme (Ralph et al. , 1976), 
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(iii) the expression of Fe and complement receptors (Guyre et al., 1983), _and (iv) the ability to 
phagocytose exogenous antigens (Sundstrom and Nilsson, 1976). This cell line does, however, 
fail to exhibit some phenotypic and functional properties of mature macrophages. They lack 
monocyte-specific differentiation markers such as CD 14 and HLA class II expression (Hass et 
I 
al., 1989), fail to generate leukotrienes (Kohler et al., 1989; Kohler et al., 1990), and do not 
produce detectable levels ofIL-6 (Hass et al. , 1991a). 
U93 7 cells can, however, be induced towards a more mature macrophage phenotype by the 
addition of various agents. These include 1,25-dihydroxyvitamin D3 (Dodd et al., 1983; Olsson 
et al., 1983 ; Trinchieri et al., 1987), retinoic acid (RA; Olsson and Breitman, 1982), phorbol 
esters such as phorbol miristate acetate (PMA; Hass et al., 1989; Lotem and Sachs, 1979; Revera 
and O' Brian, 1979), granulocyte/macrophage-colony stimulating factor (GM-CSF), dimethyl 
sulphoxide (DMSO; Nakamura et al, 1990), cyclic adenosine monophosphate (Olsson and 
Breitman, 1982), LPS (Ikewaki et al., 1993), IFN-y, and TNF-a (Harris et al., 1985; Testa et al., 
1988). In the presence of these agents, U93 7 cells develop morphologic, cytochemical, 
phenotypical and functional characteristics that are consistent with cellular maturation. 
Following differentiation, these cells showed increased expression of CDI lb (Grattage et al., 
1992), CD16, CD23 (Ikewaki et al., 1993), GM-CSF receptor (Zuckerman et al., 1988) and 
tissue factor Vila (Rana et al. , 1988). In addition, they were shown to produce various cytokines 
[IL-1 (Knudsen et al., 1986) and TNFa (Cannistra et al. , 1987)] as well as growth factors 
[macrophage-colony stimulating factor (M-CSF; Horiguchi et al., 1989), platelet-derived growth 
factors (PDGF-1, PDGF-2; Sariban et al., 1988), and prostanoids (PGE2, PGS2, PGh, TxB2; 
Kohler et al., 1989; Wiederhold et al., 1988)]. Differentiation ofU937 cells is often associated 
with inhibition of autonomous proliferative ability (Harris et al., 1985; Palacios et al., 1982) and 
induction of cellular adhesion (Hass et al., 1989; Ikewaki et al., 1993 ). The ability to further 
modulate and differentiate the phenotypic and functional properties of this cell line using various 
agents such as PMA, IFN-y or vitamin D3 may allow for more defined investigation of 
mycobacterial-macrophage interactions in tuberculosis. 
The U937 cell line has also been widely used as a model in which to study the function of human 
macrophages in host defense against a wide range of other intracellular pathogens. These 
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include Leishmania spp. (Arena et al., 1997), Toxoplasma spp. (Wing et al., 1981; Sarciron et 
al. , 1997), Legionella spp. (Abu Kwaik et al., 1998); Salmonella spp. (Brett et al., 1993; Cheteau 
et al., 1997; Scomeaux et al. , 1996), Broce/la spp. (Caron et al., 1996), and Listeria spp. (Caron 
et al., 1994a, 1994b, 1994c, 1994d; Hauck et al., 1997). They have been shown,to be capable of 
both pinocytic and phagocytic uptake of various human pathogens, mounting a respiratory burst 
following infection, releasing specific cytokines (TNF-a, IL-8), and supporting the growth of 
virulent organisms while efficiently eliminating or restricting the growth of non-pathogenic 
counterparts (Abshire & Neidhardt, 1993; Bianchi et al., 1997; Caron et al., 1994a, 1994b, 
1994c, 1994d; Husmann & Johnson, 1992; Iwamoto et al. , 1997; King et al., 1991; Pearlman et 
al. , 1988) 
Fewer reports have investigated the ability of this monocytic cell line to process and present 
exogenous or endogenous antigens. While U937 cells were found to express cell surface HLA 
class I (Sundstrom and Nilsson, 1976), they neither constitutively nor inducibly expressed HLA 
class II (Sundstrom and Nilsson, 1976; Peterlin et al. 1984). U937 cells have also been shown to 
possess an efficient HLA class I processing pathway that not only facilitates the normal 
presentation of endogenous self and viral antigens but also the presentation of exogenously 
derived soluble antigens in the context of HLA class I (Harris et al. , 1993; 1995). 
Because U937 cells do not constitutively nor inducibly express HLA class II despite expressing 
high levels of cell surface HLA class I (Sundstrom and Nilsson, 1976; Peterlin et al. 1984), they 
may provide a unique system in which to evaluate the ability of human macrophages to present 
mycobacterial antigens to non-HLA class II-restricted T cells. This investigation formed the 
basis for the second major focus of this study (Chapter 3). 
Although a number of reports have implicated cytolytic CD8+ T cells in defense against murine 
mycobacterial infections (Orme & Collins, 1984; Orme, 1987; Muller et al., 1987; Silva et al., 
1994; D' Sousa et al., 1998), their role in human tuberculosis has proven much more difficult to 
demonstrate. At the conception of this study in 1994, few reports had been published 
demonstrating M tuberculosis-reactive cytolytic CD8+ T cells in human mycobacterial 
infections (Rees et al. , 1988). The aim of this study was therefore to investigate the role of CD8+ 
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T cells and HLA class I presentation in mycobacterial infections using the HLA class t but HLA 
class Ir human macrophage cell line U937 (Chapter 3). 
With the emergence of more sophisticated immunological techniques, and ~ corresponding 
renewed interest in the role of C08 • CTLs in tuberculosis, a number of studies have been 
published very recently demonstrating the existence of classical HLA class I-restricted M. 
tuberculosis-responsive human C08 • T cells (Turner and Oockrell, 1996; Tan et al., 1997; 
Lalvani et al. , 1998; Lewinsohn et al., 1998; Mohagneghpour et al., 1998; Canaday et al., 1999). 
Because of the inherent difficulties associated with demonstrating the cytolytic function of CTLs 
with such low precursor frequencies, many of these studies have restricted their focus to the 
ability of cos· T cells to produce cytokines or to proliferate in response to stimulation with 
defined mycobacterial peptides (Lalvani et al. , 1998; Lewinsohn et al. , 1998; Canaday et al., 
1999) . Those studies that have evaluated the cytolytic activity of C08+ T cells against M 
tuberculosis-infected target cells have had to use very defined priming conditions to facilitate the 
generation of C08 .. CTLs. Tan et al. ( 1997), for example, reported that mycobacterial-specific 
C08 .. CTL activity was only demonstrable following in vitro co-culture with specific growth 
factors , while Mohagheghpour et al. ( 1998) made use of mycobacterial peptide pulsed dendritic 
cells to efficiently prime C08 • CTL effector cells. The results presented in this study (Chapter 
3) describe a relatively simple, robust, and easily adaptable in vitro model using U937 cells to 
efficiently present mycobacterial antigens to human HLA class I-restricted C08+ CTLs. 
An important finding which emerged during the course of this study was that U937 cells 
provided not only a useful in vitro human macrophage model for selective evaluation of HLA 
class I-restricted cos· CTL function in mycobacterial infections but were also shown to be a 
sensitive indicator for ye/ CTL activity (Chapter 3 and 4). Although it is well recognized that 
yf:/ T cells recognize an entirely different class of mycobacterial antigens through an extra-
cellular presentation pathway that does not require antigen uptake, antigen processing or known 
antigen-presenting elements (Morita et al. , 1995), their role in protective immunity in human 
tuberculosis remains contentious. The establishment of strongly cytolytic human M 
tuberculosis-specific y[:/ CTL clones (Chapter 3) afforded a unique opportunity to investigate 
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more thoroughly the role of yf/ CTL lytic activity in 
human mycobacterial infections. This 
investigation formed the basis of the third and final fo
cus of the present study (Chapter 4). 
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2.1 INTRODUCTION 
Macrophages are central to an efficient protective immune response following infection with 
M tuberculosis and have evolved diverse anti-microbial mechanisms to deal with this 
intracellular pathogen (Chan and Kaufmann, 1994). Their four most important functions in 
mycobacterial infections are: (i) their ability to phagocytose M tuberculosis; (ii) their ability 
to produce proteolytic enzymes and other metabolites following phagocytosis that exhibit 
mycobactericidal effects; (iii) their ability to process and present antigens derived from M 
tuberculosis to T cells; and (iv) their ability to produce cytokines in response to M 
tuberculosis infection that have the potential to exert potent immuno-regulatory effects 
(Valone et al., 1988; Toossi et al., 1991 ; Barnes et al. , 1992; Zhang et al. , 1993; Barnes & 
Modlin, 1994). 
Unfortunately, the logistic restrictions and heterogeneity within and between even steady-
state human mononuclear phagocytes at all levels of analysis (Forster and Landy, 1981 ; Fine, 
1995) has presented a significant obstacle for the study of macrophage-mycobacterial 
interactions. Although being less variable, murine macrophages have been shown to differ 
quite significantly from human macrophages in both their production of cytokines and 
reactive nitrogen intermediates. While murine macrophages can easily be induced by 
cytokines to form nitrogen radicals in response to mycobacterial infection, reactive nitrogen 
intermediate production in human monocytes is more difficult to demonstrate (Albina et al., 
1995; Nicholson et al., 1996; Jagannath et al., 1998). In many respects, therefore, the murine 
model of tuberculosis does not closely mimic the human disease. 
The establishment of several human leukemic cell lines, such as U937, THP-1 , Monomac-6, 
HL-60 and KG-1 , which are blocked at different steps along the monocyte to macrophage 
differentiation pathway (Sundstrom and Nilsson, 1976; Tsuchiya et al. , 1980; Collins, 1987; 
Ziegler-Heitbrook et al., 1988), have allowed the investigation of relatively homogenous cell 
populations during defined stages of maturation and differentiation. One of the most well 
characterized and widely used of these human monocytic cell lines is U937. 
The U937 cell line has been used extensively as a model in which to study the function of 
human macrophages in defense against a wide range of intracellular pathogens. These include 
Leishmania spp. (Arena et al. , 1997), Toxoplasma spp. (Wing et al., 1981 ; Sarciron et al. , 
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1997), Legionella spp. (Abu Kwaik et al. , 1998), Salmonella spp. (Brett et al. , 1993; Cheteau 
et al. , 1997), Brucella spp. (Caron et al. , 1996), and Listeria spp. (Caron et al. , 1994a, 1994b, 
1994c, 1994d; Hauck et al. , 1997). Despite being so widely used and well characterized, this 
study represents the first to investigate the usefulness of U93 7, compared with another 
commonly used human monocytic cell line THP-1 , as a model for macrophage function in 
mycobacterial infections. 
The aim of the research presented in this chapter was firstly to investigate the constitutive and 
inducible phenotypic and functional characteristics U937 cells and to compare these with 
another well established human monocytic cell line THP-1 ; and secondly, to investigate the 
usefulness of U937 as a representative human macrophage model in which to study 
mycobacterial infection. These investigations will form the basis from which more applied 
studies into the ability of U937 cells to present mycobacterial antigens to non-HLA class II-
restricted T cells will be developed (Chapter 3). The results presented in this chapter 
confirm that U937 cells were inducible towards a more mature macrophage phenotype by the 
addition of PMA, IFN-y, or l ,25-(0H)2-vitamin D3 . The efficiency of monocytic 
differentiation was demonstrated by the acquisition of certain cell surface receptors (CD14, 
CD 11 b, and CD 16) but not HLA class II, cessation of autonomous proliferation, growth 
arrest in the Go phase of the cell cycle and cellular adherence. Although U93 7 cells were 
found to be capable of phagocytosing M tuberculosis following differentiation, their 
phagocytic ability was reduced compared with THP-1 cells. Both U937 and THP-1 cells, 
however, showed similar ability to mount a respiratory burst response following phagocytosis 
of M tuberculosis. U937 cells were found to be more permissive to the intracellular growth 
of both virulent M tuberculosis and avirulent BCG than THP-1 cells. Finally, chronic 
infection ofU937 cells with virulent M tuberculosis did not influence cell surface expression 
of HLA class II but did significantly up-regulate the cell surface expression of HLA class I 
compared with uninfected cells. Evidence presented in this chapter demonstrates that, in 
many important respects, U937 cells represent a useful model for investigating defined 
interactions between human macrophages and M tuberculosis. 
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2.2 MATERIALS AND METHODS 
2.2.1 Cell lines 
U937 and THP-1 cells were maintained routinely in suspension culture in RPMI-1640 
(Flow Laboratories, Irvine, Scotland) supplemented with 10% (v/v) heat-inactivated fetal 
calf serum (FCS) (Delta Bioproducts, Kempton Park, South Africa), 2 mM L-glutamine, 
and 10 mM HEPES at 37°C in a humidified atmosphere of 5% CO2 . THP-1 culture 
medium was additionally supplemented with 10-
5 M 2-mercaptoethanol. Passage was 
performed every 2-3 days for U937 and every 4 days for THP-1. Cells used in experiments 
were in the logarithmic growth phase and viability exceeded 95% as measured by trypan blue 
exclusion. Mycoplasma infection was excluded by regular monitoring using the Bisbenzanide 
fluorochrome stain (Hoescht No. 33258, Germany). 
2.2.2 Induction of Differentiation 
Differentiation was induced by treating U937 or THP-1 cells (5 x 10
5 cells.m1-1 in 6- or 24-
well plates) with PMA (5 ng.m1-1; Sigma, St. Louis, MO; Hewison et al., 1992), 1,25-
(0H)i-vitamin D3 (10-
7-10-9M; Roche Products Ltd, U.K.; Zuckerman et al., 1988), GM-
CSF (5 ng.mr1; Sandoz; Kelsey et al., 1992), or recombinant human IFN-y (100-200 U.mr
1 
rhIFN-y; Cetus; Roberts et al., 1991) for at least 48 hours at 37°C, 5% CO2. 
Morphological changes, adherence, autonomous proliferative ability, changes in cell cycling, 
and cell surface antigen expression following the various treatments were evaluated as 
indicators of terminal differentiation. 
Autonomous proliferative ability 
U937 and THP-1 cells (2 x 104
 cells. we1r1) were seeded into 96-well round-bottomed sterile 
tissue culture plates (Greiner, Nurtingen, Germany) in 6-well replicates. Cells were either 
untreated or induced to differentiate by the addition of PMA, rhIFN-y, or 1,25-(0H)2-
vitamin D3 as described above. [3H]-Thymidine (Amersham International, England; 
specific activity 185 MB) was added (2 µCi/well) at 0, 24, 48, and 72 hours for a further 
16 hours of incubation at 37°C, 5 % CO2 . The cells were harvested using an automated cell 
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harvester (TitertekR 630; Flow Laboratories) and the radioactivity was measured using a 
liquid scintillation counter (Tricarb 4640, Packard, Meriden, CT). To normalize the results 
for each cell line following the respective treatments, the results have been expressed as a 
'relative proliferative index' and calculated as follows : [3H-thymidine incorporation (cpm) 
for differentiated cells]..,... [3H-thymidine incorporation (cpm) for untreated cells]. 
DNA and cell cycle analysis 
U937 or THP-1 cells were untreated or induced to differentiate with PMA, rhIFN-y, or 
1,25-(0H)i-vitamin D3 as described above. Following 48 hours of differentiation, the cell 
concentration was adjusted to 2 x 106 cells.mi-
1 in 10% FCS RPMI-1640 and at least 2 x 10
5 
cells (in 100 µl) were used per analysis. Cells were permeablised, stained with propidium 
iodide and fixed using DNA Prep Kit (Coulter) . An Epics Profile II flow cytometer 
(Coulter) was used to perform cell cycle analysis and histograms were gated on the U937 or 
THP-1 population by forward scatter (FS) versus log side scatter (LSS). Single parameter 
histograms of fluorescence 3 (propidium iodide), showing GofG1, S and G2/M, were 
analyzed using Cytologies Software (Coulter). The method of rectangular integration was 
used to analyze DNA histograms (Baisch et al., 1975). Cells in G0 phase of the cell cycle 
have diploid amount of DNA (2N). Cells in GifM phase have tetraploid amounts of DNA 
(4N). Cells in the S phase of the cell cycle have an intermediate amount of DNA (2N < S 
phase <4N). Chromosomal analysis was performed by Dr. M.P. Marx in the Department 
of Human Genetics, University of Stellenbosch. 
Cell surface marker expression 
U937 and THP-1 cells, either untreated or induced to differentiate with PMA, rhIFN-y, or 
1,25-(0H)2-vitamin D3 for 48 hours, were assessed for various macrophage cell surface 
antigens. An Epics Profile II flow cytometer (Coulter) was used to perform immuno-
phenotyping and the monoclonal antibodies (Coulter, Hialeah, FL; Becktin-Dickinson, San 
Jose, CA) used were directed against HLA class I (W6/32), HLA class II (I3), CD14 (MY4), 
CD14 (Mo2), CDI lb (Mol), FcR (CD16), CDla, CDlb, and CDlc. All the monoclonal 
antibodies (with the exception of W6/32, CD la, CD lb, and CDlc) were directly conjugated 
with FITC (fluoroscein isothiocyanate) or RDl (phycoerythrin; PE). Indirect labeling was 
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performed using mouse anti-human W6/32, CDla, CDlb, CDlc and goat anti-mouse FITC. 
Antibodies were used at the concentrations suggested by the manufacturer. Histograms were 
gated on U937 or THP-1 populations by forward scatter (FS) versus log side scatter (LSS). 
Single parameter histograms of fluorescence 1 (FITC) and fluorescence 2 (RDl) were 
analyzed using Cytologies (Coulter) and WinMDI Software (Trotter, 1996). Corresponding 
isotypic control monoclonal antibodies were used in all cases to set cursors to allow 2% false 
positives. 
2.2.3 Tissue-typing 
HLA-typing of U937 and THP-1 cells was determined according to phenotype using the 
microdroplet lymphocyte cytotoxicity test described by Bodmer et al. (1977) . 
2.2.4 Isolation of human PBMC and monocyte-derived macrophages 
Peripheral blood mononuclear cells (PBMC) were obtained from healthy adult volunteers by 
centrifugation of heparinized venous blood over Ficoll-Hypaque density gradients (Sigma) as 
previously described (Boyum, 1968). Monocyte-derived macrophages were prepared by 
culturing PBMC (1 x 106 cells.mr1
 in 10% pooled AB+ human serum RPMI-1640) in 24-well 
plates (1 ml.welr1) for 4 to 6 days. Non-adherent cells were removed and adherent 
monocyte-derived macrophages were washed 3 times with warmed 10% AB RPMI-1640. 
2.2.5 Mycobacterial growth conditions 
M tuberculosis H37Rv (ATCC) and M bovis BCG (Trudeau strain) were grown in 
Middlebrook 7H9 broth (Difeo Laboratories, Detroit, MI, USA) supplemented with 10% 
OADC (Oleic Acid-Albumin-Dextran-Catalase growth supplement; State Vaccine, Cape 
Town, South Africa) and 0.02% Tween-80 (Merck, Darmstadt, Germany) at 37°C, 5% CO2. 
Mid-log phase cultures were supplemented with 15% sterile glycerol, divided into aliquots, 
snap frozen in liquid nitrogen and immediately stored at -70°C until needed. Viability of the 
frozen mycobacterial stocks was monitored over time by determining colony forming units 
(CFU) of serial 10-fold dilutions of the bacterial preparations on Middlebrook 7Hl O agar 
(Difeo) supplemented with 10% OADC. Frozen aliquots were thawed immediately before 
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use in an assay and clumps were disrupted by repeated passage through a 25-gauge tuberculin 
needle. Where indicated, mycobacterial preparations were coated with serum opsonins by 
incubating thawed aliquots with an equal volume of fresh human serum for 30 minutes at 
37°C. 
For experiments usmg flow cytometric assessment of mycobacterial phagocytosis, M 
tuberculosis was labeled with fluoroscein isothiocyanate (FITC) isomer I according to the 
method described by Drevets and Campbell (1991). Briefly, mycobacterial broth culture (6 x 
107 CFU.ml"1) was incubated with O. lmg.ml"
1 FITC isomer I (Sigma) in 0.1 M NaHC03, pH 
9.0 for 1 hour at 25°C. Bacteria were washed three times with PBS by centrifugation at 
11000 g for 5 min and reconstituted in original volume in 10% OADC Middlebrooks 7Hl 0 
broth. An Epics Profile II flow cytometer (Coulter) was used to assess the efficiency of 
FITC-labeling and histograms were gated on the mycobacterial population by forward scatter 
(FS) versus log side scatter (LSS). Viability of the FITC-labeled M tuberculosis 
preparations was measured by determining CFU' s as described above. 
2.2.6 Phagocytosis of M tuberculosis 
U937 and THP-1 cells were untreated or induced to differentiate by the addition of PMA, 
rhIFN-y, or 1,25-(0H)2-vitamin D3. Following 48 hours of differentiation, the non-adherent 
rhIFN-y- or 1,25-(0H)2-vitamin D3-treated cells were re-adjusted to 0.5 x 10
6.ml"1. Initial 
experiments using PMA-differentiated cells confirmed that their cell concentration did not 
significantly increase following treatment and, as a result, no concentration re-adjustment 
was necessary in subsequent experiments. U937 or THP-1 cells were infected with M 
tuberculosis H3 7R v (in the absence or presence of serum opsonins) and phagocytic ability 
was determined using three independent techniques: (i) mycobacterial binding assay using 
Ziehl-Neelson (ZN) staining for acid fast bacilli ; (ii) transmission electron microscopy 
(TEM) of M tuberculosis-infected cells; and (iii) flow cytometric evaluation phagocytosis 
using FITC-labeled M tuberculosis. 
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Monitoring M tuberculosis infection using Ziehl-Neelson staining 
Untreated or differentiated U937 or THP-1 cells (treated for 48 hours with PMA, rhIFN-y or 
1,25-(0H)2-vitamin D3) were infected with M tuberculosis H37Rv (10 CFU.celr
1
) for 90 
minutes. Infected cells were washed 3 times in 10% FCS PBS to remove non-ingested bacilli 
and re-suspended in 10% FCS RPMI-1640 (2 x 10
6 cells.mr1). Suspension cells were coated 
onto duplicate glass slides and allowed to air-dry. Following heat-fixation, efficiency of 
infection was visualized using ZN staining for acid fast bacilli as described by Bishop and 
Neumann (1970) . Fixed slides were stained for 10 minutes with carbol fuchsin (10g fuchsin; 
50g phenol dissolved in 100 ml 95 % ethanol; diluted to 11 in distilled water) . During this 
period, the carbol fuchsin flooded slide was gently heated twice. After 10 minutes, excessive 
stain was removed by rinsing under running water. The slides were de-stained by flooding 
repeatedly with acid alcohol (3% HCl diluted in 85% ethanol) and rinsed in between each de-
colourizing step with water. Finally, the cells were counter-stained using 0.5% aqueous 
malachite green for 1 minute. The number of cells containing acid-fast M tuberculosis was 
evaluated using oil immersion light microscopy and infected cells were expressed as a 
percentage of the total number of cells counted. At least 200 cells per slide were assessed for 
each treatment. 
Transmission electron microscopy of infected U937 cells 
U937 cells were differentiated with PMA for 48 hours and then infected with M tuberculosis 
H37Rv (50 CFU.ceir1) for 90 minutes at 37°C, 5% CO2. The cells were EDTA-detached, 
washed 3 times in 10% FCS PBS, and fixed with 1 % paraformaldehyde PBS for 1 hour at 
room temperature. Cells were washed three times with O. 1 M sodium cacodylate buffer 
containing 0.1 M sucrose (pH 7.2) and then fixed again with 2.5% gluteraldehyde in 0.1 M 
sodium cacodylate buffer containing 0.1 M sucrose (pH 7.2) overnight at 4°C. The cells were 
post-fixed with 1 % osmium tetroxide, dehydrated in graded ethanol solutions, and embedded 
in Spurs resin. Thin sections were stained with uranyl acetate and lead citrate before 
examination with a Jeol 200 CX Electron microscope. A minimal estimate of the efficiency 
of infection with M tuberculosis was determined by assessing at least 100 independent cells. 
This method of quantifying infection was considered to give a minimal estimate because 
infection was evaluated from only a single section through infected cells. 
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Flow cytometric evaluation of phagocytosis 
Phagocytosis of FITC-conjugated M tuberculosis by U937 cells, human monocytes and 
macrophages was assessed using the commercially available "Phagotest" kit (Orpegen, 
Heidelberg, Germany). FITC conjugated-£. coli (1 x 10
9 .mr1), provided with the kit, was 




prepared as described above. Fresh monocytes were derived from heparinized whole blood 
(100 µl per test) as described by the manufacturers. Monocyte-derived macrophages were 
prepared as described above. U93 7 cells were either undifferentiated or treated with PMA, 
rhIFN-y, or l ,25-(0H)2-vitamin D3 for 48 hours as described above. 
Untreated and differentiated U937 cells, fresh human monocytes, and monocyte-derived 
macrophages were infected with either E. coli (1000 bacteria.celr
1
) or M tuberculosis (100 
bacteria.celr1) for 90 minutes in the presence of serum opsonins at 37°C, 5% CO2. Adherent 
macrophages and PMA-differentiated U937 cells were EDTA-detached following the 90 
minutes of infection, and washed once with washing solution provided by the manufacturers. 
All the samples were placed into an ice water bath at the end of the 90-minute infection 
period to stop phagocytosis. Quenching solution (100 µl.sampk
1
; provided by the 
manufacturer) was added to each sample to quench any extracellular fluorescence due to 
associated but not incorporated bacteria. Each sample was washed 3 times with washing 
solution to remove remaining non-ingested bacteria. Any contaminating red blood cells from 
the fresh monocyte population were lysed using the lysing solution provided with the kit and 
all the samples were fixed with 1 % buffered paraformaldehyde PBS for 1 hour at room 
temperature. Samples were washed once with washing solution, stained with DNA staining 
solution (100 µl.sample-
1
; provided by the manufacturers) and incubated for a further 10 
minutes at 0°C in the dark before evaluating the results. Phagocytic efficiency was quantified 
by using an Epics Profile II flow cytometer (Coulter) and histograms were gated on U937 
cells, monocytes or macrophages by forward scatter (FS) versus fluorescence 3 (propidium 
iodide; DNA stain provided by the manufacturers' ). Single parameter histograms of 
fluorescence 1 (FITC) showing the percentage of the gated population having incorporated 
FITC-labeled E. coli or M tuberculosis were used to determine phagocytic efficiency. 
Chapter 2 In vitro Macro
phage Models 51 
Uninfected monocytes, macrophages or U937 cells, prepared in parallel, were used in all 
cases to set cursors to allow 2% false positives. 
2.2. 7 Respiratory burst activity 
Respiratory burst activity was measured using both nitroblue tetrazolium (NBT) reduction 
and the commercially available flow cytometric "Burst-Test" kit (Orpegen, Heidelberg, 
Germany). 
NET reduction 
Measurement of respiratory burst activity using NBT reduction was carried out using the 
method described by Roberts et al. (1991) with the following modifications. U937 and THP-
1 cells were untreated or induced to differentiate by the addition of PMA, rhIFN-y, or 1,25-
(0H)2-vitamin D3. Following 48 hours of differentiation, the cells were re-suspended in 10% 
FCS RPMI-1640 containing 0.05% NBT (1 x 10
6 cells.mr1). In the presence ofNBT, U937 
and THP-1 cells were stimulated with PMA (10 µg .mr
1
; Spittler et al., 1997); infected with 
M tuberculosis (100 bacteria.ceU-
1
) or left untreated for 1 hour at 37°C. Each independent 
experiment was carried out in duplicate and NBT reduction was quantified by counting at 
least 100 cells from each sample. 
Flow cytometric evaluation of respiratory burst 
Respiratory burst activity following infection of human monocytes, macrophages and U93 7 
cells with either opsonized M tuberculosis or E. coli was assessed using the commercially 
available "Burst-Test" kit (Orpegen, Heidelberg, Germany). The principle of the test is the 
oxidative conversion of non-fluorogenic dihydrorhodamin-123 to green fluorescent 
rhodamine-123 by activated cells exhibiting respiratory burst activity (Rothe et al. , 1988). 
Pre-opsonised E. coli (1 x 10
9 CFU.mr1) was provided by the manufacturers as a positive 
control and used according to their direction, while M tuberculosis (5 x 10
8 CFU.mr1) was 
coated with fresh serum opsonins as previously described. Fresh monocytes were derived 
from heparinized whole blood (100 µl per test) as described by the manufacturers. 
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Monocyte-derived macrophages and differentiated U93 7 cells were prepared as described 
above. 
Untreated and differentiated U937 cells, fresh human monocytes, and monocyte-derived 
macrophages were infected with pre-cooled, pre-opsonized E. coli (1000 bacteria.celr1), M 
tuberculosis (100 bacteria.celr') or with an equal volume of washing solution (negative 
control suggested by the manufacturer) for 10 minutes at 37°C, 5% CO2. After 10 minutes, 
20 µl freshly prepared dihydrorhodamin-123 substrate solution (provided by the 
manufacturer) was added to each sample and the cells were incubated for a further 10 
minutes at 37°C. To terminate the reaction, 1 % paraformaldehyde in PBS was added to each 
sample for 1 hour at room temperature. Adherent macrophages and PMA-differentiated 
U937 cells were subsequently EDTA-detached. Samples were washed once with washing 
solution, stained with DNA staining solution (100 µI.sample-' ; provided by the 
manufacturers) and incubated for a further 15 minutes on ice, in the dark before evaluating 
the results. Respiratory burst activity was quantified by using an Epics Profile II flow 
cytometer (Coulter) and histograms were gated on U937 cells, monocytes or macrophages by 
forward scatter (FS) versus fluorescence 3 (propidium iodide; DNA stain). Single parameter 
histograms of fluorescence 1 ( rhodamine-123) showing the percentage of the gated 
population exhibiting oxidative conversion of dihydrorhodamine-123 to rhodamine-123 were 
used to determine respiratory burst potential of the different populations of cells. Uninfected 
U93 7 cells, monocytes and macrophages, prepared in parallel, were used in all cases to set 
cursors to allow 2% false positives. 
2.2.8 Measurement of intracellular mycobacterial growth 
U937 and THP-1 cells were untreated or induced to differentiate by the addition of PMA, 
rhIFN-y, or l ,25-(0H)2-vitamin D3. Following 48 hours of differentiation, the cell 
concentration was re-adjusted to 0.5 x 106 cells.mr' in fresh medium containing PMA, 
rhIFN-y or l ,25-(0H)2-vitamin D3. The cells were infected with pre-opsonized M 
tuberculosis H37Rv or BCG (0.1 CFU.ceU-1) . Following 90 minutes of infection (day 0), at 
day 3 and again at day 7 following infection, supernatants were removed and collected and 
the cells solubilized with 0.25% SDS PBS. The cell lysate and corresponding supernatant 
were pooled to compensate for mycobacteria released into the surrounding medium from 
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damaged cells during the course of the infection. Because U93 7 have demonstrated the 
ability to retro-differentiate (Hass et al., 1991), each well was supplemented on day 3 with 
fresh medium containing PMA, rhIFN-y or l ,25-(0H)2-vitamin D3. Mycobacterial growth 
was measured by [3H]-Uridine (Amersham International; specific activity 185 MB; 1 
µCi. wen-1) incorporation. Pooled cell lysate and supernatant (100 µl. weU-1) were incubated 
together with [3H]-Uridine in 6-well replicates for 10 days at 37°C, 5 % CO2 • On day 10, 
the cells were fixed by the addition of an equal volume of 1 % paraformaldehyde for 1 hour, 
harvested using an automated cell harvester (TitertekR 630), and the radioactivity (cpm) was 
measured using a liquid scintillation counter (Tricarb 4640). 
2.2.9 Statistical analysis 
Statistical analyses were performed using the Wilcoxon ranks test for paired non-parametric 
data and the Mann-Whitney U-test for unpaired non-parametric data (Kaplan, 1987). 
2.3 RESULTS 
2.3.1 Characterization and differentiation of U937 and THP-1 cells 
The present study was designed to investigate and compare the phenotypic and functional 
characteristics displayed by the monocytic cell lines U937 and THP-1 both before and 
following differentiation. Both cell lines showed strong and diffuse cytoplasmic staining for 
non-specific esterase activity consistent with their monocytic cell ancestry. U937 and THP-1 
cells were induced to differentiate by the addition of various agents such as PMA, rhlFN-y, or 
1,25-(0H)2-vitamin D3; and the efficiency of differentiation was compared by assessing (i) 
autonomous proliferative ability, (ii) cell cycle distribution, (iii) adherence, (iv) cell surface 
marker expression, (v) phagocytic ability, and (vi) respiratory burst activity following 
infection. 
Autonomous proliferative ability and cell cycle distribution 
An important indicator of monocyte/macrophage terminal differentiation is their arrest in the 
Go/G1 phase of the cell cycle and their reduced proliferative potential (Abrink et al. , 1994). 
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Although untreated U937 and THP-1 cells showed good ability to proliferate autonomously, 
differentiation with PMA, rhIFN-y or 1,25-(0H)2-vitamin D3 differentially arrested this 
proliferative ability (Fig. 2.1). Differentiation with PMA, in particular, resulted in almost 
complete arrest of proliferation (85-93% reduction) and this effect was detectable as early as 
24 hours post-treatment. Interestingly, this PMA-induced growth arrest followed an initial 
burst in [3H]-thymidine uptake (0-16 hours) in U937 but not THP-1 cells. IFN-y-induced 
differentiation ofU937 and THP-1 cells resulted in a more gradual loss of proliferative ability 
with its effect reaching a peak of 65-87% inhibition after 72 hours of treatment. 1,25-(0H)2-
vitamin D3-treatment (10-
7 to 10-9 M), in contrast, resulted in only slight inhibition of cellular 
proliferation of U93 7 cells after 72 hours ( 48% inhibition) but had no effect on THP-1 
proliferative ability. 
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FIGURE 2.1 The effect of differentiation on the autonomous proliferative ability ofU937 and TIIP-1 cells. 
(a) U937 and (b) TIIP-1 cells were induced to differentiate by the addition of (a ) PMA (5ng.mr1), (• ) rhIFNy 
(200 iu.mr1) or(• ) 1,25-(0H)i-vitamin D3 (10-
7 M). Relative proliferative index was calculated as follows : 
[{3H)-thymidine incorporation (cpm) for differentiated cells] + [{3H)-thymidine incorporation (cpm) for 
untreated cells] and expressed as a percentage. Each data point represents the mean percentage ( error bars 
represent SD) of at least 3 independent experiments. 
Analysis of the effects of PMA-, rhIFN-y-, and l ,25-(0H)2-vitamin D3-induced 
differentiation ( 48-72 hours) on the cell cycle distribution of U93 7 and THP-1 cells (Fig. 2.2) 
revealed only slight differences between these cell lines. Untreated, both cell lines showed a 
high proportion of the population cycling through S- and G2/M-phases of the cell cycle ( 40-
55%) consistent with their ability to proliferate autonomously. PMA-treatment of both cell 
lines resulted in a striking accumulation of cells in Go with 93 .1 % of U93 7 and 81 . 6% of 
Chapter 2 In vitro Macrophage Models 55 
THP-1 cells having accumulated in this phase. rhIFN-y or 1,25-(0H)2-vitamin D3-treatment, 
by comparison, showed only a slight accumulation of cells in the Go-phase for U937 and no 
significant accumulation for THP-1 cells. Differential accumulation of cells in the Go phase 
of the cell cycle following treatment with PMA is consistent with the observed inhibition in 
the autonomous proliferation of both cell lines. 
(a) U937 cells (b) THP-1 cells 
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FIGURE 2.2 Cell cycle distribution of U937 and THP-1 cells following differentiation. (a) U937 and (b) 
THP-1 cells were either untreated or induced to differentiate by the addition of PMA (5 ng.mr1), rhIFNy (200 
iu.mr1) or 1,25-(0H)i-vitamin D3 (10-
7 M) for 48-72 hours at 37°C. The blue bars represent cells in G0 phase, 
the green bars represent cells in S phase, and the yellow bars represent cells in Gi M phase of the cell cycle. 
Each bar represents the mean percentage of at least 3 independent experiments. 
Comparison of the DNA content of human mononuclear cells, U937 and THP-1 cells showed 
that while both THP-1 cells and human mononuclear cells had diploid chromosome number 
(2N), U937 cells were clearly aneuploid. Chromosomal analysis confirmed that U937 had a 
mean of 57 chromosomes per cell (and a range of 50-63) with many of the chromosomes 
exhibiting extensive structural abnormalities. 
Kinetics of Adherence 
While THP-1 and U93 7 remained in suspension following 1,25-(0H)2-vitamin D3-treatment, 
differentiation of the U937 with PMA and THP-1 with PMA or rhIFN-y resulted in the cells 
becoming adherent within 24-48 hours. Whereas THP-1 cells formed relatively uniform 
macrophage-like mono-layers following PMA- or rhIFN-y-differentiation with a significant 
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proportion of the cells becoming elongated and spindle shaped, PMA-treated U937 cells 
formed irregular and ' patchy' mono-layers . 
Cell surf ace marker expression 
Surface expression of important macrophage markers, such as CD14, CD16 (Fey receptor), 
CD1 lb (CR3), and HLA class I and class II, were monitored following PMA-, rhIFN-y- and 



































FIGURE 2.3 Effect of differentiation on U937 and THP-1 cell surface marker expression. The distribution 
of certain monocyte-specific cell surface markers were assessed on (a) U937 or (b) THP-1 cells which were 
either untreated (dark blue) or induced to differentiate by the addition of PMA (medium blue, 5 ng.mr1), rhIFN-
Y (light blue, 200 iu.mr1), 1,25-(0H)rvitamin D3 (pale blue, 10-
7 M), GM-CSF (light green, 5 ng.mr1) or a 
combination of l ,25-(0H)2-vitamin D3 (10-
7 M) and GM-CSF (5 ng.mr1, medium green). Each bar represents 
the mean of at least 5 independent experiments (error bars represent SD). (*) Represents significantly increased 
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Both U937 and THP-1 cells were found to constitutively express high levels of cell surface 
filA class I. Levels of filA class I expression were further induced [as determined by 
increased mean channel fluorescence (MCF), Table 2.1] on U937 cells following 
differentiation with rhIFN-y, 1,25-(0H)2-vitamin D3 and GM-CSF and on THP-1 cells 
following differentiation with PMA, rhIFN-y and 1,25-(0H)2-vitamin D3. Tissue typing 
showed that U937 cells express cell surface filA-A3 , -B18, -B51 , and -Cwl while THP-1 
express surface filA-A2, -A9, and -BS . 
U93 7 and THP-1 cell lines do not constitutively express detectable levels of filA class II. 
Despite showing a relative increase in MCF following differentiation with rhIFN-y and l,25-
(0H)2-vitamin D3, the absolute percentage of U937 cells staining positive for cell surface 
filA class II was not concurrently up-regulated. Several earlier studies have characterized 
U937 as a filA class II-deficient monocytic cell line and the inability of U937 cells to 
express filA class II was found to reside at the level of gene transcription (Sundstrom and 
Nilsson, 1976; Peterlin et al. , 1984). DNA typing of U937 cells confirmed that they do 
possess the relevant genes for filA class II (DRl , DQ2) despite their not being detectable at 
the cell surface. In contrast, THP-1 cells could be induced to express filA class II following 
differentiation with rhIFN-( but not PMA, 1,25-(0H)2-vitamin D3 or GM-CSF. Both the 
percentage of cells expressing filA class II (Fig. 2.3b) and the relative intensity of cell 
surface staining on individual cells ( determined by increased MCF) was significantly 
increased following rhIFN-(-treatment (p<0.05). 
U937 cells do not express detectable levels of the CD la (2.3 ± 0.6%) (mean ± SD), CD lb 
(1.9 ± 0.6%), or CDlc (2.3 ± 0.4%). The expression levels of these highly conserved antigen 
presenting structures did not increase following PMA-, rhIFNy- and l ,25-(0H)2-vitamin D3-
treatments nor with a combination of GM-CSF and IL-4. This is consistent with the 
previously published findings of Kasinrerk et al. (1993) who demonstrated that U937 cells 
(unlike human monocytes and macrophages) could not be induced to express CDI. 
Both cell lines were found to constitutively express very low levels of cell surface CD14. 
This important monocyte/macrophage marker was differentially inducible in both U937 and 
THP-1 , however, with the percentage of cells expressing CD14 (as detected by Mo2 antibody 
staining) being up-regulated following differentiation with 1,25-(0H)2-vitamin D3 but not 
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PMA, rhIFN-y, or GM-CSF. U937 and THP-1 cells showed similar levels of CD14 (Mo2) 
expression following 1,25-(0H)2-vitamin D3-differentiation. Induction of CD 14 ( as detected 
by MY4 antibody staining) on THP-1 (and U937 to a lesser extent) was greater when 
compared with CD14 (Mo2). PMA, rhIFN( and l ,25-(0H)2-vitamin D3 treatment of both cell 
lines resulted in a significant increase (p<0.05) in the percentage of cells staining positive for 
CD14 (MY4) and the relative intensity of cell surface staining for this marker. 
Whereas 63.1 (± 21.8) % of untreated U937 cells express CD16 (Fey receptor), only 18.5 (± 
5.1) % of THP-1 cells express CD16 constitutively. Neither U937 nor THP-1, however, 
showed significant changes in CD16 expression following exposure to PMA, rhIFNy, l,25-
(0H)2-vitamin D3 or GM-CSF. Both cell lines express comparable levels of CDllb 
(complement receptor 3); and both the percentage of cells staining positive as well as the 
relative intensity of expression in both lines were similarly up-regulated following exposure 
to PMA, rhIFNy, and l,25-(0H)2-vitamin D3. 
In summary, some important constitutive and inducible phenotypic differences have emerged 
when comparing U937 cells with THP-1. Although both cell lines express similar levels of 
cell surface CDI lb (complement receptor 3), U937 but not THP-1 express detectable levels 
of CD16 (Fey receptor) while THP-1 to a greater extent than U937 cells can be induced to 
express CD 14. Most importantly and unlike THP-1 cells, U93 7 cells do not constitutively 
express HLA class II nor can they be induced to do so despite expressing high levels of cell 
surface HLA class I. 
2.3.2 Phagocytosis of M. tuberculosis 
The ability of U93 7 cells to bind and subsequently phagocytose M tuberculosis was 
investigated using three independent techniques: (i) mycobacterial binding assay using ZN 
staining; (ii) TEM of M tuberculosis-infected cells; and (iii) flow cytometric evaluation of 
phagocytosis using FITC-labeled M tuberculosis. 
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M tuberculosis binding assay using Ziehl-Neelson staining 
The ability ofU937 and THP-1 cells (untreated, PMA-, IFN-y- or vitamin D3-treated) to bindM 
tuberculosis (in the presence or absence of fresh human serum) was compared using ZN-
staining and light microscopy (Fig. 2.4). THP-1 cells showed a greater ability to bind M 
tuberculosis than U937 cells. Whereas untreated U937 cells showed poor ability to bind M 
tuberculosis (2.0 ± 1.4 %; mean ± SD), 50.7 ± 19.0 % (mean± SD) of undifferentiated THP-
1 cells had associated mycobacteria. Both cell lines showed strong dependence on serum 
opsonins for mycobacterial binding as indicated by the 2- to 4-fold increase in associated 
bacteria in the presence of fresh human serum. Low levels of bacterial association were also 
found in the absence of serum components suggesting that while bacterial entry into both 
U93 7 and THP-1 cells is predominantly opsonic, a non-opsonic pathway is possibly also 
operative. For U937 specifically, differentiation with PMA-, rhIFN-y-, or l,25-(0H)2-
vitamin D3 had a significant effect on their ability to incorporate M tuberculosis. rhIFN-y-
and l ,25-(0H)2-vitamin D3-treatment of THP-1 cells, by comparison, did not result in a 
significant increase in their ability to phagocytose mycobacteria compared to the untreated 
population. For both cell lines, PMA-treatment showed the most striking results with 57% of 
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FIGURE 2.4. The ability of (a) U937 and (b) THP-1 cells, differentiated with PMA (5 ng.mr1), rhIFN-y (200 iu.mr 
1
) or 1,25-(0H)i-vitamin D3 (10-
7 M), to bind M tuberculosis was compared using ZN staining. U937 or THP-1 
cells (0.5 x 106 cells.mr1) were infected with M tuberculosis (10 CFU.ceU-1) in the absence (green bars) or presence 
(blue bars) of human serum for 90 minutes at 37°C. The bars represent the percentage ofU937 or THP-1 cells with 
at least one associated mycobacterium. Each data point represents the mean (± SD) of at least 3 independent 
experiments, each experiment was carried out in duplicate and at least 200 cells from each sample was assessed. 
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Transmission electron microscopy 
Transmission electron microscopy (TEM) of PMA-differentiated U93 7 cells infected with M 
tuberculosis showed that intracellular mycobacteria were always found within membrane bound 
vacuoles which were usually tightly apposed (Fig. 2.5 a-c) although larger phagosomes 
containing M tuberculosis were also evident (Fig. 2.5 d-e). The majority of infected U93 7 cells 
(35%) contained less than 5 bacilli per cell each contained within single vacuoles. Although 
infrequent, larger vacuoles containing clumps of up to 20 bacteria were also evident (Fig. 2.5 
f) . Quantitative analysis of the infected cells by TEM showed that 53% of PMA-treated 
U937 cells contained one or more bacilli . This level of infection correlates well with the 
results presented in Fig. 2.4 where 57% of PMA-differentiated U937 had associated 
mycobacteria. 
Flow cytometric evaluation of phagocytosis 
The ability ofU937 cells to phagocytose FITC-conjugatedM tuberculosis and FITC-conjugated 
E. coli was compared to human monocytes and monocyte-derived macrophages (but not THP-1 
cells) and evaluated using flow cytometry (Fig. 2.6). The results demonstrate that both human 
monocytes and macrophages have higher phagocytic ability than U93 7 cells differentiated with 
PMA, rhIFN-y or l,25-(0H)2-vitamin D3. While monocytes showed the highest phagocytic 
ability for E. coli (3-fold greater than macrophages and 5-fold greater than PMA-treated U937), 
they phagocytosed M tuberculosis with similar efficiency to macrophages and with a 3-fold 
greater efficiency than PMA-differentiated U937. Undifferentiated U937 showed poor ability to 
phagocytose both E. coli and M tuberculosis. Differentiation of U937 with rhIFN-y, PMA or 
l ,25-(0H)2-vitamin D3 resulted in a 2- to 4-fold increase in the phagocytosis of both bacteria 







FIGURE 2.5. TEM photomicrographs of PMA-differentiated U937 cells (5 ng.mr1) infected with M 
tuberculosis (50 CFU.mr1; 5000x magnification). The bacilli were contained within tightly apposed 
phagosomes (a-c) or within larger vacuoles (d-e). (f) Histogram illustrating the distribution of M tuberculosis 
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FIGURE 2.5. Continued. 
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FIGURE 2.6. Flow cytometric evaluation of phagocytosis of FITC-conjugated (a) E. coli (1000 CFU.ml-1) or (b) 
M tuberculosis H37Rv (100 CFU.ml-1) by human monocytes, macrophages, undifferentiated U937 cells or U937 
cells treated with PMA (5 ng.mr1), rhIFN-y (200 iu.m1-1), or 1,25-(0H)rvitamin D3 (10-
7 M) for 48 hours at 37°C. 
Each box-and-whisker plot shows the distribution, median, and 10th and 90th percentile of at least 4 independent 
experiments. ( •) Indicate possible outliers. 
The level of phagocytosis measured by flow cytometry was significantly lower than the 
mycobacterial binding levels shown in Fig 2.4. There are a number of possible explanations for 
the discrepancies between these two methods. Firstly, conjugating the bacteria with FITC may 
alter cell recognition and therefore uptake of these organisms. Not only may FITC-labeling 
obscure surface structures on the bacilli that are targets for either antibody or complement 
binding but may also affect the interaction of these organisms with their specific macrophage 
entry receptors (complement receptors or Fe receptors, for example). Previous studies have 
demonstrated, however, that FITC-labeling does not alter the ability of human macrophages or 
polymorphonuclear cells to phagocytose other intracellular pathogens (Cantinieaux et al., 1989; 
Drevets and Campbell, 1991). Secondly, it may be that many more mycobacteria (5-fold) bind 
to differentiated U937 than are subsequently incorporated by phagocytosis. It may be that most 
of the associated organisms become non-specifically bound to the surface of U937 cells and 
only those bacilli that have associated with phagocytic receptors become internalized. However, 
the strong correlation found between mycobacterial binding (Fig. 2.4) and IBM-determined 
infection efficiency (Fig. 2.5) argues against this possibility. Thirdly, it is possible that E. coli 
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and M tuberculosis were not uniformly or adequately labeled with FITC resulting in differential 
fluorescence at the single cell level. Because the TEM results confirmed the mycobacterial 
binding results, it is reasonable to conclude that flow cytometric assessment of intracellular M 
tuberculosis is a less sensitive approach resulting in measurable under-estimations of true 
phagocytic ability for U937 cells. 
2.3.3 Respiratory burst activity following infection 
Consistent with their immature phenotype, undifferentiated U93 7 and THP-1 cells were 
unable to reduce NBT in response to stimulation with PMA or infection with M tuberculosis 
(Fig. 2.7 a-b) . Following differentiation with rhIFN-y, 1,25-(0H)2-vitamin D3 and to a lesser 
extent PMA, however, the ability of differentiated cells to reduce NBT in response to PMA-
activation was measurably increased. Despite showing moderate to strong respiratory burst 
activity following PMA-stimulation, however, both THP-1 and U937 cells showed uniformly 
poor oxidative burst activity following infection with M tuberculosis. By comparison, freshly 
isolated human monocytes showed a much stronger respiratory burst response following 
infection with both E. coli and M tuberculosis than terminally differentiated macrophages or 
U937 cells (Fig. 2.7 c-d). 
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FIGURE 2. 7. The ability of U937 to mount a respiratory burst response following PMA-stimulation or infection 
with M tuberculosis was demonstrated by (a-b) NBT reduction and (c-d) flow cytometric evaluation of 
dihydrorhodamin-123 reduction and compared with either TIIP-1 or human monocytes and monocyte-derived 
macrophages. (a-b) U937 and TIIP-1 cells were either untreated or induced to differentiate with PMA (5ng.mr1), 
rhIFN-y (200 iu.mr1), or l ,25-(0H)rvitarnin-D3 (10-
7 M) for 48 hours as described in Methods and Materials. 
Untreated, PMA-, rhIFN-y-, and 1,25-(0H)rvitarnin-Dr<lifferentiated U937 and TIIP-1 cells were then re-
stimulated with PMA (10 µg.mr1) or infected with M tuberculosis (100 CFU.ceU-1) for a further 1 hour at 37°C. 
Each bar represents the mean of two independent experiments. (c-d) Fresh human monocytes were derived from 
heparinized whole blood while monocyte-derived macrophages were differentiated for 4-6 days at 37°C. U937 cells 
were induced to differentiate as described above. Cells were infected with either E. coli (1000 CFU.mr1) or M 
tuberculosis (100 CFU.mr1) for 10 minutes at 37°C. Dihydrorhodarnin-123 substrate was added to each sample for 
a further 10 minutes at 37°C. Respiratory burst activity was then quatified using an Epics Profile II flow cytometer. 
Each box-and-whisker plot shows the distribution, median, and 10th and 90th percentile of at least 3 independent 
experiments. ( •) Indicate possible outliers. 
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2.3.4 Intracellular survival of M tuberculosis H37Rv and BCG 
The influence of PMA-, rhIFN-y- and l,25-(0H)2-vitamin 03-induced differentiation on the 
permissiveness of U93 7 cells to intracellular mycobacterial growth and survival was compared 
with THP-1 cells in order to determine if observed differences in phenotype and function affect 
the anti-mycobacterial effects of these cells (Fig. 2.8). Regardless of the agent used to induce 
maturation, terminally differentiated U93 7 cells were found to be permissive to the growth of 
both virulent M tuberculosis H37Rv and, to a lesser extent, non-virulent BCG with bacterial 
cell numbers increasing by approximately one log unit over an infection period of 5 days. 
IFN-y-differentiated U937 cells were found to be the most permissive to mycobacterial 
growth compared with cells similarly differentiated with PMA or l ,25-(0H)2 vitamin 0 3 
(Table 2.2). By comparison, differentiated THP-1 cells were less permissive to the intracellular 
growth of both M tuberculosis and BCG than U93 7 cells. The kinetics of the intracellular 
infection differed quite significantly from those observed for U937 with bacterial growth 
proceeding linearly rather than exponentially in THP-1 cells. Like U937, however, rhIFN-y-
differentiated THP-1 cells were found to be the most permissive to intracellular 
mycobacterial growth compared with cells differentiated with PMA or l,25-(0H)2 vitamin 
0 3. Both U937 and THP-1 cells were better able to restrict the growth of BCG than H37Rv 
(Table 2.2). 
Table 2.2 Comparative doubling time ofM tuberculosis H37Rv and BCG within U937 and THP-1 cells 
Cell Line Treatment Doubling time (hours) • Relative doubling 
H37Rv BCG time (H37Rv:BCG) 
U937 PMA 37.2 79.0 2.1:1 
rhIFN-y 54.4 66.1 1.2:1 
VitaminD3 40.7 57.9 1.4: 1 
THP-1 PMA 491.9 797.7 1.6:1 
rhIFN-y 101.2 238 .5 2.4 :1 
VitaminD3 94.9 365.5 3.9:1 
"Doubling times were calculated from best-fit straight line through logarithmic plot of [3H]-Uridine 
incorporation (cpm) versus time (Fig. 2.9). 
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FIGURE 2.8. Effect of differentiation on the ability of U937 and THP-1 cells to control the intracellular 
growth of M tuberculosis and BCG. (a) U937 and (b) THP-1 cells, induced to differentiate with (e ) PMA (5 
ng.mr1), (• ) rhIFN-y (200 iu.mr1) or(• ) 1,25-(0H)r vit D3 (10-
7 M), were investigated for their permissiveness 
to intracellular mycobacterial growth. Differentiated cells were infected with M tuberculosis H37Rv or BCG 
(0.1 CFU.ceff1) and intracellular mycobacterial growth was determined immediately following infection (day 
0), and at 3 and 5 days post-infection. Mycobacterial growth was measured by [3H]-Uridine (specific activity 
185 MB; 1 µCi .weff1) incorporation. Pooled cell lysate and supernatant (100 µl.weff
1
) were incubated together 
with [3H]-Uridine in 6-well replicates for 10 days at 37°C, 5% COi. Each data point represents the mean of two 
independent experiments. 
2.3.5 Influence of M. tuberculosis infection on HLA class I and II expression 
The expression of HLA class I and class II molecules on the surface of U937 cells were 
monitored following infection with M tuberculosis (Table 2.3). While the relative level of 
surface HLA class I (measured by MCF) on the M tuberculosis-infected but not the BCG-
infected U937 cells was significantly up-regulated (p<0.05) compared with uninfected cells, 
no change was observed in HLA class II expression by infected U93 7 cells. Although HLA 
class I and II expression levels were monitored for 5 days following infection, no change in 
either the percentage of cells expressing HLA surface antigens or in the relative level of 
expression on individual cells (measured by MCF) was observed (data not shown). 
Chapter 2 In vitro Macrophage Models 69 
Table 2.3. Effect of mycobacteria/ infection on U937 cell surface HLA class I and class II expression. 
HLA molecule Treatment Percentage(± SD) ofU937 cells MCF• (± SD) ofU937 cells 
expressing cell surface antigen expressing cell surface antigen 
Isotypic control6 Specific Abe Isotypic control6 Specific Abe 
HLA class II Uninfected 2.3 (± 1.0) 3.2 (± 2.6) 34.4 (± 20.9) 30.3 (± 18.1) 
ECG-infected 2.1 (± 0.6) 2.5 (± 1.3) 27.5 (± 11.2) 29.7 (± 15.9) 
Mtb-infected 2.0 (± 0.7) 2.2 (± 1.2) 35.0 (± 10.7) 32.8 (± 9.4) 
HLA class I Uninfected 2.1 (± 1.9) 96 .6 (± 2.6) 12.6 (± 13.4) 27.0 (± 12.1) 
ECG-infected 2.7(±1.7) 96.7 (± 2.1) 18.2 (± 19.5) 28.2 (± 8.9) 
M lb-infected 3.3 (± 2.4) 94.3 (± 1.3) 23 .8 (± 3.5) 59.5 (± 9. 7)d 
•Mean channel fluorescence (MCF). 6Isotypic control for non-specific antibody binding. especific antibody (Ab) 
directed against HLA class II and class I, respectively. dM tuberculosis-infected U937 cells expressed 
significantly higher levels of HLA class I (as measured by MCF) than uninfected cells (p<0.05; Wilcoxon ranks 
test for paired non-parametric data). 
A summary of the results presented in Fig. 2.1 to 2.9 is given in Table 2.4. 
Table 2.4 Phenotype of U937 and THP-1 ce//s0 
Cell Lines Human monocytes or 
U937 THP-1 monocyte-derived 
Constitutive Inducible Constitutive Inducible macrophages
0 
Late Differentiation Markers 
CD14 + + +e 
CR3 (+) + (+) + +e 
HLA class II + +c 
Phagocytosis + + + + C 
Respiratory burst 
PMA + + ndd 
M tuberculosis + hie 
E. coli nd nd + blc 
Intracellular survival 
ECG nd (+) nd (+) nd 
M. tuberculosis nd + nd + nd 
•summary of results presented in Fig. 2.3 to Fig. 2.9. A+ indicates that the various phenotypic or functional 
properties were detected in a cell line or normal monocyte. A(+) indicates that the levels of expression/growth 
were low. A - indicates that the properties being assessed were not detected. ~xperiments were carried out 
using freshly isolated human monocytes. °Experiments were carried out using monocyte-derived human 
macrophages following 4-6 days in vitro differentiation. dnd (not determined) . 
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2.3 DISCUSSION 
The macrophage-like cell line U937 was investigated as a model for macrophage function in 
mycobacterial infections. U93 7 cells were inducible towards more mature macrophage 
phenotypes by the addition of PMA, rhIFNy, or 1,25-(0H)2-vitamin D3. The efficiency of 
monocytic differentiation was demonstrated by the cessation of autonomous proliferative 
ability, growth arrest in the Go phase of the cell cycle, cellular adherence under certain 
conditions, and the acquisition of monocyte-specific surface receptors (CDl lb, CD16, and 
CD14 to a lesser extent but not HLA class II) . Although all of the agents used to induce 
differentiation resulted in cellular maturation, each exhibited differing effects on these 
individual characteristics. While PMA was the most potent inducer of growth arrest in Go of 
the cell cycle, reduced proliferation and cellular adhesion, 1,25-(0H)2-vitamin D3 showed the 
most marked effect on cell surface marker expression (CD14 and CDllb). These differences 
may reflect differences in the signal transduction pathways used by these different agents 
[with IFN-y acting via specific cytokine receptors, l ,25-(0H)2-vitamin D3 via steroid 
receptors and PMA acting via protein kinase C; Auwerx, 1991]. The most significant 
phenotypic differences demonstrated by U937 cells compared with THP-1 was the 
constitutive ability of U93 7 but not THP-1 to express CD 16 and the ability of THP-1 but not 
U937 cells to express significant levels of HLA class II following IFN-y differentiation 
(Table 2.5). 
U937 cells have been used extensively as models for macrophage function in a wide range of 
bacterial and viral infections. They have been shown to be capable of both pinocytosis and 
phagocytosis, to demonstrate selective oxidative metabolism, and to release cytokines in 
response to infection (Abshire & Neidhardt, 1993 ; Bianchi et al., 1997; Caron et al., 1994a, 
1994b, 1994c, 1994d; Husmann & Johnson, 1992; Iwamoto et al., 1997; King et al., 1991 ; 
Pearlman et al. , 1988). While U937 cells have only been used fairly recently and 
comparatively rarely to investigate the role of human macrophages in mycobacterial 
infections (Lederman et al. , 1994; Ghassemi et al. , 1995; Jagannath et al. , 1998), THP-1 cells 
have been used extensively to study the interaction of a wide variety of mycobacterial species 
with human macrophages (Beimnet et al., 1996; Friedland et al. , 1992; Hayashi et al. , 1997; 
Knutsen et al. , 1998; Lee & Horwitz, 1995; Lim et al. , 1997; and Lopez-Ramirez et al., 
1994). These studies have investigated issues ranging from mycobacterial modulation of 
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macrophage adhesion molecules, heat shock protein (HSP) expression and host gene 
manipulations following infection. The majority of these studies have empirically used these 
cell lines without investigating whether they are truly representative of human monocyte or 
macrophage function. While several studies have proposed that U93 7 cells share important 
similarities to human alveolar macrophages, the first cells to be encountered by inhaled M 
tuberculosis (Gilbert et al. , 1985; Sheth et al. , 1988), this is the first study to investigate their 
usefulness compared with other models for human macrophage function in mycobacterial 
infections (THP-1 cells, human monocytes and differentiated macrophages) . 
The phagocytic function of macrophages is a central element in host defense against 
mycobacterial infection and uptake is generally accepted to be a macrophage-determined 
event initiated by direct mycobacterial binding to specific macrophage receptors (Ernst, 
1998). Results presented in this chapter demonstrate that the efficiency of M tuberculosis 
phagocytosis by U93 7, and to a lesser extent THP-1 , is highly dependent on both the agent 
used to induce differentiation and the presence of serum opsonins. Differentiation with PMA 
exerted the most potent influence on phagocytic ability for both cell lines. Although THP-1 
cells, human monocytes and differentiated macrophages generally showed greater phagocytic 
abil ity compared to U93 7 cells, U93 7 cells were found to incorporate M tuberculosis quite 
efficiently following PMA but not IFN-y or l ,25-(0H)2-vitamin D3 differentiation (Fig. 2.5-
2. 7). Complement receptors, mannose receptors, surfactant receptors, scavenger receptors 
and CD 14 have all been implicated in mycobacterial binding to human macrophages. 
Because significant differences in phagocytic ability exist between U937 and THP-1 , it 
would be interesting to investigate their respective ' favoured ' routes of mycobacterial uptake. 
While both cell lines show similarly inducible levels of CD 11 b, THP-1 cells show slightly 
enhanced (but still relatively low) CD14 expression following differentiation. By 
comparison, CD16 was constitutively expressed by U937 but not by THP-1 cells. 
Unfortunately, little is known about the cell surface expression of mannose receptors, 
surfactant receptors, and scavenger receptors on U93 7 and THP-1 cells. Regardless of the 
underlying reason for the differences in phagocytic ability, in this particular respect the 
results indicate that THP-1 cells may be functionally more mature than U93 7 cells. 
Electron microscopy of M tuberculosis-infected U937 cells, however, clearly showed that a 
significant proportion of the cells contained intracellular bacilli within membrane bound 
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vacuoles. Schaible et al. (1998) recently demonstrated that, while resting macrophages 
predominantly incorporate bacilli into individual vacuoles (as shown for U937 cells in this 
study), there is a marked trend towards larger communal vacuoles containing 2 or more 
mycobacteria following activation of the host macrophage. Resting macrophages show an 
increase in individual vacuoles as the bacteria enter exponential growth, suggesting that the 
"efficiency" of the infection is indicated by the percentage of vacuoles containing only single 
bacilli. While the majority of infected U937 cells contained bacilli within individual 
vacuoles, a small proportion of the U937 population also contained communal vacuoles 2 
hours post infection. 
The production of respiratory burst via activation of reduced nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase is one of the most important effector mechanisms 
in the bactericidal activity of phagocytes (Crawford et al., 1994). In spite of this, the 
sensitivity of mycobacterial species to toxic oxygen species remains controversial (Walker & 
Lowrie, 1981; Chan et al., 1992) and studies have shown that M tuberculosis actively employs a 
number of mechanisms to evade the toxic effects of reactive oxygen intermediates (Brennan et 
al., 1990; Wright & Silverstein, 1983). Differentiation of myeloid cells is none-the-less 
associated with the acquisition of a functional capacity to generate reactive oxygen species, 
such as superoxide, hydrogen peroxide, hypohalous acid and hydroxyl radicals (Rosen et al., 
1995). In this study the capacity of U937 cells to perform membrane-associated oxidative 
burst following infection with M tuberculosis or activation with PMA was compared with 
THP-1 cells, human monocytes and macrophages and detected by the reduction of NBT and 
dihydrorhodamine-123 dyes. In response to PMA-activation, NBT reduction was stimulated 
similarly in both U937 and THP-1 cells cultured with l,25-(0H)2-vitamin D3 and less 
efficiently with IFN-y. Synergism was demonstrated following simultaneous exposure to 
l ,25-(0H)2-vitamin D3 and IFN-y. PMA differentiated cells, in contrast, showed only limited 
ability to reduce both NBT and dihydrorhodamine-123 . Despite relatively efficient 
phagocytosis of M tuberculosis, both U937 and THP-1 cells failed to exhibit significant 
respiratory burst activity in response to infection (Fig. 2.5 & 2.8). Compared with freshly 
isolated human monocytes and terminally differentiated macrophages, U937 cells demonstrated 
reduced ability to release oxidative metobolites ( as determined by dihydrorhodamine-123 
reduction) in response to infection with E. coli and M tuberculosis. 
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While human monocytes have demonstrated the ability to produce reactive oxygen and nitrogen 
intermediates (the latter being detected much less frequently) in response to mycobacterial 
infection, numerous reports have shown that within in vitro cultured human cells these 
mechanisms are inadequate to control the intracellular growth and survival of both the virulent 
H37Rv strain of M tuberculosis (Silver et al., 1998) and the avirulent strains H37Ra and BCG 
(Molloy et al., 1994; Paul et al. , 1996). The ability of human monocytes to differentiate 
between mycobacterial species on the basis of virulence has been described but appears to 
depend on the maturational status and period of in vitro differentation of the infected phagocyte 
(Douvas et al. , 1986; Jagannath et al. , 1996; Silver et al. , 1998). The present study investigated 
(i) whether U937 and THP-1 cells could support the intracellular growth of M tuberculosis, (ii) 
whether these cells were able to discriminate between mycobacterial species on the basis of 
virulence and (iii) whether the mechanism used to induce differentiation had any impact on their 
ability to control intracellular infection. U937 cells were better able to support intracellular 
mycobacterial growth than THP-1 cells. Like human monocytes (Jagannath et al., 1996), both 
cell lines were approximately 1.5- to 4.0-fold more permissive to the growth of virulent than 
attenuated mycobacterial strains, irrespective of the agent used to induce differentiation (Table 
2.4). Similarly, IFN-y-differentiated U93 7 and THP-1 cells were more permissive to the growth 
of bothM tuberculosis and BCG than cells differentiated with PMA or 1,25-(0H)2 vitamin D3 
demonstrating that maturational status does influence the ability of these cells to control 
intracellular mycobacterial growth. 
Several studies have demonstrated that intracellular pathogens can affect the antigen-presenting 
and accessory cell functions of monocytes due to changes in the expression of molecules 
important for their interaction with T cells, presumably by distortion of signaling pathways that 
activate monocytes (Reiner, 1994). In M tuberculosis infection, Pancholi et al. (1993) 
demonstrated that chronically infected macrophages stimulated T cell proliferation poorly 
compared to cells infected for shorter periods of time. It has since been reported that altered 
antigen presentation following mycobacterial infection is associated with reduced expression of 
cell surface HLA class II (Gercken et al., 1994; Waddee et al. , 1995; Hmama et al., 1998), 
reduced expression of B7 and increased expression of ICAM-1 (Saha et al. , 1994; Lopez-
Ramirez et al. , 1994). Hmama and coworkers (1998) recently found that IFN-y induced 
expression of HLA-DR by THP-1 cells was markedly reduced in cells infected with M 
tuberculosis due to defective transport and processing of HLA class II molecules through the 
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endosomal/lysosomal system. The present study found that although chronic mycobacterial 
infection of PMA-differentiated U937 cells had no detectable effect on HLA class II expression, 
the level of HLA class I expression on cells infected with virulent M tuberculosis H3 7R v but 
not BCG was significantly increased. The inability of mycobacterial infection to influence I-ILA 
class II expression on U937 cells is not surprising since this cell line has previously been shown 
to lack the ability to express HLA class II as a result of hypomethylation of the relevant gene 
(Peterlin et al., 1984). The present study confirmed that no cell surface HLA class II molecules 
were inducible using IFN-y, PMA, GM-CSF or l ,25-(0H)2 vitamin D3 (Fig. 2.4 & Table 2.1). 
On the other hand, the increased cell surface expression ofHLA class I following infection with 
virulent but not attenuated mycobacterial strains is of particular interest since experiments 
described in the following chapter (Chapter 3) have investigated the ability of U937 cells to 
present mycobacterial antigens to I-ILA class I-restricted T cells. Although the role of I-ILA 
class I presentation in mycobacterial infections is contentious, there have been isolated reports 
indicating that infection with virulent M tuberculosis does facilitate the escape of exogenous 
antigens into the HLA class I processing pathway (Mazzaccaro et al., 1996) and that 
mycobacterial antigens are able to gain access to the alternate HLA class I pathway (Canaday et 
al. , 1999). Given the ability of M tuberculosis to evade normal HLA class II-restricted antigen 
presentation (Gercken et al., 1994; Waddee et al., 1995; Hmama et al. , 1998), it may be 
important that I-ILA class I processing and HLA class I-restricted cytotoxic T lymphocytes 
contribute to detection of intracellular, 'hidden' M tuberculosis. A recent report by Kurts et al. 
(1998) demonstrated that high antigenic loads are strongly associated with increased 'cross 
presentation' of exogenous antigens by HLA class I molecules. This may be relevant to this 
particular study since U937 cells were found to be particularly permissive to the intracellular 
growth of mycobacteria compared with THP-1 cells (Fig. 2. 9), a factor which could possibly 
favour increased mycobacterial antigen loading into the HLA class I pathway. 
This study has demonstrated that, in many respects, the U937 cell line represents a useful model 
for a variety of different aspects within the framework of mycobacteria-macrophage 
interactions. Comparing the phenotypes and functional abilities of U937 with THP-1 cells, 
human monocytes and macrophages, some maturational differences were evident. Although 
U937 cells were found to be capable of phagocytosing M tuberculosis efficiently following 
differentiation, their phagocytic ability was reduced compared with THP-1 , human 
monocytes and terminally differentiated macrophages. More importantly, following 
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phagocytosis, U93 7 cells were found to be more permissive to the intracellular growth of M 
tuberculosis than THP-1 cells and chronically infected U93 7 cells were found to express 
significantly increased levels of cell surface expression of HLA class I compared with 
uninfected cells. 
The inability of U937 cells to constitutively and inducibly express HLA class II despite 
expressing high levels of cell surface HLA class I (Sundstrom & Nilsson, 1976; Peterlin et 
al. , 1984) has provided a unique opportunity to investigate the ability of human macrophages 
to process and present mycobacterial antigens to T cells in the absence of a functional HLA 
class II presentation pathway (a subject which will form the major focus of Chapter 3). This 
characteristic in particular, together with the ability of these cells to phagocytose M 
tuberculosis relatively efficiently, to readily support the intracellular growth of these 
organisms and to show significantly increased cell surface HLA class I expression following 
chronic infection, makes the U93 7 cell line a very attractive model for further investigations 
into the presentation of mycobacterial antigens to HLA class I-restricted CTLs. 
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3.1 INTRODUCTION 
The importance of CD4+ T cell-mediated immunity is well-documented in tuberculosis 
(Barnes et al., 1994). The role of CDS+ T cells in mycobacterial infections has proven more 
difficult to demonstrate. Evidence from murine models of tuberculosis showed that CDS+ 
CTL lines were cytolytic towards macrophages infected with M tuberculosis (De Libero et 
al., 1988), f32-microglobulin deficient mice were reported to be more susceptible to 
mycobacterial infection than their wild-type littermates (Flynn et al., 1992), and mice with a 
targeted disruption in the gene for CDS were found to be highly susceptible to infection with 
M tuberculosis (D'Souza et al. , 1998). Until very recently, little success had been achieved 
in determining the role of HLA class I-restricted CDS+ T cells in human immunity to 
tuberculosis with mycobacteria-responsive CDS+ T cells only rarely having been isolated 
from patients with tuberculosis (Rees et al. , 1988). 
Generally, HLA class I-restricted CDS+ T cells respond to microbial antigens present in the 
cytoplasm of infected antigen-presenting cells. These antigens are processed via the classical 
HLA class I processing pathway, in which cytoplasmically situated protein antigens are 
degraded into peptide fragments by proteasomes. These peptides are transported into the ER, 
where they become associated with HLA class I molecules. The resulting peptide/HLA class 
I complexes are then routed through the Golgi complex and transported to the cell surface 
(Heemels & Ploegh, 1995; York & Rock, 1996). 
The mechanism by which mycobacterial antigens derived from intracellular but 
phagosomally-situated M tuberculosis might gain access to the HLA class I presentation 
pathway is slowly emerging. The ability of exogenous bacterial and particulate antigens to 
gain access to the HLA class I processing pathway has been described previously (Rock et 
al. , 1990; Kovacsovics-Bankowski et al., 1993; Pfeifer et al., 1993; Norbury et al., 1995; 
Harding, 1996) and there is now evidence to suggest that infection with M tuberculosis is 
able to facilitate such an exchange of antigens between phagosomes and the cytoplasm 
(Mazzaccaro et al., 1996). Furthermore, a recent report by Canaday et al. (1999) has 
demonstrated that M tuberculosis-derived antigens are capable of accessing the HLA class I 
pathway by an alternative route that does not require proteosomal processing or trafficking 
through the ER. The efficiency of the phagosome-to-cytosol HLA class I processing pathway 
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for presentation of exogenous antigens remains controversial, however, and does not seem to 
be a constitutive characteristic of all professional antigen presenting cells (Reis e Sousa and 
Germain, 1995). 
With the emergence of more sophisticated immunological techniques, and a corresponding 
renewed interest in the role of CD8+ CTLs in tuberculosis, a number of studies have been 
published very recently demonstrating the existence of classical HLA class I-restricted M 
tuberculosis-responsive human CD8+ T cells (Turner and Dockrell, 1996; Tan et al., 1997; 
Lalvani et al., 1998; Lewinsohn et al., 1998; Mohagneghpour et al. , 1998; Canaday et al. , 
1999). Many of these studies have focused on the ability of these CD8+ T cells to produce 
cytokines or proliferate in response to stimulation with defined mycobacterial peptides 
(Lalvani et al., 1998; Lewinsohn et al., 1998; Canaday et al. , 1999). Those reports that have 
demonstrated the existence of cytotoxic CD8+ T cells capable of lysing M tuberculosis-
infected target cells have used very defined priming conditions to facilitate the generation of 
CD8+ CTLs. Tan et al. (1997) reported that mycobacterial-specific CD8+ CTL activity was 
only demonstrable following in vitro co-culture with specific growth factors, while 
Mohagheghpour et al. (1998) made use of mycobacterial peptide pulsed dendritic cells to 
efficiently prime CD8+ CTL effector cells. 
The present chapter describes a relatively simple, robust, and easily adaptable in vitro model 
that makes use of the human macrophage cell line U93 7 (Sundstrom and Nillson, 1976) to 
present mycobacterial antigens to human HLA class I-restricted CD8+ CTLs. U937 cells 
were selected because they constitutively express high levels of cell surface HLA class I 
molecules while expressing undetectable and uninducible levels of HLA class II both at the 
mRNA level and at the cell surface (Chapter 2; Peterlin et al. , 1984). In addition, U937 cells 
have been shown to have a relatively efficient phagosome-to-cytosol pathway for delivery of 
exogenous antigens to the HLA class I processing pathway (Harris et al., 1995). Results 
presented in this chapter demonstrate thatM tuberculosis-infected U937 target cells are more 
rapidly and strongly lysed by CD8+ CTLs than infected autologous macrophages. U937 cells 
provided not only a useful in vitro human macrophage model for selective evaluation ofHLA 
class I-restricted CD8+ CTL function in mycobacterial infections but were also shown to be a 
sensitive indicator for ye/ CTL activity. 
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3.2 MATERIALS AND METHODS 
3.2.1 Cell lines and culture conditions 
U937, Daudi, and K562 were maintained routinely in suspension culture in RPMI-1640 
(Flow Laboratories) supplemented with 10% (v/v) heat-inactivated FCS (Delta Bioproducts), 
2rnM L-glutamine, and lOrnM HEPES at 37°C in a humidified atmosphere of 5% CO2. 
Passage was performed every 2-3 days. Cells used in all experiments were in the logarithmic 
phase of growth and viability exceeded 95% as measured by Trypan blue exclusion. 
3.2.2 Induction of differentiation 
Differentiation was induced by treating U937 cells (5 x 105 cells.mr1; 5ml. welr 1 in 6-well 
plates) with PMA (5 ng.mr1; Sigma; Hewison et al., 1992), 1,25-(0H)2-vitamin D3 (10-
7 M; 
Roche Products Ltd; Zuckerman et al., 1988), or recombinant human IFN-y (100-200 
U.mr1 rhlFN-y; Cetus; Roberts et al., 1991) for at least 48 hours at 37°C, as described in 
Chapter 2. 
3.2.3 Mycobacterial growth conditions 
M tuberculosis H37Rv and M bovis BCG were grown in Middlebrook 7H9 broth (Difeo 
Laboratories, Detroit, MI, USA) supplemented with 10% OADC (State Vaccine, Cape Town, 
South Africa) and 0.02% Tween-80 (Merck, Darmstadt, Germany) at 37°C, 5% CO2. Mid-log 
phase cultures were snap frozen in liquid nitrogen and stored at -70°C. Mycobacterial 
viability was monitored by determining colony forming units (CFU) of serial 10-fold 
dilutions of the bacterial preparations on Middlebrook 7Hl O agar (Difeo) supplemented with 
10% OADC. Frozen mycobacterial cultures were thawed immediately before use and clumps 
disrupted by repeated passage through a 25-gauge needle. In all experiments, bacterial 
preparations were coated with serum opsonins by incubating thawed aliquots with an equal 
volume of fresh human serum for 30 minutes at 37°C. 
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3.2.4 Isolation of human PBMC 
Peripheral blood mononuclear cells (PBMC) were obtained from healthy adult volunteers by 
centrifugation of heparinized venous blood over Ficoll-Hypaque density gradients (Sigma) as 
previously described (Boyum et al. , 1968). 
3.2.5 Selection of human subjects and tissue typing 
U937 cells were shown to express HLA-A3 , -Bl8, -B51 , and -Cwl (Chapter 2). Twelve 
suitable HLA-matched or - mismatched healthy adult employees at Groote Schuur Hospital 
and Western Province Blood Transfusion Centre were recruited for this study. HLA typing 
of U93 7 and human PBMC was performed using the microdroplet lymphocyte cytotoxicity 
test as described by Bodmer et al. (1977) and was determined according to phenotype. 
3.2.6 Flow cytometry 
An Epics Profile II flow cytometer (Coulter) was used to perform immunophenotyping. 
Histograms were gated on the PBMC populations by forward scatter (FS) versus log side 
scatter (LSS). Monoclonal antibodies were from Coulter (Hialeah, FL) or Becktin-Dickinson 
(San Jose, CA) and were directed against T cell phenotypic markers CD4, CD8, y8, and CD3, 
and the T cell activation markers IL-2 receptor (CD25) and HLA-DR. All the monoclonal 
antibodies were directly conjugated with FITC or RDl (PE). Isotypic controls were used in 
all cases to set cursors to allow 2% false positives and antibodies were used as the 
concentrations suggested by the manufacturer. 
3.2.7 T cell rosetting and monocyte-depletion 
Adsorbed FCS was prepared by incubating 50 ml FCS (Delta Bioproducts) with 25 ml 
washed sheep red blood cells (SRBC ' s) for 1 hour at 37°C, followed by 16 hours at 4°C. The 
FCS-SRBC suspension was centrifuged, the FCS collected, filtered and stored at -20°C. 
Freshly isolated PBMC were re-suspended at 5 x 106 cells per ml in 40% adsorbed FCS PBS. 
The SRBC' s used for rosetting (5-10 ml) were washed three times with PBS. An equal 
volume of freshly isolated PBMC suspended in 40% absorbed FCS PBS was added to 3% 
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packed SRBC in 40% absorbed FCS PBS. This was under-layed with Ficoll-Hypaque (5ml) 
and incubated on ice for 45 minutes. The PBMC-SRBC gradient was finally centrifuged for 
30 minutes at 900g. The supernatant was aspirated and the pellet containing SRBC-T cell 
rosettes was treated with NRiCl to lyse the SRBC' s. The rosetted T cells were then washed 
three times with 10% AB RPMI-1640 and adjusted to the desired concentration. T cells 
purified using this method yielded populations which were approximately 85-95% CD3+ by 
flow cytometry. 
For depletion of monocytes, T cells were purified by two cycles of SRBC rosetting. Purified 
T cells were further depleted of monocytes by an overnight incubation at 37°C, following 
which the non-adherent population was removed and re-plated for a further 2 hours at 37°C to 
allow for any further monocyte adherence. Non-adherent cells were then removed, washed 
once and adjusted to the desired concentration in 10% AB RPMI-1640. Measurement of the 
percentage of purified cells expressing monocyte-specific markers CD14+ and HLA-DR+ was 
used as an indicator of residual monocyte contamination. The proportion of cells staining 
positive for either CD14+ or HLA-DR+ were at the detection limit of the flow cytometer 
( < 1 %, respectively) . 
3.2.8 Stimulation of mycobacterial-specific CTLs and isolation of T cell subsets 
Conventional mycobacterial priming 
PBMC (1 x 106 cells.mr1) were stimulated with PPD (3 µg .mr1; Central Veterinary College, 
Weybridge, UK), M tuberculosis H37Rv or BCG (1 CFU.ceir1) for 6 days at 37°C. On day 
6, the primed CTLs were adjusted to the desired concentration to be used in the cytotoxicity 
assays ( described below). 
In experiments requiring isolation of individual T cell subsets, the separation was done on 
day 5 using Minimacs magnetic bead separation (Miltenyi Biotec, CA) and the cells were 
allowed to recover overnight. Purification was done according to the manufacturer' s 
directions (Miltenyi Biotec). CD4+ and CD8+ T cells were selected using directly-conjugated 
magnetic beads while yf:/ T cells were enriched by sequential CD4+/CD8+ T cell-depletion or 
isolated using indirectly-conjugated yo mAb (Becton-Dickenson) and goat anti-mouse IgG1 
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magnetic beads (Miltenyi Biotec). Briefly, PBMC (1 x 107), re-suspended in 80 µl separation 
medium [PBS containing 5 mM EDTA, 0.5% bovine serum albumin (BSA)] were incubated 
together with 20 µl CD4-, CD8- or y6-coated magnetic beads for 15 minutes at 4°C. 
Immediately prior to use, a MS+ separation column (Miltenyi Biotec) was washed with 500 
µl separation medium and placed onto the Minimacs magnet. The labelled cells were 
pipetted onto the column and allowed to run through. The column was washed once with 500 
µl separation buffer and the effluent collected as the negative fraction. The column was 
washed a further three times with 500 µl separation buffer before the column was removed 
from the magnet. The column was placed into a capture tube and the positively labelled 
(attached) cells flushed out in 1 ml separation buffer using a plunger. These cells were 
collected as the positive fraction. For sequential CD4/CD8-depletion, a flow resistor 
(provided by the manufacturer) was attached to the MS+ column to maximise the efficiency 
of CD4 or CD8 retention on the column. The purity of the CD4+, CD8+ and y6+ T cell 
fractions was determined by flow cytometry. The purity of the positively selected CD4+ and 
CD8+ T cell subsets ranged between 95-99% with the CD4+ and CD8+ purified T cell 
populations showing less than 1 % contamination with CD8 or CD4 T cells, respectively. 
The purity of the y6+ T cell fractions ranged between 85-90% but showed less than 1 % 
contamination with either CD8+ or CD4+ T cells. On day 6, the purified T cell populations 
were adjusted to the desired concentration to be used in 51 Cr release assays or used to 
generate T cell lines or clones. 
To investigate the influence of culture conditions on the efficiency of CD8+ CTL priming, 
several alternative approaches were assessed for their ability to prime M tuberculosis-
specific CD8+ CTLs. The first two approaches manipulated culture conditions at the level of 
the CD8 T cell by addition of growth factors or the early separation of CD8 T cell effectors. 
The last two approaches manipulated culture conditions at the level of the antigen presenting 
cell by either shocking mycobacterial antigens into the filA class I processing pathway or by 
using U937 cells (which are filA class t/class ff and have an efficient phagosome-to-
cytosol delivery system) to present antigen. 
Supplemented with low dose r!L-2 
PBMC were primed withM tuberculosis (l CFU.mr1) or PPD (3 µg .mr1) as described above 
for 5 days but rhlL-2 (10 iu.mr1; Cetus) was added at the initiation of the experiment 
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(adapted from Tan et al., 1997). CD8+ T cells were isolated on day 5 using Minimacs 
magnetic bead separation (described above; Miltenyi Biotec) and the purified cells allowed to 
recover for at least 16 hours prior to assessment of their cytolytic activity. 
Early CD8 selection and r!L-2 stimulation 
PBMC were primed with M tuberculosis (l CFU.mr1) for 24 hours following which the 
CD8+ CTL subset was isolated using Minimacs magnetic bead separation ( described above; 
Miltenyi Biotec) and cultured in the presence of rIL-2 (50-100 iu.mr1) for the remaining 5 
days. No additional antigen presenting cells were added to the purified CD8+ T cells. On day 
6, CTLs were adjusted to the desired concentration to be used in the cytotoxicity assays. 
Osmotic lysis 
To determine whether poor CD8+ CTL priming was the result of inefficient HLA class I 
presentation of mycobacterial antigens, osmotic shock was investigated as an alternative 
method for loading of mycobacterial antigens into the HLA class I pathway. Macrophage 
target cells were prepared according to the method described by Moore et al. (1988). 
Autologous human macrophages were prepared by culturing PBMC (1 x 106 cells.mr1; 10% 
assumed to be macrophages) in 6-well tissue culture plates. After 24 hours, non-adherent 
cells were removed and the monolayers washed three times with warmed 10% AB RPMI. 
The final wash medium was removed from the macrophage monolayers and replaced with 
1ml pre-warmed hypertonic medium [0.5 M sucrose, 10% w/v polyethylene glycol-1000, 
lOmM HEPES in RPMI-1640, pH 7.4] containing either M tuberculosis (1 x 105.mr1) or 
PPD (3 µg .mr1) for 10 minutes at 37°C. This was diluted to 10 ml with pre-warmed 
hypotonic medium (60% RPMI-1640, 40% dH20) and incubated for a further 2-3 minutes at 
37°C. The target cells were washed three times with pre-warmed 10% FCS RPMI-1640 and 
overlaid with monocyte-depleted PBMC in 10% AB RPMI-1640 to give a final concentration 
of 10 responder cell per osmotically shocked target cell . On day 5, CD8+ T cells were 
isolated using Minimacs magnetic bead separation (described above; Miltenyi Biotec) and 
allowed to recover for at least 16 hours prior to the cytotoxicity assay. 
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U937 as antigen presenting cells 
U937 cells were induced to differentiate with PMA for 48 hours. Differentiated cells were 
either (i) uninfected and then paraformaldehyde (PF A) fixed ; (ii) infected with M 
tuberculosis H37Rv (2 hours, 5 CFU.ceir1) and then PFA fixed; or (iii) PFA fixed and then 
co-cultured withM tuberculosis (6 days, 5 CFU.ceir1). For the PFA-fixation steps, adherent 
U937 cells were EDTA-detachment and then fixed with 0.75% paraformaldehyde (PFA) in 
PBS using the methods described by Pfeifer et al. (1993) and Moreno and Lipsky (1986). 
Briefly, the cells were washed three times to remove excess serum, and re-suspended in PBS 
containing a final concentration of 0.75% PFA (Merck, Darmstadt, Germany) at 37°C for 5 
minutes. The reaction was stopped by the addition of 0.4M lysine (Sigma). Cells were 
washed once with PBS and twice with 10% AB serum RPMI-1640 and re-suspended in 10% 
AB RPMI-1640. "Leaching" of any remaining PFA was accomplished by incubation at 37°C 
for at least 60 minutes, after which time the cells were washed once, re-suspended in fresh 
10% AB RPMI-1640 and adjusted to desired concentration. 
For these experiments, the ability of U937 cells to present antigen to and prime HLA class I-
matched (monocyte-depleted) PBMC proliferative ability was investigated. Monocyte-
depleted PBMC (1 x 105 cells.weir1) were cultured together with (i) uninfected (and then 
fixed); (ii) M tuberculosis-infected (and then fixed); or (iii) fixed and then M tuberculosis-
infected U937 cells (1 x 104 U937 cells.weir1) in triplicate wells for 6 days. [3H]-thymidine 
(1 µCi .welr1) was added to each well for the last 18 hours of the assay. To inactivate any 
residual infectious M tuberculosis, cells in each well were fixed by the addition of an equal 
volume of 1 % PF A for 1 hour. Cells were harvested using an automated cell harvester 
(TitertekR 630) and radioactivity (cpm) was measured using a liquid scintillation counter 
(Tricarb 4640). 
3.2.10 Cytotoxicity assays 
Adherent target cytotoxicity assay 
The adherent target cytotoxicity assay using autologous macrophages has been described 
previously by Lorgat et al. (1992). Monocyte-derived macrophages ( day 6; plated at 105 
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PBMC.weir1 in microtitre wells; 10% assumed to be macrophages) were infected with M 
tuberculosis H37Rv (5 CFU.ceir1), pulsed with the irrelevant streptococcal antigen 
streptokinase-streptodomase (SK-SD; 250 iu .mr1 SK; 62.5 iu .mr1 SD; Lederle Laboratory), 
or left uninfected and concurrently labelled with 51 Chromium (6 µCi.welr 1; 51Cr; Amersham) 
for 16 hours at 37°C. The target cells were washed three times with pre-warmed 10% FCS 
PBS. M tuberculosis-primed PBMC effector cells were serially diluted and added to 
triplicate wells at varying concentrations to achieve final effector:target ratios of 10: 1, 3: 1 
and O. 3: 1. Wells containing medium alone were used to determine spontaneous 51 Cr release. 
The effector and target cells were incubated for either 4 or 16 hours (as indicated in the figure 
legends) at 37°C, 5% CO2. The contents of each well was removed and counted to determine 
the amount of spontaneous 51Cr-release (cpm). Triton X-100 (5% in PBS; 100µ1) was added 
to each well for an additional 4 hours, removed and counted to determine the maximum 
amount of 51 Cr released. The spontaneous:maximum 51Cr-release never exceeded 15 % . 
Specific target cell lysis for triplicate wells was calculated as follows : [mean test cpm/(mean 
test cpm + mean maximum cpm)] and expressed as a percentage. 
Non-adherent target cy totoxicity assay 
U937 cells were induced to differentiate with PMA, IFN-y or l ,25-(0H)2-vitamin D3 for 48 
hours prior to the assay as described previously. The cells were either infected with M 
tuberculosis H37Rv (5 CFU.ceir1), pulsed with SK-SD (250 iu.mr1 SK; 62.5 iu.mr1 SD; 
Lederle Laboratory), or left uninfected forl6 hours at 37°C. The cells were subsequently 
labelled with 250 µCi 51Cr for 60-90 minutes, washed three times with cold 10% FCS PBS 
and adjusted to the 1 x 105 cells per ml. M tuberculosis-primed PBMC effector cells were 
serially diluted and added to triplicate wells at varying concentrations to achieve final 
effector:target ratios of 10:1, 3:1, 1:1 and 0.3:1. The effector and target cells were co-
incubated for 4 hours at 37°C, 5% CO2. Specific target cell lysis was calculated from the 
mean of triplicate wells using the following equation: [ mean test cpm-mean spontaneous 
cpm]/[mean maximum cpm-mean spontaneous cpm] and expressed as a percentage. 
Spontaneous 51 Cr release was determined from sextuplicate wells of 51Cr-labelled targets 
incubated with medium alone while maximum 5 1Cr-release was measured from sextuplicate 
wells of targets treated with 5% Triton X-100 for the duration of the assay. The 
spontaneous:maximum 51Cr-release never exceeded 25 % . 
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3.2.11 Generation of T cell clones 
T cell clones were generated by limiting dilution as previously described from M 
tuberculosis-primed bulk PBMC cultures, or from short-term yf/ T cell lines (Bach, 1983). 
Cells to be cloned were washed in PBS and re-suspended at 106 cells.mr1 in fresh culture 
medium containing RPMI-1640 supplemented with 10% autologous serum, 2-
mercaptoethanol (5 x 10-5 M; BDH Chemicals, Poole, England), non-essential amino acids 
(lOmM; Highveld Biologicals, Johannesburg, South Africa), L-glutamine (2mM; Highveld 
Biologicals), sodium pyruvate (lmM; Highveld Biologicals) (cloning medium). Cells were 
then serially diluted as required in cloning medium. Cloning was done in Terasaki plates and 
responder cells were seeded at 1.0, 0.3 or 0.2 cells per well. Feeder cells used were 
autologous irradiated ( 40 Gy) PBMC (104 cells.weU-1). Cells were stimulated with rhIL-2 
(100 iu.mr1) and either PHA (1.1 x 10-2 mu.mr1) or M tuberculosis (0.1 CFU.feede(1), in a 
final volume of 20 µl. Plates were incubated at 37°C, 5% CO2. Cell growth was determined 
by visual inspection using an inverted microscope (Nikon TMS, Japan) after 8-10 days. 
Wells were scored positive if greater than one forth of a particular well surface was covered 
with cells. 
3.2.12 Expansion and maintenance of clones 
Positively scored wells were selected on day 9 to 10 by transferring the contents of individual 
positive Terasaki wells to U-bottomed 96-well microtitre plates. Re-stimulation was 
performed using irradiated autologous PBMC as feeder cells (105 cells.weU-1), rIL-2 (100 
U.mr1) and either PHA (1.1 x 10-2 mu.mr 1) or M tuberculosis H37Rv (0.1 CFU.feeder ceU-1) 
depending on the stimulus used for the initial priming, in a final volume of 100 µl per well of 
cloning medium. The growing cultures were supplemented with 100 µl fresh cloning 
medium containing rIL-2 (100 U.mr1) 3-4 days after transfer and cells were re-suspended 
regularly to avoid formation of large clusters. Seven days after transfer, clones were split 
into two wells and re-stimulated with feeders, antigen, and rIL-2 as indicated above. Cells 
were transferred to 24 well tissue culture plates, usually by the end of the second passage in 
microtitre wells, and re-stimulated as previously described in a final volume of 1 ml. 
Cultures were re-suspended regularly, supplemented with fresh cloning medium every 3-4 
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days and passaged weekly. Once sufficient cells had been obtained, aliquots of clones were 
cryo-preserved and the remainder of the cells analysed as indicated below. 
3.2.13 Selection and characterisation of clones 
The T cell clones were selected firstly on the basis of their cytolytic function against M 
tuberculosis-infected U937 target cells, and secondly by phenotype and mycobacterial-
specific proliferative ability. 
Cytotoxicity 
The clones were screened for their cytolytic activity against M tuberculosis-infected U937 
target cells in a 4 hour 51 Cr-release assay (described above) . The initial assessment of 
cytotoxic ability was performed using 50-100 µl of each respective clone at unknown cell 
concentration against either uninfected or infected PMA-differentiated U937 cells (104 
cells.weU-1). Clones that were able to kill U937 target cells in a mycobacterial-specific 
manner (M tuberculosis-specific kill >5% above background was chosen as an arbitrary cut-
off point) were selected for further analysis. Cytotoxic function of the "positive-killer 
clones" was then confirmed in triplicate and at multiple effector to target ratios. Cytolytic 
activity of the T cell clones was measured on day 2 or 3 following re-stimulation with 
feeders, antigen and rIL-2. 
Phenotypic analysis 
Phenotypic analysis of the clones obtained was performed by flow cytometry as previously 
described using 3-colour fluorescence (CD4-FITC/CD8-PE/CD3-PI). CD3+ T cell clones that 
were both CD4- and CDS-negative were then screened using yo-FITC/CD3-PE dual colour 
fluorescence. 
Chapter 3 Models for HLA class I presentation 88 
Proliferation 
T cell clones were screened for their antigen reactivity by stimulating resting clones (1 x 106 
cells.mr1) with fresh irradiated autologous feeders (1 x 106 cells.mr1) and with either PHA 
(1.1 x 10-2 mu.mr1), PPD (3 µg .mr1), or M tuberculosis H37Rv (0.1 CFU.feede(1) for 40-48 
hours, 37°C, 5% CO2 . Proliferation to the various antigens was measured by 3H-thymidine 
incorporation. 3H-Thymidine (1 µCi .weU-1; specific activity 185 MB; Amersham 
International) was added to triplicate wells for the last 8 hours of the assay. The clones were 
fixed by the addition of an equal volume of 1 % PF A for 1 hour to inactivate any infectious 
M tuberculosis before being harvested using an automated cell harvester (TitertekR 630). 
The radioactivity (cpm) was measured using a liquid scintillation counter (Tricarb 4640). 
3.2.14 Statistical analysis 
Statistical analyses were performed using the Wilcoxon ranks test for paired non-parametric 
data and the Mann-Whitney U-Test for unpaired non-parametric data (Kaplan, 1987). 
3.3 RESULTS 
3.3.1 Selection of HLA class I-matched donors 
U937 cells were shown to express HLA-A3 , -B18, -B51 , and -Cwl (Chapter 2). Twelve 
suitable healthy adult employees at Groote Schuur Hospital and the Western Province Blood 
Transfusion Centre were recruited for this study on the basis of their HLA-typing. Six of the 
donors were selected because of their HLA class I-compatibility to U937 [4 A3- and 2 B51-
matched]. The remaining donors were HLA class I-mismatched to U937 cells. All of the 
selected donors showed strong proliferative responses to the purified protein derivative (PPD) 
of M tuberculosis. The HLA-typing and PPD response of the selected donors has been 
summarised in Table 3 .1. 
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Table 3.1 HLA-typing of class I-matched and -mismatched donors 
HLA-histocompatibility Donor SI" HLA class I-typing HLA class II-typing 
Cell Line U937 A3 ,- Bl8,51 Cwl ,-
HLA class I-matched RG 58.8 A2,31 B516,62 Cw3,- DR4,ll DQ3,-
BR 7.0 A2,24 B51\ 7 Cw3,6 DR2,13 DQl ,-
TS 125.4 A3\2 B35,44 Cw4,5 DRl ,7 DQl ,2 
PB 77.3 A3 \28 B7,42 Cw7,- DR2, ll DQl,7 
ES 89.1 A3 \28 B35,7 Cw4,- DR2,- DQl ,-
EC 91.8 A3 \30 B7,65 Cw7,8 DR2,ll DQl,7 
HLA class I-mismatched MH 12.3 Al ,28 B37,62 Cw3,6 DR2,13 DQl ,-
NP 22 .9 All ,30 Bl3 ,58 Cw6,7 DR2,17 DQl ,7 
SG 52 .3 A28,34 Bl6,40 Cw-,-C DR2,14 DQl ,-
SJ 23.4 A24,3 1 B7,8 Cw7,- DR2,17 DQl ,2 
MF 40.5 A26,33 B58,- Cw3,6 DR4,17 DQ2,8 
WM 193 .5 A30,68 B42,53 Cw4,- DR8,18 DQ4,7 
• SI (stimulation index to PPD) was calculated as follows : [cpm following PPD stimulation] + [cpm of 
unstimulated cells]. bHLA class I-matched to U937 cells. ccw-,- indicates that no HLA-Cw surface antigen was 
detected. 
3.3.2 NK and LAK activity against U937 
In order to investigate the feasibility of using U93 7 cells to present mycobacterial antigens to 
HLA class I-matched T cells, the relative contribution of natural killer (NK) cell or 
lymphokine activated killer (LAK) cell activity was investigated (Fig. 3 .1 ). Undifferentiated 
U937 cells were found to be as susceptible to NK activity as K562 (the classical NK indicator 
cell line) . And following rIL-2 stimulation of LAK effectors (6 days), U937 cells were killed 
with similar efficiency as Daudi cells (the classical LAK indicator cell line) . Differentiation 
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FIGURE 3.1. NK. (a) and LAK (b) cell-mediated kill against untreated U937 cells (T ), PMA-differentiated 
U937 cells (• ), K562 (e), and Daudi (• ). Cytotoxicity was determined after 4 hours. Each data point 
represents the mean percentage kill of duplicate experiments. 
3.3.3 Effect of differentiation on cytolysis of U937 cells 
To determine whether differentiated U937 cells could be used as targets for human CTL 
activity and whether the agent used to induce differentiation had an influence on their 
susceptibility to T cell-mediated cytolysis, the ability of this cell line to present mycobacterial 
antigens to M tuberculosis-primed, HLA class I-matched CTLs was investigated (Fig. 3.2). 
U937 cells were treated with PMA, IFN-y, or l ,25-(0H)2-vitamin D3 for 48 hours and then 
infected with M tuberculosis H37Rv and used as target cells in a 4 hour 51Chromium release 
assay. The M tuberculosis-primed ( day 6) CTLs used in these experiments were HLA-B51-
matched to U937 target cells. Following differentiation, PMA-treated U937 cells were found 
to be more susceptible to mycobacterial antigen-specific CTL activity [ 19. 7 (± 9. 7) % 
mycobacterial-specific] than IFN-y- [7.8 (± 4.4) % mycobacterial-specific) or 1,25-(0H)2-
vitamin D3-differentiated cells [9.2 (± 4.1) % mycobacterial-specific) and their susceptibility 
to lysis correlated well with their respective phagocytic abilities (Fig. 2.5; r = 0.89). PMA-
differentiated U937 cells were therefore used in all subsequent experiments. 
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FIGURE 3.2. Comparison of M tuberculosis-specific cytolysis generated against (a) PMA-, (b) IFN-y-, and 
(c) 1,25-(0H)rvitamin ~-differentiated U937 target cells. The CTLs used in these experiments were derived 
from a single donor (RG; Table 3.1) HLA-matched to U937 at -BS 1. Target cells were either infected with M 
tuberculosis(• ) or pulsed with an irrelevant streptococcal antigen SK-SD (e). Cytotoxicity was measured after 
4 hours. Each data point represents the mean percentage kill of at least two independent experiments (± SEM). 
Taken together, the results presented in Fig. 3 .1 and 3 .2 indicate that the cytolysis generated 
against M tuberculosis-infected, PMA-differentiated U937 target cells is antigen-specific and 
not influenced by either NK- or LAK-mediated cytolytic activity. 
3.3.4 Cytolysis of U937 and autologous macrophages 
Fig. 3 .3 shows the mean susceptibility of M tuberculosis-infected U937, compared with 
autologous macrophage targets, to CTL activity. To investigate the HLA-restriction of the 
mycobacterial antigen-specific cytolysis generated against U937 targets, the CTLs used in 
these experiments were HLA-A3-matched, HLA-B51-matched or HLA-mismatched to U937 
target cells. Both HLA-A3- and -BS I-matched CTLs showed significantly greater ability 
(p<0.05, Wilcoxon ranks test) to lyse M tuberculosis-infected U937 cells than SK-SD-pulsed 
cells (Fig. 3.3a & b, respectively) . The HLA-B51-restricted CTLs in particular mediated 3-
fold stronger mycobacterial antigen-specific cytolysis against U937 than against autologous 
macrophage targets. The magnitude of the mycobacterial-specific response was influenced 
by the HLA-restriction of the CTLs since the HLA-A3-restricted CTL population showed 
reduced cytolysis against antigen-pulsed U93 7 target cells as compared with autologous 
macrophage targets. Mycobacterial-specific CTLs generated from donors which were HLA-
mismatched to U937 cells did not demonstrate any significant ability to lyse U937 targets 
(p>0.2), but showed cytolytic activity against autologous macrophage targets (Fig. 3.3c). 
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FIGURE 3.3. M tuberculosis-specific cytolysis generated by (a) HLA-A3-matched, (b) HLA-B51-matched, 
and (c) HLA-mismatched donor CTLs against PMA-treated U937 (top panel) and autologous macrophage 
targets (bottom panel). Target cells were infected with Mtuberculosis (5 CFU.ceff
1
) (II) or pulsed with an 
irrelevant antigen, SK-SD (e ). Cytotoxicity against U937 and autologous macrophage targets was measured 
after 4 hours. Each data point represents the mean percentage cytolysis (± SEM) of at least 3 independent 
experiments. 
Lysis by the HLA class I-matched CTL populations was found to be restricted to live 
organisms since both M tuberculosis H37Rv- and BCG-infected (but not PPD-pulsed) U937 
targets were recognised by the M tuberculosis-primed CTLs and lysed with similar 
efficiency (Fig. 3.4). The M tuberculosis-primed CTLs were, however, capable of 
recognising and lysing autologous macrophage targets pulsed with PPD. The inability of 
PPD-pulsed U937 target cells to be recognised in this context is consistent with the absence 
of a functional HLA class II-processing pathway in the U93 7 cell line. 
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FIGURE 3.4. Mycobacterial antigen-specific cytolysis generated by HLA-B51-matched CTLs against U937 
targets infected with (a) M tuberculosis H37Rv, (b) BCG, or (c) pulsed with the soluble mycobacterial extract 
PPD. Cytotoxicity was measured against target cells infected/pulsed with mycobacterial antigens (a ) or with an 
irrelevant antigen, SK-SD (e ). Cytotoxicity was measured after 4 hours. Each data point represents the mean 
percentage cytolysis(± SEM) of at least 2 independent experiments. 
3.3.5 T cell subset purification 
To directly determine the contribution of the different T cell subsets to mycobacterial 
antigen-specific cytolysis generated against U937 cells, CD8+, CD4+ and y'f:/ T cells were 
isolated from M tuberculosis-primed PBMC by positive selection and, in the case of yf/ T 
cells, by sequential negative selection with anti-CDS- or anti-CD4-coated magnetic beads. 
As shown in Fig. 3. 5 (top panel), M tuberculosis-activated, purified CD8+ T cells were 
cytolytic towards HLA class I-matched M tuberculosis-infected U937 but not cells pulsed 
with the irrelevant streptococcal antigen, SK-SD (15 .7 ± 5.0 % mycobacterial-specific 
cytolysis, p<0.05). The CD8+ CTL activity was HLA class I-restricted since CD8+ cells from 
HLA class I-mismatched donors (Fig. 3.5, bottom panel) showed no significant ability to lyse 
M tuberculosis-infected U937 targets (p>0.1). No cytolysis was obtained with purified 
CD4+ T cells from both the HLA class I-matched and HLA-mismatched donors. 
Interestingly, the ylt -enriched CTL population showed the most significant ability to lyse M 
tuberculosis-infected U937 target cells (17 .9 ± 9.3 % mycobacterial-specific cytolysis, 
p<0.02). Although clearly mycobacterial antigen-specific, these cells were found not to be 
restricted to the classical HLA class I or class II molecules because yf/ CTLs from both HLA 
class I-matched and the HLA-mismatched donors showed strong cytolytic activity against 
infected U937 targets. This study therefore found that although U937 target cells are 
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selectively lysed by CD8+ rather than CD4+ CTLs, the T cell population which demonstrated 
the strongest mycobacterial antigen-specific cytolytic activity against U937 targets was in 
fact yo-TCR +. 
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FIGURE 3.5. Characterisation of the cytolytic T cell subset generating mycobacterial-specific cytolysis 
against U937 target cells. The M tuberculosis-primed HLA-B51-matched CTL (top panel) and the HLA-
mismatched CTL (bottom panel) populations were fractionated into CD8+, CD4+ or yf,+ T cell subsets and 
assessed for their respective cytolytic abilities against U937 target cells. U937 target cells were eithetinfected 
with M tuberculosis (5 CFU.cen-1). (• ) or pulsed'with an irrelevant antigen, SK..:.SD (e ). Cytotoxicity was 
measured ..after--4-hours. -Each data point represents the mean-pei:centag.e-cytolysis-(± SEM) of at least 3 
independent experiments. 
3.3.6 U937 cells and autologous macrophages as targets 
Differentiated U937 cells were more rapidly and strongly lysed by CD8+ T cells than 
autologous macrophage targets (Fig. 3.6). Although all target cells were infected with 
M tuberculosis for the same period of time and under identical conditions, macrophages 
required longer to be efficiently lysed by CD8+ CTLs. By comparison, infected U937 target 
cells were lysed far more rapidly by CD8+ CTLs with the level of mycobacterial-specific 
cytolysis reaching a maximum within 4 hours ( data not shown). 
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FIGURE 3.6. Comparison of CD8+ CTL activity against U937 versus autologous macrophage targets. 
Cytotoxicity was measured after 4 hours for U937 targets, and after 4 and 18 hours for macrophage targets (as 
indicated). The CTLs used in these experiments were derived from a single donor (RG; Table 3. 1) Ill.,A-B51-
matched to U937. Mycobacterial-specific lysis was calculated as follows : [% cytolysis against M tuberculosis-
infected targets]-[% cytolysis against SK-SD-pulsed targets]. Each box-and-whisker plot shows the distribution, 
median (solid line), mean (dotted line), 10th and 90th percentile of 6 independent experiments. (• ) Represent possible 
out-liers. 
3.3. 7 CDS+ T cell activation 
Phenotypic characterization of the CD8+ T cell population showed that under conventional 
priming conditions (M tuberculosis-priming of bulk PBMC in the absence of additional 
growth factors) only 22.9 (± 14.4) % of the CD8 cells expressed IL-2 receptor (CD25) while 
16.0 (± 11.4) % expressed HLA-DR (Table 3.2). Although CD8+ CTLs were not selectively 
expanded following exposure to mycobacterial antigens [relative expansion ratio of 0.9 (day 
0:day 7)] , there was no significant reduction in proportion of CD8 T cells (CD4:CD8 ratio) 
following stimulation. 
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Table 3.2. Phenotype and activation marker expression by the M tuberculosis-primed CD8+ CTL populations 
CTL Donor CD4:CD8" Relative Expansion of CD8+ Activation Marker expression (%) 
DayO Day7 CD8+ T cellsb IL2-R+ HLA-DR+ 
RG 1.8 1.5 0.9 24.8 17.4 
RG 2.2 0.8 0.8 14.6 8.9 
RG 2.6 1.3 0.8 3.4 9.2 
TS nd0 1.8 nd 20.4 9.7 
MA nd 1.5 nd 61.7 46.7 
SG 1.5 2.9 0.7 19.2 15.4 
SC 1.0 1.0 0.8 17.3 11.9 
EC 0.9 2.0 0.7 19.4 9.5 
MH 1.5 1.4 1.0 28.7 24.3 
SJ 2.5 2.5 1.1 20.0 15.8 
BR 2.7 2.5 1.0 22.9 6.6 
Mean(± SD) 1.9 (± 0.7) 1.7 (± 0.7) 0.9 (± 0.2) 22.9 (± 14.4) 16.0 (± 11.4) 
• CD4:CD8 ratios were calculated from absolute % cells expressing CD4 or CD8 as determined by flow 
cytometry. b Relative expansion was calculated from % CD3+ cells expressing CD8 TCR at day O compared 
with at day 6. °Not determined. 
Because it has been well established that conventional mycobacterial priming preferentially 
activates and expands CD4+ and possibly yf/ T cells, it has been proposed that more defined 
culture conditions may be necessary for optimal activation of M tuberculosis-specific CDS+ 
CTLs ex vivo (Tan et al. , 1997; Lalvani et al. , 1998; Lewinsohn et al., 1998). For instance, 
Tan and colleagues ( 1997) reported that CD8+ CTL activity was only evident in human 
alveolar lymphocytes and PBMC cultured with mycobacterial antigens in the presence (but 
not in the absence) of rIL-2. In order to define the optimal conditions necessary for CD8+ 
CTL priming in mycobacterial infections, the effect of various alternative strategies on CD8 
activation marker expression and cytolytic ability were investigated (Fig. 3. 7). The results 
showed that priming of bulk PBMC with the virulent H3 7R v strain of M tuberculosis did not 
result in any significant enhancement in CD8+ CTL activation or function compared with the 
stimulation with the attenuated vaccine strain BCG. In contrast, PBMC cultured together 
with a combination of M tuberculosis and low doses of rIL-2 (10 iu.mr1) showed increased 
expression of IL-2 receptor on CD8+ CTLs but no concomitant enhancement of 
mycobacterial-specific CD8 T cell cytolytic activity. An alternative approach using short-
term bulk stimulation of PBMC with M tuberculosis (24 hours) followed by CD8+ CTL 
subset isolation and rIL-2 (50-100 iu.mr1) activation was used to investigate whether early 
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exclusion of CD4+ T cells enhanced mycobacterial-specific CD8+ CTL activity. The results 
showed, however, that this approach provided no significantly enhanced CD8+ CTL 
activation or cytolytic activity compared with conventional M tuberculosis priming used 
throughout this study. Another approach investigated in this study was the use of osmotic 
shock or lysis to facilitate the release of exogenous antigens into the filA class I processing 
pathway (Moore et al. , 1988). Although priming of PBMC effector cells using osmotically 
shocked, M tuberculosis-infected target cells resulted in increased expression of IL-2 
receptor on CD8+ T cells compared with conventional priming, these CD8 cells did not 
demonstrate any enhanced cytolytic ability. 
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FIGURE 3. 7. The effect of priming conditions on mycobacterial antigen-specific CD8+ CTL cytolytic 
activity. (a) CD8+ CTL activation marker expression (IL-2R) and (b) mycobacterial-specific cytolytic activity 
was assessed following conventional BCG- and M tuberculosis H37Rv-priming, following addition of 
exogenous low-dose rlL-2, following early isolation and rlL-2 stimulation, or following osmotic lysis of M 
tuberculosis-infected stimulator cells (described in Materials and Methods). IL-2 receptor expression (a) has 
been presented as the percentage of CD8+ T cells expressing this activation marker. Cytotoxicity against 
autologous macrophage targets was measured after 18 hours. Mycobacterial-specific cytolysis was calculated as 
follows : [% cytolysis against M tuberculosis infected targets]-[% cytolysis against SK/SD pulsed targets] . Each 
box-and-whisker plot shows the distribution, median (solid line), mean (dotted line), 10th and 90th percentile of 6 
independent PBMC donors. ( •) Represent possible out-liers. 
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Taken together, the experiments described in this Chapter have demonstrated that U93 7 cells 
can present antigen to conventionally primed CD8+ CTLs in standard cytotoxicity 
(51chromium release) assays (Fig. 3.2-3 .6). The ability of M tuberculosis-infected, PMA-
differentiated U937 cells to activate CD8+ T cells was subsequently investigated (Fig. 3.8). 
Because U937 cells do not express HLA class II (Peterlin et al., 1984) and have an efficient 
phagosome-to-cytosol delivery system for exogenous antigens (Harris et al., 1995), the 
ability of these monocytic cells to preferentially prime M tuberculosis-specific, HLA class I-
restricted CD8+ T cells was of particular interest. M tuberculosis infected U937 cells 
showed good ability to present antigen to monocyte/macrophage-depleted HLA-B51-matched 
PBMC. This ability was abrogated if U937 were fixed prior to M tuberculosis infection 
indicating that antigen uptake and processing was a requirement for antigen recognition. 
(a) Uninfected U937 / Fixed 
(b) M. th-infected U937 / Fixed 
(c) Fixed U937 / then M. th-infected 
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FIGURE 3.8. Antigen presentation by M tuberculosis-infected U937 cells. Monocyte-depleted, filA-B51-
matched PBMC were co-cultured for 6 days with PMA-differentiated U937 presenting cells that were either (a) 
uninfected and then paraformaldehyde-fixed; (b) M tuberculosis-infected (2 hours; 5 CFU.ceir1) and then fixed; 
or (c) fixed and then co-cultured with M tuberculosis (6 days; 5 CFU.ceir1). The inability of U937 cells that 
were fixed prior to the addition of M tuberculosis to present mycobacterial antigens served to control for 
antigen carry-over or presentation by residual, non-depleted autologous monocytes. Each bar represents the 
mean of at least 3 independent experiments (± SD). 
While M tuberculosis infected U937 cells were capable of stimulating mycobacterial 
antigen-specific PBMC proliferation, antigen presentation by U937 cells activated CD8+ T 
cells poorly compared with autologous macrophage APC's (Table 3.3). yf/ T cells, in 
contrast, were strongly activated and preferentially expanded. 
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Table 3.3. Comparison of U937 versus macrophage CDS and yoTceJJ priming 





with U937 cells• 
0.7 
17.2 
Activation marker expression (%) 
IL-2 receptor HLA-DR 
U937 Macrophage U937 Macrophage 
7.7 (±7.1) 18.9 (± 12.8) 6.5 (± 0.6) 12.7 (± 4.3) 
68.9 (± 6.4) 93 .1 (±4.6) 70.4 (± 15.9) 56.4 (± 11.5) 
"Relative expansion was calculated from % CD3+ cells expressing CD8 or y8 TCR at day 6 compared with at 
day 0. 
b Assessed by flow cytometry using 2-colour fluorescence [CD8-FITC1IL2R-PE or DR-PE; and y8-FITC/IL2R-
PE or DR-PE] . Activation marker expression has been presented as the percentage of CD8+ or y8+ T cells 
expressing IL-2R or HLA-DR. The data represents the mean percentage (± SD) of 2 to 4 independent 
experiments. 
3.3.8 T cell clones 
T cell clones were generated from M tuberculosis-primed HLA-B5 l-matched PBMC and 
selected on the basis of their cytolytic activity against U93 7 target cells. Table 3 .4 
summarises the cloning strategy used and the cloning efficiency obtained. Because no 
significantly enhanced CD8+ CTL cytolytic activity was generated by implementing various 
in vitro culture manipulations (Fig. 3. 7), M tuberculosis-reactive CD8+ CTL clones were 
generated from short-term PBMC lines primed under conventional conditions with M 
tuberculosis. The y'f/ T cell clones were generated from short-term M tuberculosis-primed 
CD4/CD8-depleted (yet-enriched) or y'f/ T cell lines. 
Initial experiments made use of M tuberculosis as the primary cloning stimulus (Table 3.4). 
The T cell clones generated under these conditions (87.9% CD8+, 12.1 % yo+) showed poor 
ability to lyse M tuberculosis-infected U937 targets and, in the case of the yo+ T cell clones, 
poor subsequent in vitro survival. To overcome these problems and to improve the efficiency 
of yo+ T cell cloning, subsequent experiments were carried out in the presence of PHA rather 
than M tuberculosis. Using this strategy, 48 CD8+ and 8 yet T cell clones capable of lysing 
M tuberculosis-infected U937 targets were generated. 
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Table 3.4. Summary of limiting dilution cloning ofT cells 
Cloning T cell line Cells Positive wells Negative Cloning M tb-spec. CTL 
stimulus per well per total wells wells(%)" Efficiency(%/ clones(%)° 
M tb M tb-stim. PBMC 0.3 63/2500 97 .5 8.4 9.0 
CD4/8-depleted 0.3 143/2400 94.0 19.9 1.6 
1.0 48/600 92 .0 8.0 0.0 
1.0 66/1800 96.3 3.7 12.0 
yl:i+ T cell line 0.3 20/2100 99.0 3.2 0.0 
1.0 4/600 99.3 0.7 0.0 
1.0 64/1800 96.4 3.6 33.0 
PHA M tb-stim. PBMC 0.2 124/600 79.3 100.0 17.0 
CD4/8-depleted 0.3 246/600 59.0 100.0 15.6 
yl:i+ T cell line 0.3 137/300 54.3 100.0 12.5 
• Positive wells are likely to be monoclonal according to Poisson statistics (95% probability) when >37% 
negative wells are obtained (Bach, 1983). b Cloning efficiency has been defined as the proportion of seeded 
cells that give rise to a growing clone (Stemme & Kallberg, 1992). c Percentage of total clones screened that 
were able to kill U937 target cells in a mycobacterial-specific manner (with an arbitrary cytotoxicity "cut-off 
point" of >5% above background). 
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FIGURE 3.9 A representative panel of mycobacterial antigen-specific CD8+ (a) and yl:i+ (b) CTL clones 
mediating cytolytic activity against U937 cells. U937 target cells were either infected with M tuberculosis (5 
CFU.ceU-1) (green bars) or pulsed with an irrelevant antigen, SK-SD (blue bars). Cytotoxicity against U937 
targets was measured after 4 hours. Each data point represents the mean percentage cytolysis (± SD) of at least 
3 independent experiments. 
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The CD8+ CTL clones exhibited lower levels of mycobacterial antigen-specific cytolysis 
(13.2 ± 8.1 %) against U937 cells (Fig. 3.9a) compared with they<~,+ CTL clones (31.2 ± 7.8%) 
(Fig. 3.9b). The CD8+ T cell clones were also cytolytic towards M tuberculosis-infected 
autologous macrophage targets but the level of cytolysis was reduced compared with U937 
target cells (5.4 ± 3.3% mycobacterial-specific). All of the CD8+ T cell clones tested 
proliferated strongly to live M tuberculosis and less vigorously to soluble PPD (Fig. 3 .10). 
The y'f/ T cell clones proved very difficult to maintain in vitro with only 3 of the 8 y'f:/ clones 
(y8.8, y8.19 and y8.32) surviving for longer than 4 passages and only 2 of these 3 clones (y8.8 
and y8. l 9) maintaining their cytolytic function . 
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FIGURE 3.10. Proliferative responses of CD8+ T cell clones to (a) soluble PPD or (b) M tuberculosis. CD8+ 
T cell clones were incubated with no antigen, PPD (3 µg.mr1) or M tuberculosis (5 CFU.feeder·1) in triplicate 
wells in the presence of autologous irradiated (40 Gy) PBMC feeders as APC's. After 40 hours, cultures were 
pulsed with [3H]-thymidine (lµCi .welr1) for 8 hours. Results are expressed as stimulation indices and were 
calculated as follows : [mean cpm of antigen stimulated wells]+ [mean cpm of unstimulated wells]. 
3.4 DISCUSSION 
The present study investigates the human macrophage cell line U937 as an in vitro model for 
HLA class I-restricted presentation of mycobacterial antigens to human cytolytic T cells. 
PMA-differentiation of U937 cells completely abrogated their susceptibility to both NK- and 
LAK-mediated anomolous cytotoxicity, and U937 target cells infected with M tuberculosis 
were effectively lysed by M tuberculosis-specific HLA class I-matched human CTLs. 
Cytolysis against U937 target cells was directed against mycobacterial antigens and mediated 
by HLA class I-matched but not HLA-mismatched CTLs. The HLA class I-matched CTL 
activity was shown to be restricted to live mycobacterial organisms (H3 7R v and BCG) but 
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not to soluble PPD. Finally, purified CD8+ CTL lines and CD8+ T cell clones from HLA 
class I-matched but not HLA-mismatched donors showed mycobacterial antigen-specific 
cytolysis against infected U937 target cells. Given the absence of HLA class II (Chapter 2; 
Peterlin et al. , 1984) and CDl (Kasinrerk et al. , 1993) expression on U937 cells, the data 
supports the conclusion that antigens derived from M tuberculosis can access the HLA class 
I processing pathway. 
Many of the more recent studies describing mycobacterial-specific CD8+ CTLs have focused 
on their ability to produce cytokines or to proliferate in response to stimulation with defined 
mycobacterial antigens (Lalvani et al. , 1998; Lewinsohn et al. , 1998; Canaday et al. , 1999). 
Those studies that have demonstrated the existence of CD8+ CTLs able to lyse M 
tuberculosis-infected target cells have used very defined conditions to facilitate efficient CTL 
pnmmg. For instance, Tan et al. (1997) found that mycobacterial-specific CD8+ CTL 
activity was only demonstrable following in vitro co-culture together with IL-2. While 
Mohagheghpour et al. (1998) used dendritic cells pulsed with defined mycobacterial HLA 
class I peptide epitopes to prime strong CD8+ CTL activity. It has been suggested that for 
investigation of CTL activity using standard 51Cr release assays is not a very sensitive 
approach for detecting CTL activity in cells under conditions of low precursor frequencies 
(Lalvani et al. , 1998). In the present study, we demonstrated CD8+ CTL activity against 
U93 7 cells under conventional priming conditions, both at the bulk and clonal level. 
Although U937 target cells shared only a single HLA class I haplotype match (HLA-A3 or -
B5 l ) with the CTL donors, they were more rapidly and strongly lysed than autologous 
macrophage targets . The most direct interpretation of these results is that U93 7 cells have a 
more efficient phagosome-to-cytosol delivery system for HLA class I-restricted presentation 
of exogenous antigens compared with macrophages. A recent report by Harris and 
colleagues (1995) provides strong support for this interpretation. These authors directly 
isolated and identified HLA class I-associated peptides from HIV nef-transfected U937 cells 
and found that, in addition to the anticipated HIV nef- and endogenously-derived peptides, a 
significant proportion (10% or 20 pmol) of peptides isolated from the HLA-A, B, and C pools 
were derived from identifiable exogenous proteins. Although Harris et al. (1995) showed 
relatively good yields of exogenously-derived HLA class I-associated peptides, they 
calculated that HLA class I presentation of endogenously derived peptides was still 200-fold 
more efficient than presentation of peptides derived from exogenous proteins. 
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The difference in kinetics and efficiency of CTL-mediated cytolysis against U937 versus 
macrophage target cells may, however, reflect either a fundamental difference in the 
interaction of these targets with the CTL effectors or differential susceptibility of the target 
cells to CTL-mediated cytolytic mechanisms. A recent study demonstrated, however, that 
U937 cells, either untreated or terminally differentiated, were no more sensitive to perforin-
mediated cytotoxicity than human monocytes (Jones and Morgan, 1994). Unlike human 
monocytes which can be induced to express cell surface Fas (CD95), U937 cells are 
considered to be a Fas· cell line and would therefore not be susceptible to Fas-mediated 
cytolysis (Zeine et al. , 1998). The differential sensitivity of U93 7 cells and macrophages to 
mycobacterial-specific cytolysis could reflect other fundamental differences in the 
mechanism of cytolysis against these disparate target cells, an intriguing possibility that 
would require further investigation. 
Despite the finding that U937 cells are more sensitive to mycobacterial-specific CD8+ CTL 
activity than autologous macrophages, the level of CD8 CTL-mediated cytolysis of U93 7 
targets was lower than observed for ye/ CTLs. The CTL effectors used in this study were 
generated using conventional priming conditions in that M tuberculosis-infected monocyte-
derived autologous macrophages were used for the initial priming and CD8+ CTLs were 
generated in bulk in the absence of any additional cytokines or growth factors . To address 
whether the low levels of CD8+ cytolysis generated against target cells during the effector 
phase of the CTL activity was due to restricted HLA class I presentation of mycobacterial 
antigens by target cells or due to poor initial priming of the CTL population, we investigated 
the effects of varying culture conditions on CTL generation. Although a few studies have 
shown mycobacterial-specific CD8+ cytolytic activity following conventional priming 
(Turner & Dockrell, 1996), the majority of authors have found that CD8+ CTL functional 
activity is difficult to demonstrate in vitro and required very specific manipulation 
(Lewinshon et al. , 1998; Tan et al., 1997; Lalvani et al. , 1998; Monagneghpour et al. , 1998). 
We were unable to demonstrate enhanced CD8+ T cell cytolytic activity following the various 
culture manipulations assessed in this study, as compared with conventional priming using 
either M tuberculosis or BCG. It seems likely that low cytolytic capacity demonstrated by 
CD8+ CTLs in mycobacterial infections is due to the combined effects of inadequate initial 
priming of this T cell subset (with CD8 CTLs being represented at very low precursor 
frequency), together with the relative inefficiency of the pathway allowing HLA class I-
Chapter 3 Models for HLA class I presentation 104 
presentation of exogenously-derived bacterial antigens (Reis e Sousa and Germain, 1995). 
T cell activation in response to antigen requires at least two types of signals to be provided by 
an antigen-presenting cell (APC) (Schwartz, 1992). The first is the interaction between the T 
cell receptor with peptide that is associated with HLA molecules on the surface of the APC 
(Schwartz, 1985). As a result of this interaction, the TCR-associated CD3 complex mediates 
intracellular signals that are necessary but not sufficient for T cell clonal expansion (Barber et 
al., 1989; Weiss et al. , 1994). The second critical signal is mediated by receptors on the T 
cell that interact with co-stimulatory molecules on the surface of the APC (Jenkins & 
Johnson, 1993; Linsley et al. , 1991 ). The type of co-stimulatory signal that is delivered is 
dependent on several factors, including the type and activation status of the APC (Thomas et 
al., 1993), the type of T cell (CD4 versus CDS), and whether the T cells are nai"ve or memory 
phenotype (Byrne et al. , 1988). Several cell surface co-stimulatory interactions have been 
implicated in T cell activation. The most thoroughly investigated are those between CD80 
(B7. l)/CD86 (B7.2) on the APC and CD28/CTLA-4 on T cells (Jenkins & Johnson, 1993; 
Linsley et al. , 1991 ; Norton et al. , 1992; Moudgil & Sercarz, 1993). Although CD80 
(B7. l)/CD28 co-engagement between T cells and APC has been demonstrated to be critical 
during the inductive phase of the T cell response, this interaction has been shown to be less 
important during the subsequent effector phase of CTL activity (Harding & Allison, 1993). 
Previous studies have reported that CD80 (B7. l) is absent on U937 cells, while CD86 (B7.2) 
is present at very low levels (Palmer & van Seventer, 1997; Stonehouse et al. , 1999). Despite 
this, U937 cells have been shown to provide efficient co-stimulatory signals for the priming 
of Th1-like cells by a CD80/CD86-independent pathway and that the co-stimulatory signal is 
as potent as the one provided by B7+ human monocytes (Johnson and Jenkins, 1994; Palmer 
& van Seventer, 1997; Stonehouse et al. , 1999). Consistent with their strong HLA class I 
expression but lack of HLA class II expression, a recent study confirmed that U93 7 cells 
preferentially provide co-stimulatory activity for CDS+ rather than CD4+ T cell responses 
(Stonehouse et al. , 1999). 
It is noteworthy that both purified y'f:/ CTLs and yf/ T cell clones recognised and lysed M 
tuberculosis-infected U937 target cells very efficiently. Previous reports have found that 
antigen-specific responses of yo T cells are not restricted by classical HLA class I or II, or 
non-classical CD 1 a, CD 1 b or CD 1 c antigen presenting molecules and that antigens may be 
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presented directly on the surface of infected cells smce no apparent antigen processmg 
appears necessary (Morita et al., 1995). y8 T cells have consistently been implicated in 
mycobacterial infections and have been shown to produce Th1-type cytokines as well as 
being strongly cytolytic (Balaji and Boom, 1998). The present study has clearly 
demonstrated that U937 cells provide a very selective model for evaluating the 
mycobacterial-specific cytolytic abilities of this T cell subset and could therefore provide a 
useful tool for further investigations into the protective role of y8+ CTLs in mycobacterial 
pathogenesis. 
Despite being strongly cytolytic towards M tuberculosis-infected U937 targets, the purified 
y8 T cell lines and y8 clones generated in the present study were very difficult to maintain in 
vitro. The problems associated with generating and maintaining mycobacterial antigen-
specific y8 T cell clones have been widely experienced (De Libero, personal communication; 
Holoshitz, personal communication) and appear to be a recurrent theme in published reports 
on y8 T cell activity in a variety of infectious models. Earlier studies found that the majority 
of y8 T cells underwent apoptosis following priming and that the remaining population 
became functionally anergic to re-stimulation (Janssen et al., 1991 ; Spaner et al. , 1993; 
Ferrarini et al. , 1995; Rovere et al. , 1996). These studies showed that, despite expressing 
constant amounts of Fas (CD95) throughout their in vitro propagation, y8 T cells became 
prone to Fas-FasL triggered apoptosis only when chronically stimulated (Ferrarini et al., 
1995). More recently, Manfredi et al. (1998) and Li et al. (1998) provided an explanation for 
these findings by demonstrating that the engagement of the y8 TCR by mycobacterial 
antigens induced the expression of Fas ligand (FasL) by chronically activated Fas+/FasL- y8 T 
lymphocytes. Activation-induced cell death (AICD) of y8 T cells has been proposed to 
represent a negative feedback mechanism for controlling their own expansion and may 
contribute to explain the limited time span of y8 T cell expansion during an infection, even in 
situations where the pathogen has not been fully eliminated (Ferrarini et al. , 1995). y8 T cell 
expansion takes place during the acute phases of most infections, a characteristic that has 
contributed to these cells being considered to be a first line of defence against many 
microbial and viral infections (Boismenu and Havran, 1997). Their expansion is crucial in 
controlling multiplication of microorganisms at a time when no specific al3 T cells are yet 
available. Later, the AICD of antigen-stimulated y8 T cells may provide a feedback 
mechanism, avoiding the potentially harmful persistence of activated y8 T cells when the 
Chapter 3 Models for HLA class I presentation 106 
more protective antigen-specific a~ T cells were expanded enough to eradicate the infection. 
Despite being of obvious biological benefit to the host, AICD of yo T cells creates significant 
problems for the study of this T cell subtype in culture. 
The results presented in this Chapter have demonstrated that the human monocytic cell line 
U937 is a suitable in vitro model for HLA class I-restricted presentation of mycobacterial 
antigens to human cytolytic T cells. U93 7 cells, in addition to phagocytosing M tuberculosis 
efficiently and supporting the intracellular growth of this organism (Chapter 2), present M 
tuberculosis-derived antigens to HLA class I-matched CD8+ CTLs more effectively than 
monocyte-derived macrophages. This study also demonstrated that this cell line provides a 
highly selective indicator for mycobacterial-specific yo+ CTL cytolytic activity. 
There have been several recent reports linking the precise mechanism of cytolysis utilised by 
cytotoxic CD8+ T cells towards M tuberculosis-infected target cells to their ability to directly 
restrict intracellular mycobacterial survival (Stenger et al., 1997; 1998). Similar 
investigations into the mechanism of cytolysis favoured by the CD8+ T cell lines and CD8+ 
CTL clones described in this Chapter and their effect on intracellular mycobacterial survival 
were not feasible due to the consistently low cytolytic capacity demonstrated by these cells 
against M tuberculosis-infected targets. The establishment of strongly cytolytic human M 
tuberculosis-reactive yo+ CTL clones, however, afforded a unique opportunity to investigate 
more thoroughly the protective role of this T cell subset in human mycobacterial infections. 
To date, there have been no published reports on the mechanism/s of cytolysis utilised by 
cytotoxic yo+ T cells in mycobacterial infection and no reports on the effect of yo+ T cell-
mediated cytolysis on intracellular mycobacterial survival. For these reasons, the following 
Chapter (Chapter 4) has specifically focused on these issues. 
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4.1 INTRODUCTION 
Although almost a decade has past since the identification of T cells bearing the y8 TCR, the 
biological significance of this unique T cell subset still remains uncertain. It is clear, however, 
that y8+ T cells contribute to protective immunity in mycobacterial infections. y8+ T cells are 
markedly expanded during mycobacterial infections (Kabelitz et al. , 1990; Pfeffer et al. , 1990; 
De Libero et al., 1991 ; Kabelitz et al. , 1991 ; Panchamoorthy et al., 1991 ; Pechhold et al. , 
1994) and accumulate at the site of pathology (Modlin et al. , 1989; Griffin et al., 1991). It is 
also clear that there are several features that distinguish this T cell subset from a~+ T cells. y8+ 
T cell responses precede those of af T cells (Ferrick et al. , 1995); they home to distinct 
physiologic locations; they express a much more limited repertoire of TCR variable genes 
(Bluestone et al., 1991) and, perhaps the most striking distinction, they recognise low MW, 
phosphorylated, non-peptidic mycobacterial antigens in a non-HLA-restricted manner 
(Constant et al., 1994; Tanaka et al., 1994; Tanaka et al., 1995; Morita et al. , 1995; Lang et 
al., 1995; Kabelitz et al., 1991 ; reviewed by Porcelli et al. , 1996). 
One of the most important effector functions of mature activated y8+ T cells is their HLA-
unrestricted cytolytic activity against infected target cells. Accordingly, a significant amount 
of attention has focused on their ability to destroy cells infected with both bacterial and viral 
pathogens (Munk et al. , 1990; Malkovsky et al. , 1992a; Bukowski et al. , 1994; Tsukaguchi et 
al., 1995). Few studies, however, have examined the mechanism of y8+ T cell cytolytic 
activities against infected target cells or the impact of this cytolysis on the survival of infecting 
pathogens. 
Two major mechanisms have been described for the successful cytolysis of target cells by 
cytotoxic T lymphocytes (summarized in Fig. 4.1; Kagi et al. , 1994; Lowin et al., 1994; 
Atkinson & Bleackley, 1995; Henkart et al., 1995). The first mechanism involves granule 
exocytosis and is mediated by perforin and granzymes (reviewed recently by Page et al. , 
1998). Following TCR-dependent recognition of the target cells, a number of signals, which 
include protein tyrosine phosphorylation and increased intracellular calcium levels, are 
generated within the CTL. These signals result in the transcription of effector proteins and 
eventually the appearance of electron-dense granules within the CTL. These effector proteins 
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are the mediators of CTL function and are stored in the granules until required. Subsequent 
interaction with a target cell results in directed exocytosis of the CTL granules towards the 
point of contact with the target cell (Geiger et al. , 1982; Kupfer and Dennert, 1984; Kupfer et 
al., 1985; Yannelli et al. , 1986). During granule-mediated cytotoxicity, the cytolytic proteins 
released from the granules result in a "lethal hit" on the target cell and the cell dies. Perforin 
contained within the CTL granules causes osmotic damage due to its binding of 
phosphorylcholine headgroups, polymerisation, and subsequent pore formation in the lipid 
bilayer of the target (Lichtenheld et al., 1988; Shinkai et al. , 1988; Tschopp and Nabholz, 
1990). Granzymes are the major protein components of CTL granules and are postulated to 
synergise with perforin to trigger an internal disintegration pathway within the target cell that 
is mediated by caspases and apoptosis (Page et al., 1998). 
The second major mechanism by which T lymphocytes lyse target cells is receptor mediated by 
Fas-Fas ligand (Fas-FasL) interaction. A number of cell types express a surface protein called 
Fas/APO-l/CD95 which contains a "death domain" in its cytoplasmic region (Nagata and 
Goldstein, 1995). During CTL activation, levels of a protein named Fas ligand (FasL) are 
upregulated on the CTL surface. FasL can cross-link target cell Fas receptors, and the 
oligomerized receptors can then transduce a death signal to the target cell through a number of 
associated proteins (Cleveland and Ihle, 1995; Fraser and Evan, 1996). Following the initial 
interaction, which results in FasL expression, no further specific recognition of the target cell 
through TCR is required for Fas-mediated cytotoxicity. Thus, a FasL bearing CTL is able to 
destroy any Fat cell, whether it has been specifically recognised or not (Page et al., 1998). 
The available evidence suggests that granule exocytosis is the predominant mechanism 
involved in the elimination of infected cells (Kagi et al. , 1994), while Fas-mediated lysis may 
be reserved for homeostatic control of activated peripheral T cells (Ramsdell et al., 1994; 
Singer & Abbas, 1994; Nagata & Goldstein, 1995). 
While human y'f/ T cells constitutively possess cytoplasmic granules containing cytolytic 
mediators (perforin and serine esterases; Nakata et al. , 1990; Koizumi et al. , 1991), they have 
also been shown to express FasL (Nagata & Golstein, 1995; Suda et al. , 1995; Vincent et al., 
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FIGURE 4.1 The two proposed mechanisms of cytotoxicity (adapted from Berke, 1994). 
The precise role of CTL's in controlling the spread of intracellular pathogens such as M 
tuberculosis remains uncertain and this intriguing question has been the focus of several recent 
reviews (Tschopp and Hofmann, 1996; Mazzaccaro et al., 1998; Stenger and Modlin, 1998; 
Kaufmann, 1999). One postulate that has been favoured in the past is the ability of T cell 
mediated cytolysis to release live bacteria from inefficiently activated macrophages, allowing 
these bacilli to be taken up and killed by newly recruited and freshly activated macrophages 
(De Libero et al. , 1988; Kaufmann, 1988). The ability of T cell-mediated cytolysis to directly 
impact on the viability of intracellular pathogens was considered highly controversial. 
However, recent findings by Stenger and colleagues (1997; 1998) have suggested that such a 
role for CTL-induced lysis does exist. Moreover, this ability of CTL's to reduce the 
intracellular survival of M tuberculosis was found to be restricted to effector cells utilising the 
granule-exocytosis pathway (Stenger et al., 1997; Stenger et al., 1998). 
Experiments presented in this chapter investigated two important issues. Firstly, which 
cytolytic mechanism was used by yf/ CTL clones againstM tuberculosis-infected U937 target 
cells, and secondly, did yf/ CTL-mediated cytolysis impact on intracellular mycobacterial 
viability? The y'f/ T cell clones were shown to mediate strong cytolytic activity against M 
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tuberculosis-infected target cells that was dependent on cell-to-cell contact. Cytolysis was 
Ca2+-dependent and completely inhibited by de-granulation of the yf/ effector T cells (using 
Sr2+) indicating that the predominant mechanism of target cell lysis was granule exocytosis. 
Despite mediating significant target cell cytolysis, however, the y'{:/ CTL clones did not result 
in a detectable reduction in intracellular mycobacterial survival. 
4.2 MATERIALS AND METHODS 
4.2.1 Mycobacterial growth conditions 
M tuberculosis H37Rv cultures were grown in Middlebrook 7H9 broth (Difeo Laboratories, 
Detroit, MI, USA) supplemented with 10% OADC (State Vaccine, Cape Town, South Africa) 
and 0.02% Tween-80 (Merck, Darmstadt, Germany) at 37°C, 5% CO2. Mid-log phase cultures 
were snap frozen in liquid nitrogen and stored at -70°C until needed. Frozen mycobacterial 
cultures were thawed immediately before use and clumps were disrupted by repeated passage 
through a 25-gauge needle. In all experiments, bacteria were coated with serum opsonins by 
incubating thawed aliquots with an equal volume of fresh human serum for 30 minutes at 
37°C. Mycobacterial viability, was measured by determining colony forming units (CFU) of 
serial IO-fold dilutions of bacterial preparations on Middlebrook 7Hl0 agar (Difeo 
Laboratories) supplemented with 10% OADC. 
4.2.2 Isolation of M tuberculosis-reactive y[/ T cell lines 
Peripheral blood mononuclear cells (PBMC) were obtained from healthy PPD+ BCG-
vaccinated adult volunteers by centrifugation of heparinized venous blood over Ficoll-
Hypaque density gradients (Sigma) as previously described (Chapter 3; Boyum et al., 1968). 
PBMC (1 x 106 cells.ml"1) were stimulated with M tuberculosis H37Rv (1 CFU.ceU-1) for 6 
days at 3 7°C to prime and expand M tuberculosis-responsive yf/ T cells. y[:/ T cells were 
isolated by sequential CD4+/CD8+ T cell-depletion either using directly conjugated CD4+ and 
CD8+ Minimacs magnetic beads or by positive selection using yf/ mAb (Becton-Dickenson; 
San Jose, CA) indirectly conjugated to goat anti-mouse IgG1 Minimacs magnetic beads 
(Miltenyi Biotec, CA). Short term y'f/ T cell lines were maintained by re-stimulating cells 
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weekly with irradiated ( 40 Gy) autologous PBMC feeders ( 1 x 10
6 cells.mr1), M tuberculosis 
H37Rv (1 CFU.celr1) and bi-weekly with rIL-2 (100 iu.mr1). The phenotype of yf/ T cell 
lines was monitored weekly using flow cytometry and 2-colour fluorescence (y8-FITC/CD3-
PE). The y8+ T cell lines were difficult to maintain beyond 3-4 passages using M tuberculosis 
as the antigenic stimulus, and this finding coincided with the lines rapidly becoming 
functionally anergic and loosing their cytolytic ability. 
4.2.3 Generation of y8+ T cell clones 
The y8+ T cell clones were generated by limiting dilution as described by Bach (1983) from 
bulk M tuberculosis-primed PBMC or y8+ T cell lines (Chapter 3; Table 3.4). Briefly, the 
cells were seeded at 0.2 cells.welr1 into Terasaki wells in fresh cloning medium [RPMI-1640 
supplemented with 10% autologous serum, 2-mercaptoethanol (5 x 10·
5 M; BDH Chemicals, 
Poole, England), non-essential amino acids ( 1 OmM; Highveld Biologicals, Johannesburg, 
South Africa), L-glutarnine (2mM; Highveld Biologicals), sodium pyruvate (lmM; Highveld 
Biologicals)]. Cells were stimulated with PHA (1.1 x 10·
2 mu.mr1, Murex Biotec; Dartford; 
England), rhIL-2 (100 iu.mr1) and fresh, irradiated (40 Gy) autologous PBMC feeders (1 x 
106 cells.mr1) in a final volume of 20 µl.welr 1. Plates were incubated at 37°C, 5% CO2. Cell 
growth was determined by visual inspection using an inverted microscope (Nikon TMS, 
Japan) after 10-12 days. Wells were scored positive if greater than one fourth of a particular 
well surface was covered with cells. 
Positively scored wells were selected between days 10 and 12 by transferring the contents of 
individual positive Terasaki wells into U-bottomed 96-well microtitre plates. Re-stimulation 
was performed using irradiated autologous PBMC as feeder cells (105 cells.welr1), rIL-2 (100 
U.mr1) and PHA (1.1 x 10·2 mu.mr1) in a final volume of 100 µl per well of cloning medium 
(described above) . The growing cultures were supplemented with 100 µl fresh cloning 
medium containing rIL-2 (100 U.mr
1
) 3-4 days after transfer and cells were re-suspended 
regularly to avoid formation of large clusters. Seven days after transfer, clones were split into 
two wells and re-stimulated with feeders, PHA, and rIL-2 as indicated above. By the end of 
the second passage in microtitre wells, the cells were transferred to 24 well tissue culture 
plates and re-stimulated as previously described in a final volume of 1 ml. Cultures were re-
Chapter 4 Mechanism of yi5 T Cell Cytotoxicity 113 
suspended regularly, supplemented with fresh cloning medium every 3-4 days and passaged 
weekly. 
The mycobacterial-responsive yf/ T cell clones were selected on the basis of their cytolytic 
function against M tuberculosis-infected U93 7 target cells ( described in more detail in 
Chapter 3). The initial assessment of cytotoxic ability was performed using 50-100 µl of each 
respective T cell clone at unknown cell concentration against either M tuberculosis-infected 
or SK-SD-pulsed PMA-differentiated U937 cells (10
4 cells.weir1). Clones that were able to 
kill U93 7 target cells in a mycobacterial antigen-specific manner were selected for further 
analysis (M tuberculosis-specific kill >5% above background was chosen as an arbitrary cut-
off point) . Cytotoxic function of the "positive-killer clones" was then confirmed in triplicate 
wells and at multiple effector to target ratios . 
Both the yet CTL lines and clones were extremely difficult to maintain in vitro. Despite a 
total of 8 y'f:/ T cell clones having been generated, only 3 of the 8 clones survived for longer 
than 4 passages (y8.8, y8 .19 and y8.32) . Only 2 of these 3 y8+ T cell clones (y8.8 and y8.19) 
maintained long term cytolytic function against M tuberculosis-infected U93 7 cells and have 
been investigated extensively in the present chapter. 
4.2.4 Flow cytometry 
An Epics Profile II flow cytometer (Coulter) was used to perform immunophenotyping. 
Histograms were gated on the PBMC populations by forward scatter (FS) versus log side 
scatter (LSS). Monoclonal antibodies were obtained from Coulter (Hialeah, FL) or Beckton-
Dickinson (San Jose, CA) and were directed against CD4, CD8, y8, and CD3 . All the 
monoclonal antibodies were directly conjugated with FITC or RD 1 (PE). Isotypic controls 
were used in all cases to set cursors to allow 2% false positives and antibodies were used as 
the concentrations suggested by the manufacturer. Five percent colour compensation was 
used for samples analysed using 2-colour immuno-fluorescence. 
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4.2.5 Cell lines 
PMA-differentiated U937 cells were used widely in the present study as target cells for y'f/ T 
cell mediated cytolytic activity. U937 cells were maintained routinely in suspension culture in 
RPMI-1640 (Flow Laboratories, Irvine, Scotland) supplemented with 10% (v/v) heat-
inactivated fetal calf serum (FCS) (Delta Bioproducts, Kempton Park, South Africa), 2 mM L-
glutamine, and 10 mM HEPES at 3 7°C in a humidified atmosphere of 5% CO2. Passage was 
performed every 2-3 days. They were induced to differentiate using PMA (5 ng.mr1; Sigma, 
St. Louis, MO) for 48 hours (as described extensively in Chapter 2 and 3) before infection 
with M tuberculosis and use as targets in cytotoxicity assays. Daudi B cell lymphoma cell line 
and Jurkat T cell lines were also used in this study to investigate various functional properties 
of yt;+ CTL activity. Cells used in all experiments were in the logarithmic phase of growth and 
viability exceeded 95% as measured by trypan blue exclusion. 
4.2.6 Cytotoxicity assay 
PMA-differentiated U937 cells were used as targets for assessment of y'f:/ T cell cytolytic 
ability. Target cells were either infected with M tuberculosis H37Rv (5 CFU.ceU-1), pulsed 
with the irrelevant streptococcal antigen streptokinase-streptodomase (SK-SD; 250 iu.mr' 
SK; 62.5 iu.mr' SD; Lederle Laboratory, Wayne, NJ), or left uninfected for16 hours at 37°C. 
On the day of the experiment, adherent U937 cells were EDTA-detached, labelled with 250 
µCi 51Cr for 60-90 minutes, washed 3 times with cold 5% FCS PBS and finally adjusted to the 
desired concentration in 10% AB serum RPMI. 
The cytolytic activity of the yf/ T cell clones was assessed three days following the last 
addition of feeder cells or 2 days following the last addition of rhlL-2 (section 4.2.5). The y'f:/ 
T cell clones were incubated in 10% AB serum RPMI (containing no IL-2) for 8-24 hours 
prior to cytotoxicity assay. The yf/ T cell clones were finally adjusted to the desired 
concentration and incubated together with the 
51Cr-labelled target cells at indicated 
effector:target cell ratios for 4 hours at 37°C. The percentage specific target cell lysis was 
calculated from the mean of triplicate wells using the following equation: [ mean test cpm-
mean spontaneous cpm]/[mean maximum cpm- mean spontaneous cpm] x 100. Spontaneous 
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s1er release was determined from sier-labeled targets incubated with medium alone while 
maximum s1er-release was measured from targets treated with 5% Triton X-100 for the 
duration of the assay. 
4.2. 7 Prevention or disruption of cytotoxicity 
Prevention of cell-cell contact 
Prevention of cell-cell contact was carried out as previously described by Lang et al. (1995) . 
Briefly, the yf/ T cell clones and M tuberculosis-infected U93 7 targets were either 
centrifuged (50g for 5 minutes) at the beginning of the cytotoxicity assay or maintained in 
suspens10n throughout the entire 4-hour incubation period by gentle pipetting every 15 
minutes. 
Disruption of granule exocytosis 
Three alternative approaches were used to disrupt granule exocytosis of the yf/ eTL clones 
(Fig. 4.1): (i) Previous studies have demonstrated that extracellular ea
2
+ ions are necessary for 
granule exocytosis and perforin-based cytotoxicity, but not for the interaction of Fas-FasL 
(Berke, 1994; Nagata and Goldstein, 1995). In the present study, the ea
2
+ chelator 
EGTA/Mg2+ (6mM/3mM, Saarchem Ltd., South Africa) was added to remove extracellular 
ea2+ from the culture medium. (ii) eyclosporin A (esA) has previously been shown to 
interfere with the biochemical events in the later stages of ea
2
+ -dependent granule exocytosis 
that follows the binding of calmodulin to cytoskeletal or cytoplasmic calmodulin binding 
proteins (Trenn et al., 1989). The y'f/ eTL clones used in this study were pre-incubated with 
100-200 ng.mr1 esA (Sandoz, Switzerland) for 30 minutes and then added to sier-labelled 
target cells in the absence or presence of 100-200 ng.mr
1 esA. (iii) Strontium ions (Sr2+) have 
previously been found to result in de-granulation of CTL' s and release of cytotoxic granule 
contents thereby transiently inhibiting CTL lytic activity (Neighbour and Huberman, 1982; 
Stenger et al. , 1997). In the present study, the yf/ CTL clones were pre-incubated for 10-24 
hours in the presence of 25 mM SrCh (Sigma, St. Louis, MO) and then added to sier-labelled 
target cells in the absence or presence of 25 mM SrCh. 
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Prevention of Fas-FasL interaction 
To prevent the interaction of Fas with FasL, 51Cr-labelled target cells (Fas+ Jurkat cells) were 
pre-incubated for 1 hour with 0.5-2 µg .mr1 anti-Fas monoclonal antibody (ZB4; Immunotech, 
Westbrook, ME) prior to the addition of the yf/ CTL clones. 
Table 4.1 Summary of the agents used to prevent or disrupt cytolysis 
Cytolytic Pathway Agent Concentration Mechanism Reference 
Granule exocytosis Mg2/EGTA 3mM/6mM Removes Ca 
2
+ from the culture MacLennan et al. (1980) 
medium. 
SrCh 25mM Causes degranulation and release of Neighbour et al. ( 1982) 
granule contents in the absence of 
additional immunologic stimuli. 
Cyclosporin A 100-200 ng.mr' Inhibits biochemical events in the Trenn et al. (1989) 
late stages of Ca2+ -dependent granule 
exocytosis that follow binding of 
calmodulin to cytoskeletal or 
cytoplasmic calmodulin binding 
proteins 
Fas-FasL ZB4 0.5-2 µg.mr' Inhibits the physical interaction of Mori et al. ( 1997) 
(Anti-Fas mAb) Fas-FasL 
In control experiments, EGT A/Mg 2\ CsA, SrCh, and ZB4 did not cause lysis of either the 
target cells or the yf/ CTL clones at the concentrations used in this study ( as measured by 
trypan blue exclusion and the spontaneous:maximum ratio of the 
51Cr-release assay) . 
4.2.8 Effect of yf/ CTL clone cytotoxicity on intracellular mycobacterial survival 
To investigate the effect of yf/ T cell clone cytotoxicity on intracellular mycobacterial survival, 
M tuberculosis-infected U93 7 targets cells were cultured in either the presence or absence of 
the yf/ T cell clones (at an E :T of 10:1) for 4 hours in parallel with the 51chrornium labelled 
target cells in the standard cytotoxicity assay ( described above) . At the end of the incubation 
period, yf/ T cell clones and target cells were pelleted by centrifugation at 200 g for 10 
minutes. The supernatant was decanted and the remaining cell pellet solubilised using 0.25% 
SDS PBS. The cell lysate and corresponding supernatant were pooled to compensate for 
mycobacteria released into the surrounding medium as a result of cell lysis. Mycobacterial 
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survival in the absence or presence of the y'f/ CTL clones was measured by determining 
colony forrning units (CFU) of serial 10-fold dilutions of bacterial preparations on 
Middlebrook 7H10 agar (Difeo Laboratories) supplemented with 10% OADC. 
4.3 RESULTS 
4.3.1 y8+ T cells are expanded and activated following stimulation with M tuberculosis 
y8+ T cells were found to represent only a small percentage of the CD3 + cells ( 5. 9 ± 3. 9 % ) 
present in freshly isolated PBMC from the donors evaluated in this study. They became 
significantly expanded following stimulation with M tuberculosis with a mean of 43 .2 (± 18.4) 
% of M tuberculosis-primed PBMC expressing yo TCR (Table 4.2). The M tuberculosis-
stimulated y8+ T cell population was found to be strongly activated with 79.7 (± 17.7) % of 
yo+ cells expressing IL-2 receptor and 60.9 (± 20.1) % expressing HLA-DR. 
Table 4.2. y6" T cells are preferentially expanded and activated following stimulation with M tuberculosis 
Donor Percentage y8+ T cells Relative y8+ activation marker expression (%)° 
following M lb-priming• expansionb IL-2R+ HLA-DR+ 
RG 38.1 14.7 85 .1 100.0 
JP 33.5 12.9 100.0 58.6 
MW 31.8 12.2 91.2 65 .5 
TS 65 .1 25 .0 90.0 66.0 
MA 69.5 8.2 55 .6 66.5 
SG 20.3 2.4 65.7 56.7 
SC 33.0 3.9 98.1 74.9 
EC 23.3 4.3 85.4 42.4 
MH 50.4 5.9 77.5 56.0 
BR 66.7 7.8 48.1 23.0 
Mean(± SD) 43 .2 (± 18.4) 9.7 (± 6.8) 79.7 (± 17.7) 60.9 (± 20.1) 
"Expressed as a percentage of CD3+ cells 
bExpressed as a ratio of y8+ T cells at day 6 versus day 0 
"Results have been expressed as a percentage of y8+ T cells expressing IL-2R or HLA-DR following 6 days of in 
vitro priming with M tuberculosis. 
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4.3.2 y'{:/ T cell-mediated lysis of M tuberculosis-infected U937 cells 
This study has demonstrated that PMA-differentiated U937 cells provide a highly selective 
indicator for mycobacterial-specific yf/ CTL cytolytic activity (Chapter 3) and y'{/ T cell lines 
and yf/ T cell clones capable of specifically lysing M tuberculosis-infected U937 cells have 
been generated. To further investigate the functional activity of this T cell subset in 
tuberculosis, two of the yf/ CTL clones ( y8. 8 and y8. 19) were studied in more detail. Fig. 4. 2 
(a-b) shows that y8.8 and y8.19 CTL clones were preferentially cytolytic towards M 
tuberculosis-infected U937 cells as compared with cells pulsed with an irrelevant 
streptococcal antigen, SK-SD. In all experiments, the y8+ CTL clones were found to be 
similarly cytolytic towards the control, uninfected U93 7 target cells and cells pulsed with an 
irrelevant streptococcal antigen, SK-SD (data not shown). To allow clear comparison 
between the mycobacterial antigen-specific and non-specific cytolysis generated by the y8+ T 
cell clones, only SK-SD-pulsed (irrelevant antigen) U937 target control has been included in 
figures throughout this chapter. 
The cytolytic ability of y8.8 and y8.19 T cell clones was not restricted exclusively to target 
cells infected with M tuberculosis, however, since both y8+ T cell clones were also cytolytic 
towards Daudi Burkett's lymphoma cell line (Fig. 4.2c). The cross-reactivity between 
mycobacterial antigen- and Daudi-reactive y8+ T cell subsets is well described and studies have 
shown that, although the stimulatory ligands within these antigen preparations differ (Kaur et 
al., 1993; Constant et al., 1994; Tanaka et al. , 1995), the y8+ T cell responses against these 
two antigens are nonetheless closely related and strictly overlapping (Davodeau et al., 1993; 
Bukowski et al., 1995). 
4.3.3 Cellular contact requirement for y8+ T cell cytotoxicity 
When the y8+ CTL clones were kept in suspension throughout the assay, the level of 
cytotoxicity generated against M tuberculosis-infected U937 cells was greatly reduced 
(75 .9% inhibition) compared with parallel experiments in which y8+ CTL clones were kept in 
close contact with 51Cr-labelled targets (Fig. 4.3). These results suggest that lysis of U937 
target cells was dependent on cell-to-cell contact. 
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FIGURE 4.2. M tuberculosis-specific cytolysis generated by yo+ CTL clones (yo.8 and 
yo.19) against infected 
U937 target cells. (a) yo.8 and (b) yo.19 CTL clones were evaluated for cytolytic ac
tivity against U937 targets 
either infected with M tuberculosis (5 CFU.ceU-
1
) (• ) or pulsed with an irrelevant streptococcal antigen, SK-
SD (e ). Each data point represents the mean percentage cytolysis (± SEM) of
 at least 3 independent 
experiments. (c) In a separate set of experiments, the M tuberculosis-reactive yo+ C
TL clones were used as 
effectors against Daudi target cells at an E:T of 10: 1. In all experiments, cytotoxic
ity was evaluated after 4 
hours. 
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FIGURE 4.3. Prevention ofyo+ CTL-mediated cytolysis by impeding cell-to-cell contac
t. Clone yo.19 and M 
tuberculosis-infected U937 targets were either allowed close effector-to-target cell c
ontact (• ; solid line) or 
kept in suspension by repeated gentle pipetting every 15 minutes throughout the co
urse of the experiment (o ; 
dashed line). U937 target cells pulsed with an irrelevant antigen, SK-SD (e ; solid line)
 were included as an 
antigen-specificity control for the yo CTL-mediated cytolysis. Each data point repres
ents the mean (± SEM) of 
at least 2 independent experiments. Cytotoxicity was measured after 4 hours. 
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4.3.5 Mechanism of cytotoxicity mediated by y8+ CTL clones 
To examine the cytolytic mechanism/s used by the y8+ CTL clones (y8.8 and y8. l 9), various 
inhibitors of granule exocytosis (EGT A/Mg
2
\ Strontium; Cyclosporin A) or Fas-FasL 
mediated cytolysis (ZB4) were used to systematically disrupt key points in these major cell 
death pathways. 
Calcium and granule exocytosis requirements of y$' CTL cytotoxicity 
Three alternative approaches were used to disrupt granule exocytosis of the y8+ CTL clones: 
(i) The release of soluble mediators from cytoplasmic granules is mediated by Ca
2
+ release and 
granule exocytosis can be blocked using the Ca2+ chelator EGT A/Mg
2
+. Fig. 4.4 demonstrates 
the effect ofremoving Ca2+ using EGTA prior to the addition of 
51Cr-labelled target cells. The 
presence of EGT A/Mg2+ completely abrogated mycobacterial antigen-specific cytolysis for 
both y8+ CTL clones (Fig. 4.4, left panel) . (ii) Cyclosporin A (CsA) has previously been 
shown to interfere with biochemical events in the later stages of Ca
2
+ -dependent granule 
exocytosis which follow the binding of calmodulin to cytoskeletal or cytoplasmic calmodulin 
binding proteins (Treon et al., 1989). In the present study, CsA only partially inhibited 
mycobacterial antigen-specific cytolysis by 46. 6% for y8. 8 and 23 . 0% for y8 .19 (Fig. 4 .4, 
middle panel) . (iii) Previous studies have shown that Sr
2
+ induces a non-specific and transient 
degranulation of granule-containing cells, rendering them unable to lyse susceptible target cells 
(Neighbour and Huberman, 1982; Quan et al. , 1982). Fig. 4.4 (right panel) demonstrates the 
effect of pre-incubating the y8+ CTL clones in the presence of Sr2+ on y8+ T cell-mediated 
cytolysis. Degranulation of y8+ CTL clones using Sr2+ completely abrogated mycobacterial 
antigen-specific cytolysis against U937 target cells. Taken together, these results suggest a 
predominant role for the Ca2+ -dependent/perforin-based mechanism in y8+ T cell cytotoxicity 
in the present system. 
Both yf:/ T cell clones generated an element of non-specific cytolysis against U93 7 targets 
pulsed with the irrelevant antigen, SK-SD. Treatment of the clones with EGTA and, to a 
lesser extent, SrCli also abrogated this non-specific component of cytolysis . 
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FIGURE 4.4. Characterisation of the effector mechanisms used by y8.8 (left panel) an
d y8.19 (right panel) 
C1L clones against U937 target cells. Mycobacterial-specific cytolytic activity against
 U937 target cells was 
investigated using EGT A (left panel), CsA (middle panel), and SrCii (right panel) to b
lock granule-mediated 
effector mechanisms. U937 target cells were either infected with M tuberculosis(• ; so
lid line) or pulsed with 
an irrelevant antigen, SK-SD (e ; solid line). Alternatively, cytotoxic activity against M 
tuberculosis-infected 
U937 cells was determined in the presence of either EGTA, CsA or SrCii (D; dashed 
line). Each data point 
represents the mean percentage cytolysis(± SEM) of at least 3 independent experiments.
 
Fas-based mechanisms are not required for yo" CTL mediated cytolysis 
Even though many Fas-negative targets (such as Daudi and U937 cells; Zeine et al., 199
8) are 
lysed by ye/ T cells, it is still possible that Fas-mediated cytolysis occurs. In order to ev
aluate 
the importance of Fas-FasL interactions, the present study made use of the strongly
 Fas-
positive Jurkat target cell line that has previously been shown to be susceptible to ye/ T
 cell-
induced cytotoxicity even in the absence of Ca
2+ (Haeker and Wagner, 1994). Both yo.8 and 
yo.19 CTL clones showed strong cytolytic activity against Jurkat cells (Fig. 4.5.). 
Pre-
activation of the yo+ CTL clones using PMA and ionomycin did not augment the efficie
ncy of 
cytolysis against Jurkat target cells (data not shown). Figure 4.5 shows that pre-incubati
on for 
1-2 hours at 37°C with an anti-Fas mAb (clone ZB4; Immunotech) at concentr
ations 
recommended by the manufacturer to neutralize Fas-mediated apoptosis (0.5-2 µg.mr
1
) did 
little to interfere with Jurkat cell lysis by the yo+ CTL clones. Indirect immuno-fluores
cence 
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confirmed that pre-incubation of the Jurkat cells with ZB4 under these conditions resulted in 
strong staining of these cells for Fas as assessed by flow cytometry [with 98 .9 (± 0.3) % 
staining positive for Fas, mean channel fluorescence of 2.9 (± 0.3)] down to a dilution of 
0.125 µg .ml" 1. Cytolysis of Fas+ Jurkat target cells was found to be sensitive to Mg
2"EGTA 
( 47.0% inhibition), however, suggesting that the y'f/ T cell clones preferentially use a perforin-
based mechanism of cytolysis, even when given the opportunity to use a Fas-based system. 
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FIGURE 4.5. The role of Fas in mediating y'f/ CTL clone cytotox.icity against Jurkat target cells. ZB4, an 
anti-Fas monoclonal antibody (500 ng.ml-1), does not interfere significantly with the lysis of Fas+ Jurkat cells 
by y'&.8 and y'&.19 CTL clones. Cytolysis was measured either in the absence (e) or presence of inhibitors of 
either Fas-FasL interaction [ZB4 (• )] or granule exocytosis [EGTA!Mg2+ (..-)]. Each data point represents the 
mean percentage cytolysis (± SEM) of at least 3 independent experiments. 
4.3.6 Effect of yf/ CTL cytolysis on intracellular mycobacterial survival 
The precise role of CTL's in the control of intracellular pathogens in vivo remains uncertain. 
One possibility is that cytolysis of infected macrophages by CTL's directly impacts on the 
viability of the pathogens. This effect has been demonstrated with mycobacteria-specific 
CTL's (DeLibero et al., 1988; Silva et al., 1996; Stenger et al., 1997; Stenger et al., 1998). 
The present study set out to investigate whether the yet CTL clones, shown to use 
predominantly granule-dependent cytotoxicity mechanisms (Fig. 4.4), exerted any effects on 
survival of intracellular M tuberculosis. No reduction in mycobacterial viability was observed 
with either of the y'f:/ CTL clones despite their ability to induce significant cytolysis of M 
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FIGURE 4.6. Granule-dependent cytolysis by y'f/ CTL clones does not restrict intracellular mycobacterial 
growth. M tuberculosis-infected U937 targets cells were incubated either in the absence (blue bars) or 
presence (green bars) ofy8.8 and y8.19 CTL clones at an E:T ratio of 10:1 for 18 hours. Following incubation, 
U937 targets and clones were lysed with detergent and released bacilli were serially diluted and plated onto 
Middlebrooks agar to determine colony forming units (CFU). Each bar represents the mean percentage 
CFU.mr1 (± SD) of 2 independent experiments. 
4.4 DISCUSSION 
The present study demonstrates that yf/ CTL's are capable of specific and rapid cytolysis of 
M tuberculosis-infected U937 target cells. Lysis of infected U937 cells was dependent on 
cell-to-cell contact and was mediated by the granule exocytosis pathway. Accordingly, the 
ability of the yf/ CTL clones to lyse infected targets was found to be Ca2+ -dependent, was 
significantly reduced in the presence of CsA (a specific inhibitor of granule exocytosis), and 
completely abrogated following de-granulation of the yf/ T cell effectors using Sr2+. Despite 
being strongly cytolytic against infected U93 7 cells, however, the yf/ CTL clones did not have 
any impact on the survival of intracellular M tuberculosis. 
Although the mycobacterial antigen-responsive yf/ CTL clones described in this study were 
shown to selectively lyse M tuberculosis-infected U937 but not cells pulsed with the 
streptococcal antigen SK-SD (Fig. 4.2), the ability of ylt T cells to mediate antigen-specific 
cytolysis is a contentious issue. Initial reports describing the responses of cytolytic yf/ T cells 
in tuberculosis showed that the lytic activity was restricted to target cells infected with M 
tuberculosis because cells similarly infected with group A streptococci or L. monocytogenes 
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were not sensitive to ye/ T cell-mediated cytolysis (Munk et al. , 1990). More recent studies 
have found, however, that the ye/ T cell response is directed against "infected" cells rather 
than specific pathogens. y'f/ T cells derived from herpes simplex virus (HSY)-stimulated 
PBMC were cytotoxic towards both HSY-infected target cells as well as cells infected with 
unrelated viruses (Bukowski et al. , 1994). Moreover, yf/ T cells have been shown to lyse 
cells infected with human immunodeficiency virus (Wallace et al. , 1996), HSY (Bukowski et 
al. , 1994), simian immunodeficiency virus (Malkovsky et al. , 1992a; Malkovsky, 1992b) and 
human herpes virus-6 (Lusso et al., 1995) without previous exposure to corresponding viral 
antigens. In light of this evidence, it has been postulated that yf/ T cells function early in viral 
and bacterial diseases as front line defenders to remove infected or otherwise stressed cells 
(Janeway et al., 1988) and that the antigens recognised are likely to be of cellular origin 
(Bukowski et al., 1994). yf/ T cells are therefore poised, as are macrophages, to recognise 
structures presented by both micro-organisms and stressed cells but not by normal cells 
(Tanaka et al., 1995; Porcelli et al. , 1996; Havran et al., 1994). 
The M tuberculosis-responsive yf/ T cell clones described in this chapter were found to be 
strongly cytolytic towards Daudi Burkitt's lymphoma cells (Fig. 4.2c) . This cross-responsive 
property of both mycobacterial antigen- and Daudi-derived yf/ T cells has been extensively 
described in earlier studies (Fisch et al. , 1990a; Fisch et al. , 1990b; De Libero et al. , 1991 ; 
Fisch et al., 1992; Davodeau et al., 1993). Interestingly, while it is well established that 
mycobacterial antigens and Daudi Burkitt's lymphoma cells are both potent stimulators of 
human yf/ T cells (Davodeau et al. , 1993; Bukowski et al. , 1995; Marx et al. , 1997), the 
stimulatory ligands within these antigen preparations have been found to differ. The major 
mycobacterial y'f/ T cell-stimulating ligands were found to be non-proteinaceous, low MW, 
phosphate-containing molecules (Constant et al., 1994; Tanaka et al., 1995; Schoel et al. , 
1994; Morita et al. , 1995), while the target antigens on the surface ofDaudi cells appear to be 
heat shock proteins (Kaur et al. , 1993). Although the ability of yf/ T cells to recognise 
structurally unrelated antigens seems to indicate that recognition must be TCR-independent, 
several studies have demonstrated the contrary (De Libero et al., 1991 ; Davodeau et al. , 1993; 
Tanaka et al. , 1994). 
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In order to examine the cytotoxic mechanism/s utilised by the M tuberculosis-primed y'f/ CTL 
clones described in this study, a series of key steps along the major cell death pathways were 
sequentially disrupted. yf:/ T cells have been shown to have the ability to mediate cytolysis by 
either granule exocytosis (Koizumi et al. , 1991 ; Nakata et al. , 1990; Gan and Malkovsky, 
1996; Zeine et al. , 1998) or Fas-FasL interaction (Nagata and Goldstein, 1995; Suda et al. , 
1995; Vincent et al. , 1996). This study found that cytolysis by the M tuberculosis-reactive y'f/ 
CTL clones against infected U937 target cells was exquisitely sensitive to EGTA, 
demonstrating that target cell lysis was strongly Ca
2+ -dependent. Ca2+ is not only essential for 
granule exocytosis but also for binding of perforin to target cell membranes (Ishiura et al., 
1990). By comparison, several reports have demonstrated that Fas-mediated apoptosis is 
Ca2+-independent (Odake et al., 1991 ; Esser et al. , 1996; Anel et al. , 1994; Lowin et al., 
1994; Rouvier et al. , 1993; Mori et al. , 1997). The ability of specific inhibitors of granule 
exocytosis, such as CsA, and de-granulation of the yf:/ CTL clones using Sr
2+ to abolish the 
cytolysis of infected U937 targets (Fig. 4.4) provided further evidence that the y'f/ CTL clones 
mediated cytolysis by the granule exocytosis pathway. More directly, because U937 do not 
express detectable levels of cell surface Fas (Zeine et al. , 1998), it is improbable that Fas-FasL 
interaction is involved in y'f:/ CTL-mediated cytolysis ofU937 target cells. 
Fashigh Jurkat cells have been widely used as susceptible targets for investigating Fas-FasL-
mediated cytolysis (Gan and Malkovsky, 1996; Mori et al., 1997). Despite their sensitivity to 
Fas-mediated cytolytic mechanisms, the present data (Fig. 4.5) and previous reports (Haeker 
and Wagner, 1994; Zeine et al. , 1998) have demonstrated that y'f/ CTL' s preferentially kill 
Jurkat targets by the granule exocytosis pathway and that cytolysis was strongly inhibited in 
the presence of even low concentrations of EGT A. These results suggest that yf/ T cells 
prefer the granule exocytosis pathway for mediating cytolysis even when presented with the 
opportunity to use a Fas-based mechanism. Similarly, CD8 T cells and NK cells have also 
been shown to preferentially utilise a Ca
2+-dependent pathway for cytolysis (Kagi et al., 1994; 
Lowen et al., 1994; Mori et al., 1997). 
Since yf/ T cells are capable of killing targets cells using either mechanism of cytolysis 
(granule exocytosis or Fas-FasL interaction), the relative contribution of each mechanism and 
the trigger dictating which mechanism is favoured has become the focus of several recent 
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studies (Haeker and Wagner, 1994; Gan and Malkovsky, 1996; Zeine et al., 1998). While 
some studies have demonstrated that y'f/ T cells are able to utilise both the Ca
2+ -dependent 
and the Fas-based pathways depending on the target cell being recognised (Haeker and 
Wagner, 1994; Vincent et al. , 1996), others have found that granule exocytosis or the 
perforin-based pathway was predominant (Zeine et al., 1998; Gan and Malkovsky, 1996). It 
is becoming apparent that intrinsic properties of the target cell may dictate whether cytolytic 
y'f:/ T cells utilise granule exocytosis, the Fas pathway or both pathways (Berke, 1991; Haeker 
and Wagner, 1994). The underlying mechanism that preferentially triggers one or the other 
pathway remains to be established. 
The significance of cytolytic T cells in the control of intracellular pathogens in vivo remains 
unclear. One possibility is that T cell mediated cytolysis facilitates the release of live bacteria 
from inefficiently activated macrophages, thereby allowing these bacilli to be taken up and 
killed by newly recruited and freshly activated macrophages (De Libero et al., 1988; 
Kaufmann, 1988). Until recently, the ability of T cell-mediated cytolysis to directly affect the 
viability of intracellular pathogens was considered highly controversial. Several studies have 
since demonstrated that cytolytic CD8+ T cells are able to restrict the intracellular growth of 
M tuberculosis by virtue of their ability to lyse infected target cells (Silva et al., 1996; Stenger 
et al., 1997; Stenger et al. , 1998). Stenger et al. (1997) found that CD8+ CTL's that induced 
target cell lysis by granule exocytosis were able to reduce intracellular bacterial survival but 
that similarly cytotoxic CD4-CD8- (double negative) T cells that lysed target cells by the 
interaction of Fas-FasL were not. The ability of these CD8+ CTL's to kill intracellular M 
tuberculosis was found to be dependent on the presence of a critical effector molecule, 
granulysin, within their cytolytic granules (Stenger et al., 1998). In contrast, Oddo et al. 
( 1998) described the ability of F asL-induced apoptosis to reduce the viability of intracellular 
M tuberculosis. Although this study artificially induced target cell lysis using soluble 
recombinant Fas ligand, it serves to demonstrate that this mechanism of cytolysis can also be 
directly linked with anti-mycobacterial activity. 
A similar mycobactericidal role for y'f/ T cells in mycobacterial infections was thus 
investigated. Although the y'f/ CTL clones investigated in the present study demonstrated a 
significant ability to lyse M tuberculosis-infected U93 7 target cells by granule exocytosis, they 
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failed to effect mycobacterial survival (Fig. 4.6). It is likely that some key differences exist in 
the complement of cytolytic molecules contained within the granules of the mycobacterial 
antigen-specific CD8+ CTL's described by Stenger et al. (1997, 1998) and the y'f/ CTL clones 
described in this Chapter. While it remains to be established whether granulysin is present 
within the cytotoxic granules of yf/ CTL's, this protein has been detected within cytotoxic 
granules of both CD8+ CTL's and NK cells (Jongstra et al. , 1987; Pena et al. , 1997). 
The present study brings us closer to understanding the exact physiological role of y'f/ T cells 
in tuberculosis. It demonstrates that y'f/ T cells are significantly expanded and strongly 
activated following exposure to mycobacterial antigens, that they demonstrate a striking 
propensity for killing M tuberculosis-infected cells, that they preferentially mediate cytolysis 
by the granule exocytosis pathway but that they fail to demonstrate any direct microbicidal 
effects of intracellular mycobacteria. It is plausible that the unique role of y'f:/ CTL's in 
tuberculosis stems from their ability, on the one hand, to become activated and produce 
significant amounts ofIFN-y and IL-2 very early following infection (Tsukaguchi et al., 1995); 
and, on the other hand, to facilitate the release of intracellular mycobacteria from inadequately 
primed "first line of defence" phagocytes, thereby allowing the invading bacilli to be taken up 
by more effectively activated and mycobactericidal macrophages. 
CHAPTERS 
CONCLUSIONS AND GENERAL DISCUSSION 
The aim of the research presented in this thesis was to examine the use of the human 
macrophage cell line U93 7 as an in vitro model for human macrophage function m 
mycobacterial infections. This involved evaluation of the ability of U937 cells to 
phagocytose M. tuberculosis, to control the intracellular replication of this organism, and 
present mycobacterial antigens to human HLA class I-matched CTLs. In this concluding 
chapter, I present my evaluation of the utility that this cell line may have in the study of 
mycobacterial infections. 
U9 3 7 as a model for human macrophage function in tuberculosis 
This study has demonstrated that, in many respects, the U937 cell line is useful for the study of a 
variety of different aspects of mycobacterial-macrophage interactions. Differentiation of U93 7 
cells using IFN-y, 1,25-(0H)2 vitamin 0 3, or PMA was shown to significantly enhance their 
ability to phagocytose M tuberculosis but failed to influence their ability to mount a 
subsequent respiratory burst response. Following infection, U937 cells were found to be 
highly permissive to the intracellular growth of both the virulent H37Rv strain of M 
tuberculosis and the attenuated vaccine strain of M bovis BCG. U937 cells have been 
shown to constitutively express high levels of cell surface HLA class I while producing 
undetectable levels of HLA class II both at the rnRNA level and at the cell surface. HLA 
class II expression was neither up-regulated following infection with M. tuberculosis nor 
inducible using IFN-y, 1,25-(0H)2 vitamin D3, PMA, GM-CSF or a combination of these 
agents. In contrast, chronic infection of U937 cells with virulent H37Rv M tuberculosis but 
not with BCG resulted in the cell surface expression of HLA class I being significantly up-
regulated. Taken together, these characteristics made U937 cells a very attractive model for 
further investigations into their ability to present mycobacterial antigens to human HLA class 
I-restricted CTLs. 
A comparison of the phenotypic and functional characteristics ofU937 cells with another human 
monocytic cell line THP-1 , human monocytes and macrophages revealed some interesting 
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maturational differences. THP-1 but not U937 cells could be induced to express cell surface 
HLA class II . CD 14 expression was more readily inducible on THP-1 cells compared with 
U937. U937 cells, on the other hand, expressed CD16 (Fey receptor) constitutively while 
THP-1 cells showed reduced expression of this antigen at the cell surface. Functionally, 
THP-1 cells, human monocytes and terminally differentiated macrophages were better able to 
I 
phagocytose M. tuberculosis than U937 cells. Following phagocytosis, however, U937 cells 
were more permissive to the intracellular growth of M tuberculosis than THP-1 cells. 
This represents the first study to thoroughly investigate and compare the phenotypic and 
functional characteristics and utility of U93 7 and THP-1 cells in the context of mycobacterial 
infection. Although distinct phenotypic and functional differences between U93 7 and THP-1 
cell lines have been identified in this study, the impact of these differences on later events in 
mycobacterial infection is an exciting area that still needs to be examined. Future 
experiments aimed at exploiting these differences would contribute significantly to 
understanding of the ways in which phenotypically distinct phagocytes initially interact with 
M. tuberculosis, how differing routes of mycobacterial entry influence subsequent 
intracellular processing, and the influence of disparate HLA expression on mycobacterial 
antigen presentation to human T cells. 
U93 7 as a mode/for HLA class I presentation of mycobacterial antigens 
The inability of U93 7 cells express HLA class II while expressing high levels of cell surface 
HLA class I, together with their ability to phagocytose M tuberculosis and support the 
intracellular growth of this pathogen made this particular monocytic cell line very attractive 
for further investigations into the presentation of mycobacterial antigens to HLA class I-
restricted CTLs. Results presented in this study demonstrated that M. tuberculosis-primed 
CTLs from HLA class I-matched donors lysed M. tuberculosis-infected U937 target cells in 
an antigen-specific manner and with a similar efficiency to autologous macrophage targets . 
This cytolytic activity was restricted to live organisms since only U937 cells infected with 
M. tuberculosis and BCG but not those pulsed with soluble PPD were lysed by the HLA 
class I-matched effector cells. Furthermore, M. tuberculosis-stimulated but HLA-
mismatched CTLs failed to lyse infected U937 cells in an antigen-specific manner. T cell 
subset fractionation of the HLA class I-matched M. tuberculosis-primed CTL population 
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and limiting dilution cloning demonstrated that the cytolytic activity was mediated by CD8+ 
cytolytic T cells and confirmed that CD4 + T cells showed no significant ability of lyse 
infected U937 target cells. Although M. tuberculosis-infected U937 targets shared only a 
single HLA class I haplotype match (either HLA-A3 or -B51) with the CTL donors, they 
were more rapidly and strongly lysed by cos+ CTLs than similarly infected autologous I 
macrophage targets. 
A panel of M. tuberculosis-reactive CD8+ CTL clones was generated which proliferated 
strongly in the presence of virulent M. tuberculosis and les-s vigorously to soluble PPD but 
demonstrated only low levels of cytolytic activity against M. tuberculosis-infected U937 
targets. Although there has been an isolated report of moderate mycobacterial antigen-
specific C08 .. cytolytic activity following conventional antigenic priming (Turner & 
Dockrell, 1996), the majority of published reports describing the cytolytic capacity of 
C08 .. T cells in mycobacterial infections have used sophisticated technology or defined in 
vitro culture conditions to demonstrate even low levels of cos+ CTL functional activity 
(Tan er al., 1997; Lalvani et al., 1998; Lewinshon et al., 1998; Monagneghpour et al., 
1998; Canaday et al., 1999). It seems likely that the low cytolytic capacity demonstrated 
by cos- CTLs in mycobacterial infections is the result of a number of ciosely related 
factors. It is recognized that 'cross-presentation' of exogenously-derived bacterial antigens 
by HLA class I molecules is relatively inefficient with only an estimated 10% of phagocytes 
being capable of this kind of presentation (Reis e Sousa & Germain, 1995; Harris et al., 
1995). Furthermore, it has been suggested that the standard 
51Cr release assay used to 
determine cytolytic activity is not sensitive enough to detect cells with low precursor 
frequencies (Lalvani er al., 1998). Unfortunately, and as a result of these limitations, many 
of the more recent studies have focused instead on the ability of M. tuberculosis-reactive 
C08 + T cells to produce cytokines or proliferate in response to stimulation with very 
defined mycobacterial peptides or antigens (Lalvani et al., 1998; Lewinsohn et al., 1998; 
Canaday et al., 1999). Although providing valuable insight into various other aspects of 
cog+ T cell function in mycobacterial infections, these studies have done little to further 
our understanding of classical HLA class I-restricted cos+ CTL lytic activity in 
tuberculosis. 
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The present study, using U93 7 as an in vitro model to directly investigate M tuberculosis-
reactive cos· T cell cytolytic activity, has provided not only an innovative but also a 
relatively simple and robust approach to a difficult problem. Furthermore, it is easily 
amenable to further development by the introduction of genes encoding other HLA class I 
molecules as well as co-stimulatory molecules. Future studies should be directed at more 
I 
intensive investigations into the conditions required to enhance CDS+ CTL lytic activity in 
response to M. tuberculosis stimulation. With the establishment of M tuberculosis-specific 
COS · T cells demonstrating greater lytic ability, this model could facilitate more defined 
evaluation of the mechanisms of HLA class I presentation of mycobacterial antigens to CDS+ 
CTL, investigations into the mechanism of cytolysis favoured by these cells, the effects of 
cytolysis on intracellular mycobacterial viability, and identification of mycobacterial epitopes 
responsible for priming cos· CTL. 
U93 7 provide a good indicator for yo CTL activity in mycobacterial infections 
This study further demonstrated that M tuberculosis-infected U937 were highly sensitive to 
mycobacterial antigen-specific cytolysis mediated by yf/ CTL. Mycobacterial-specific yf/ 
CTLs consistently showed stronger cytolytic activity against infected U937 target cells than 
cos· CTL but were not restricted to classical HLA class I or class II molecules. Although 
y8 · CTLs proved exceptionally difficult to maintain in long tenn in vitro culture, the 
establishment of a panel of strongly cytolytic human M tuberculosis-reactive y8+ CTL clones 
provided a unique opportunity to investigate more thoroughly the role of y8+ CTL lytic 
activity in human mycobacterial infections. This study found that cytolysis mediated by the 
y8· T cell clones was dependent on cell-to-cell contact and was mediated by the granule 
exocytosis/perforin pathway. Accordingly, the ability of the yf,+ CTL clones to lyse infected 
targets was found to be Ca2 • -dependent, was significantly reduced in the presence of 
cyclosporine A (a specific inhibitor of granule exocytosis), and completely abrogated 
following de-granulation of the y8+ T cell effectors using Sr2+. 
The significance of cytolytic T cells in the control of intracellular pathogens in vivo remains 
unclear. It has been suggested that T cell mediated cytolysis facilitates the release of live 
bacteria from infected but inadequately activated macrophages that have failed to either 
control or destroy their intracellular quarry (De Libero et al. , 1988; Kaufmann, 1988). This 
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in turn would allow these bacilli to be engulfed and killed by newly recruited and freshly 
activated macrophages. The ability of T cell-mediated cytolysis to directly effect the viability 
of intracellular pathogens was considered, until fairly recently, to be highly controversial. 
Several studies have since confirmed that non-classical CD1-restricted CD8+ CTLs are able 
to directly restrict the intracellular growth of M tuberculosis by virtue of their ,ability to lyse 
infected target cells (Stenger et al., 1997; Stenger et al., 1998). Stenger et al. (1997) found 
that CDS · CTLs that induced target cell lysis by granule exocytosis were able to reduce 
intracellular bacterial survival but that similarly cytotoxic co4·cos· (double negative) T 
cells that lysed target cells by the interaction of Fas-FasL were not. Granulysin, contained 
within the cytolytic granules of these CDS+ CTLs, was identified as the cytolytic molecule 
responsible for the mycobactericidal activity (Stenger et al., 1998). 
Despite being significantly expanded and strongly activated following exposure to 
mycobacterial antigens, demonstrating a striking propensity for killing M tuberculosis-
infected cells, and preferentially mediating cytolysis by the granule exocytosis pathway, the 
y'f/ CTL clones investigated in this study failed to exhibit any direct microbicidal effects on 
intracellular mycobacteria. It remains to be established whether granulysin is present within 
the cytotoxic granules of yt/ CTLs and this would obviously provide a future direction for 
this study. 
From the results presented in this study, however, it seems likely that the role of y&+ CTL' s in 
mycobacterial infections stems not from their ability to directly restrict mycobacterial growth 
but rather from their ability, on the one hand, to become activated very early following 
infection and produce significant amounts of IFN-y and IL-2 (Tsukaguchi et al., 1995) and, 
on the other hand, to facilitate the release of intracellular mycobacteria from inadequately 
primed " first line of defence" phagocytes, thereby allowing the invading bacilli to be taken 
up by more effectively activated and mycobactericidal macrophages. This study represents 
the first examination of the mechanism of cytolysis utilized by cytolytic y&+ T cells in 
mycobacterial infection and the first to investigate the effect of yo+ T cell-mediated cytolysis 
on intracellular survival. 
In conclusion, the present study has demonstrated that there is definite potential for the use of 
the human monocytic cell line U93 7 as an in vitro model for macrophage function in 
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mycobacterial infections. U937 cells engulfed M tuberculosis efficiently, clearly supported 
the intracellular growth of this organism, and presented M tuberculosis-derived antigens to 
HLA class I-matched cos· CTL more effectively than monocyte-derived macrophages. 
Furthermore, this study has demonstrated that this cell line provides a highly selective 
indicator for mycobacterial-specific yo· CTL cytolytic activity. 
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